27 - The role of gonadotropins and testosterone in the regulation of beta-amyloid metabolism  pp. 259-268

The role of gonadotropins and testosterone in the regulation of beta-amyloid metabolism

By Giuseppe Verdile and Ralph N. Martins

Chapter Abstract

Regulation of testosterone and luteinizing hormone (LH) is tightly linked, and following reproductive senescence, sex hormone reductions are coupled with elevated gonadotropin levels. This chapter focuses on the sex hormone, testosterone, and the gonadotropin, LH. It outlines the role of these hormones in regulating beta-amyloid (Aβ) metabolism and amyloid precursor protein (APP) processing and discusses their potential as targets for developing effective therapeutic agents for Alzheimer's disease (AD). Sex steroid production is under the control of complex feedback loops within the hypothalamic-pituitary-ovary/ gonadal axis that regulate the levels of the pituitary gonadotropins, follicle stimulating hormone (FSH), and LH, in turn controlling estrogen and testosterone levels. The relative contributions of LH and testosterone to AD remain a challenge to be overcome by further experimentation. Given the diverse actions of the reproductive hormones, combinational hormone therapy may prove to be more efficacious in the prevention of AD.


Keywords:

beta-amyloid metabolism; gonadotropins; amyloid precursor protein; testosterone; Alzheimer's disease; luteinizing hormone;

27

Reference Title: References

Reference Type: reference-list

Hersch AL , Stefanick ML , Stafford, RS . National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA. 2003;291:47–53.
The Women's Health Initiative Study Group . Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials. 1998; 19:61–109.
The PEPI Investigators . Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA. 1995;273:199–208.
Rossouw JE , Prentice RL , Manson KE , et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007;297:1465–77.
Writing Group for the Women's Health Initiative Investigators . Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321–33.
The Women's Health Initiative Steering Committee . Effects of conjugated equine estrogens in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004;291:1701–12.
Wassertheil-Smoller S , Hendrix SL , Limacher M , et al. Effect of estrogen plus progestin on stroke in postmenopausal women. JAMA. 2003;289:2673–84.
Shumaker SA , Reboussin BA , Espeland MA , et al. The Women's Health Initiative Memory Study: a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Control Clin Trials. 1998;19:604–21.
Teng EL , Chui HC . The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry. 1987;48:314–18.
Morris JC , Heyman A , Mohs RC , et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer disease. Neurology. 1989;39:1159–65.
Spitzer RL , Williams JB , Kroenke K , et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA. 1994;272:1749–56.
Burke WJ , Roccaforte WH , Wengel SP . The short form of the Geriatric Depression Scale: a comparison with the 30-item form. J Geriatr Psychiatry Neurol. 1991;4:173–8.
American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
Welsh KA , Butters N , Mohs RC , et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology. 1994;44:609–14.
Shumaker S , Legault C , Rapp S , et al. The effects of estrogen plus progestin on the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's Health Initiative Memory Study. JAMA. 2003;289:2651–62.
Ellis RJ , Jan K , Kawas C , et al. Diagnostic validity of the dementia questionnaire for Alzheimer disease. Arch Neurol. 1998;55:360–5.
Shumaker SA , Legault C , Kuller L , et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study. JAMA. 2004;291:2947–58.
Rapp SR , Espeland MA , Shumaker SA , et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;20:2663–72.
Espeland MA , Rapp SR , Shumaker SA , et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study. JAMA. 2004;291:2959–68.
Espeland MA , Robertson J , Albert M , et al. Benchmarks for designing two-stage studies using modified mini-mental state examinations: experience from the Women's Health Initiative Memory Study (WHIMS). Clin Trials. 2006;3:99–106.
Resnick SM , Coker LH , Maki PM , et al. The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline. Clin Trials. 2004;1:440–50.
Shock NW , Greulich RC , Andres R , et al. Normal human aging: the Baltimore Longitudinal Study of Aging. Washington, DC: US Government Printing Office, 1984.
Resnick SM , Maki PM , Rapp SR , et al. Effects of combination estrogen plus progestin hormone treatment on cognition and affect: the Women's Health Initiative Study of Cognitive Aging (WHISCA). J Clin Endocrinol Metabol. 2006;91:1802–11.
Pantoni L , Garcia JH . Pathogenesis of leukoaraiosis: a review. Stroke. 1997;28:652–9.
Moody DM , Bell MA , Challa VR . Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency: an anatomic study. AJNR Am J Neuroradiol. 1990;11:431–9.
Coker LH , Hogan PE , Bryan NR , et al. Postmenopausal hormone therapy and subclinical cerebrovascular disease: the WHIMS-MRI study. Neurology. 2009;72:125–34.
Resnick SM , Espeland MA , Jaramillo SA , et al. Effects of postmenopausal hormone therapy on regional brain volumes in older women: the Women's Health Initiative Magnetic Resonance Imaging Study (WHIMS-MRI). Neurology. 2009;72:135–42.
Shen D , Davatzikos C . HAMMER: hierarchical attribute matching mechanism for elastic registration. IEEE Trans Med Imaging. 2002;21:1421–39.
Jaramillo SA , Felton D , Andrews LA , et al. Enrollment in a brain magnetic resonance study: results from the Women's Health Initiative Memory Study Magnetic Resonance Imaging Study (WHIMS-MRI). Acad Radiol. 2007;14;603–12.
Elkins JS , Longstreth WT , Manolio TA , et al. Education and the cognitive decline associated with MRI-defined brain infarct. Neurology. 2006; 67:435–40.
Bland RC , Newman SC . Mild dementia or cognitive impairment: the Modified Mini-Mental State examination (3MS) as a screen for dementia. Can J Psychiatry. 2001;46:506–10.
Prentice RL , Langer R , Stefanick ML , et al. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial. Am J Epidemiol. 2005;162: 404–14.
Prentice RL , Langer RD , Stefanick MR , et al. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease. Am J Epidemiol. 2006;163:589–99.
Zhao L , Brinton RD . Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease. BMC Neurosciences. 2006;7:24.
Chen S , Nilsen J , Brinton RD . Dose and temporal pattern of estrogen exposure determines neuroprotective outcome in hippocampal neurons: therapeutic implications. Endocrinology. 2006;147: 5303–13.
Ravaglia G , Forti P , Maioli F , et al. Endogenous sex hormones as risk factors for dementia in elderly men and women. J Gerontol. 2007;62A:1035–41.
Dhandapani KM , Wade FM , Mahesh VB , Brann DW . Astrocyte-derived transforming growth factor-β mediates the neuroprotective effects of 17β-estradiol: involvement of nonclassical genomic signaling pathways. Endocrinology. 2005;146:2749–59.
Rozovsky I , Hoving S , Anderson SP , O'Callaghan J , Finch CE . Equine estrogens induce apolipoprotein E and glial fibrillary acidic protein in mixtures of glial cultures. Neurosci Lett. 2002;323(3):191–4.

Reference Title: References

Reference Type: reference-list

Shumaker SA , Legault C , Kuller L , et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA. 2004;291(24):2947–58.
Espeland MA , Rapp SR , Shumaker SA , et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA. 2004;291(24):2959–68.
Shumaker SA , Legault C , Rapp SR , et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289(20):2651–62.
Rapp SR , Espeland MA , Shumaker SA , et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289(20):2663–72.
Henderson VW , Paganini-Hill A , Miller BL , et al. Estrogen for Alzheimer's disease in women. Neurology. 2000;54:295–301.
Mulnard RA , Cotman CW , Kawas C , et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer's disease. JAMA. 2000;283:1007–15.
Wang PN , Liao SQ , Liu RS , et al. Effects of estrogen on cognition, mood, and cerebral blood flow in AD. Neurology. 2000;54:2061–6.
Barrett-Connor E , Grady D , Stefanick ML . The rise and fall of menopausal hormone therapy. Annu Rev Public Health. 2005;26:115–40.
Brinton RD . Impact of estrogen therapy on Alzheimer's disease: a fork in the road? CNS Drugs. 2004;18(7):405–22.
Sherwin BB . Estrogen and memory in women: how can we reconcile the findings? Horm Behav. 2005; 47(3):371–5.
Maki PM . Hormone therapy and risk for dementia: where do we go from here? Gynecol Endocrinol. 2004;19(6):354–9.
Resnick SM , Henderson VW . Hormone therapy and risk of Alzheimer disease: a critical time. JAMA. 2002;288(17):2170–2.
Hogervorst E . The short-lived effect of hormone therapy on cognitive function. In Rasgon NL , ed. The Effects of Estrogen on Brain Function. Baltimore, MD: John Hopkins Press, 2006, pp. 46–78.
Pinkerton JV , Henderson VW . Estrogen and cognition, with a focus on Alzheimer's disease. Semin Reprod Med. 2005;23(2):172–9.
Hogervorst E , Mendes-Ribeiro H , Molyneux A , Budge M , Smith AD . Serum homocysteine, cerebrovascular risk factors and white matter low attenuation on CT scans in patients with post-mortem confirmed Alzheimer's disease. Arch Neurology. 2002;59:787–93.
Hogervorst E , Williams J , Budge M , Riedel W , Jolles J . The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience. 2000;101:485–512.
Petitti DB , Buckwalter JG , Crooks VC , Chiu V . Prevalence of dementia in users of hormone replacement therapy as defined by prescription data. J Gerontol A Biol Sci Med Sci. 2002;57:M532–8.
Matthews KA , Kuller LH , Wing RR , Meilahn EN , Plantinga P . Prior to use of estrogen replacement therapy: are users healthier than nonusers? Am J Epidemiol. 1996;143(10):971–8.
Jacobs DM , Tang M-X , Stern Y , et al. Cognitive function in non-demented older women who took estrogen after menopause. Neurology. 1998;50(2):368–73.
Matthews K , Cauley J , Yaffe K , Zmuda J . Estrogen replacement therapy and cognitive decline in older community women. JAGS. 1999;47:518–23.
Launer LJ , Andersen K , Dewy ME , et al. Rates and risk factors for dementia and Alzheimer's disease. Neurology. 1999;1(52):78–84.
Henderson VW . Hormone therapy and Alzheimer's disease: benefit or harm? Expert Opin Pharmacother. 2004;5(2):389–406.
Gibbs R . Preclinical data relating to estrogen's effects on cognitive performance. In Rasgon NL , ed. The Effects of Estrogen on Brain Function. Baltimore, MD: John Hopkins Press, 2006, pp. 9–45.
Paganini-Hill A , Henderson VW . Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol. 1994;140:256–61.
Balderischi M , DiCarlo A , Lepore V , et al. Estrogen-replacement therapy and Alzheimer's disease in the Italian longitudinal study on aging. Neurology. 1998; 50:996–1002.
Kawas C , Resnick S , Morrison A , et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease. Neurology. 1996;48:1517–21.
Waring SC , Rocca WA , Peteresen RC , et al. Postmenopausal estrogen replacement therapy and risk of AD. Neurology. 1999;52(2):965–70.
McLay RN , Maki PM , Lyketsos CG . Nulliparity and late menopause are associated with decreased cognitive decline. J Neuropsychiatry Clin Neurosci. 2003;15(2):161–7.
Geerlings MI , Ruitenberg A , Witteman JC , et al. Reproductive period and risk of dementia in postmenopausal women. JAMA. 2001;285(11):1475–81.
Ayatollahi SM , Dowlatabadi E , Ayatollahi SA . Age at menarche in Iran. Ann Hum Biol. 2002;29(4):355–62.
Kato I , Toniolo P , Akhmedkhanov A , et al. Prospective study of factors influencing the onset of natural menopause. J Clin Epidemiol. 1998;51(12):1271–6.
Merchant C , Tang M-X , Albert S , et al. The influence of smoking on the risk of Alzheimer's disease. Neurology. 1999;52(7):1408–12.
Meek MD , Finch GL . Diluted mainstream cigarette smoke condensates activate estogen receptor and aryl hydrocarbon receptor-mediated gene transcription. Environ Res. 1999;80(1):9–17.
Brenner DE , Kukull WA , Stergachis A , et al. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population based case-control study. Am J Epidemiol. 1994;140:262–7.
Lerner A , Koss E , Debanne S , et al. Smoking and oestrogen replacement therapy as protective factors against AD. Lancet. 1997;349(Feb 8):403–4.
Hogervorst E , Smith AD . The interaction of serum folate and estradiol levels in Alzheimer's disease. Neuroendocrinol Lett. 2002;23:155–60.
Verghese J , Kuslansky G , Katz M , et al. Surgically menopausal women on estrogen have better cognitive performance. Neurology. 2000;54(Suppl 3):A210–A211.
Sherwin BB . Cognitive assessment for postmenopausal women and general assessment of their mental health. Psychopharmacol Bull. 1998;34(3):323–6.
Nappi RE , Sinforiani E , Mauri M , et al. Memory functioning at menopause: impact of age in ovariectomized women. Gynecol Obstet Invest. 1999;47:29–36.
File SE , Heard JE , Rymer J . Trough oestradiol levels associated with cognitive impairment in post-menopausal women after 10 years of oestradiol implants. Psychopharmacology (Berl). 2002;161(1):107–12.
Szklo M , Cerhan J , Diez-Roux AV , et al. Estrogen replacement therapy and cognitive functioning in the Artherosclerotic Risk In Communities (ARIC) study. Am J Epidemiol. 1996;144:1048–57.
Yaffe K , Sawaya G , Lieberburg I , Grady D . Estrogen therapy in postmenopausal women. JAMA. 1998; 279(9):688–95.
LeBlanc ES , Janowsky J , Chan BK , Nelson HD . Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA. 2001; 285(11):1489–99.
Rumelhart DE , Hinton G , Williams R . Learning internal representations by error propagation. In McClelland JL , Rumelhart DE and the PDP research group, ed. Parallel Distributed Processes: Explorations in the Microstructure of Cognition. Volume 2: Foundations. Cambridge, MA: Bradford Books/MIT Press, 1986.
French BM , Dawson MR , Dobbs AR . Classification and staging of dementia of the Alzheimer type: a comparison between neural networks and linear discriminant analysis. Arch Neurol. 1997;54:1001–9.
Shumaker SA , Reboussin BA , Espeland MA , et al. The Women's Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Control Clin Trials. 1998;19(6):604–21.
Women's Health Initiative Study Group . Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials. 1998;19:61–109.
Stefanick ML , Cochrane BB , Hsia J , et al. The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants. Ann Epidemiol. 2003;13(9 suppl):578–86.
Writing Group for the Women's Health Initiative Investigators . Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321–33.
The Women's Health Initiative Steering Committee . Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004;291:1701–12.
Anderson GL , Manson J , Wallace R , et al. Implementation of the Women's Health Initiative study design. Ann Epidemiol. 2003;13:S5–17.
Hayes J , Hunt JR , Hubbell FA , et al. The Women's Health Initiative recruitment methods and results. Ann Epidemiol. 2003;13:S18–77.
Teng EL , Chui H . The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry. 1987;48:314–18.
McDowell I , Kristjansson B , Hill GB , Herbert R . Community screening for dementia: the Mini Mental State Examination (MMSE) and Modified Mini Mental State Examination (3MS) compared. J Clin Epidemiol. 1997;50:377–83.
Bravo G , Herbert R . Age- and education-specific reference values for the Mini-Mental and Modified Mini-Mental State Examinations derived from a non-demented elderly population. Int J Geriatr Psychiatry. 1997;12:1008–18.
Petersen RC , Smith GE , Waring SG , et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303–8.
Yaffe K , Haan M , Byers A , Tangen C , Kuller L . Estrogen use, APOE, and cognitive decline. Neurology. 2000;54:1949–53.
Burkhardt MS , Foster JK , Laws SM , et al. Oestrogen replacement therapy may improve memory functioning in the absence of APOE epsilon4. J Alzheimer's Dis. 2004;6(3):221–8.
Tang MX , Jacobs D , Stern Y , et al. Effect of estrogen during the menopause on risk and age of onset of Alzheimer's disease. Lancet. 1996;348:429–32.
Steffens DC , Noron MC , Plassman BL , et al. Enhanced cognitive performance with estrogen use in nondemented community dwelling older women. JAGS. 1999;47:1171–5.
Slooter AJC , Bronzova J , Witteman JCM , van Broekhoven C , van Duijn C . Estrogen use and early onset Alzheimer's disease: a population based study. J Neurol Neurosurg Psychiatry. 1999;67(6): 779–81.
Zandi PP , Carlson MC , Plassman BL , et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County study. JAMA. 2002;288(17):2123–9.
Henderson VW , Benke KS , Green RC , Cupples LA , Farrer LA . Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. J Neurol Neurosurg Psychiatry. 2005;76:103–5.

Reference Title: References

Reference Type: reference-list

Shumaker SA , Legault C , Thal L , et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289:2651–62.
Shumaker SA , Legault C , Kuller L , et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study. JAMA. 2004;291:2947–58.
Rossouw JE , Anderson GL , Prentice RL , et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321–33.
Anderson GL , Limacher M , Assaf AR , et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004;291:1701–12.
Hulley S , Grady D , Bush T , et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA. 1998;280:605–13.
Henderson BE , Paganini-Hill A , Ross RK . Decreased mortality in users of estrogen replacement therapy. Arch Intern Med. 1991;151:75–78.
Whittle C , Corrada MM , Dick M , et al. Neuropsychological data in non-demented oldest-old: the 90+ Study. J Clin Exp Neuropsychol. 2006;29:290–9.
Kahle-Wrobleski K , Corrada MM , Li B , Kawas C . Sensitivity and specificity of the mini-mental state examination for identifying dementia in the oldest-old: the 90+ Study. J Am Geriatr Soc. 2007;55:284–9.
Paganini-Hill A , Corrada MM , Kawas CH . Increased longevity in older users of postmenopausal estrogen therapy: the Leisure World Cohort Study. Menopause. 2006;13:12–18.
Bush TL , Barrett-Connor E , Cowan LD , et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987;75:1102–9.
Criqui MH , Suarez L , Barrett-Connor E , et al. Postmenopausal estrogen use and mortality. Results from a prospective study in a defined, homogeneous community. Am J Epidemiol. 1988;128:606–14.
Hunt K , Vessey M , McPherson K . Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis. Br J Obstet Gynaecol. 1990;97:1080–6.
Sturgeon SR , Schairer C , Brinton LA , Pearson T , Hoover RN . Evidence of a healthy estrogen user survivor effect. Epidemiology. 1995;6:227–31.
Ettinger B , Friedman GD , Bush T , Quesenberry CP, Jr . Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol. 1996;87:6–12.
Rodriguez C , Calle EE , Patel AV , et al. Effect of body mass on the association between estrogen replacement therapy and mortality among elderly US women. Am J Epidemiol. 2001;153:145–52.
Hulley S , Furberg C , Barrett-Connor E , et al. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement Study follow-up (HERS II). JAMA. 2002;288:58–66.
Viscoli CM , Brass LM , Kernan WN , et al. A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med. 2001;345:1243–9.
Corrada M , Brookmeyer R , Berlau D , Paganini-Hill A , Kawas C . Prevalence of dementia after age 90: results from the 90+ Study. Neurology. 2008;71(5):337–43.
Henderson VW , Paganini-Hill A , Emanuel CK , Dunn ME , Buckwalter JG . Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neurol. 1994;51:896–900.
Lerner A , Koss E , Debanne S , et al. Smoking and oestrogen-replacement therapy as protective factors for Alzheimer's disease. Lancet. 1997;349:403–4.
Baldereschi M , Di Carlo A , Lepore V , et al. Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging. Neurology. 1998;50:996–1002.
Broe GA , Henderson AS , Creasey H , et al. A case-control study of Alzheimer's disease in Australia. Neurology. 1990;40:1698–707.
Mortel KF , Meyer JS . Lack of postmenopausal estrogen replacement therapy and the risk of dementia. J Neuropsychiatry Clin Neurosci. 1995;7:334–7.
Graves AB , White E , Koepsell TD , et al. A case-control study of Alzheimer's disease. Ann Neurol. 1990;28:766–74.
Brenner DE , Kukull WA , Stergachis A , et al. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am J Epidemiol. 1994;140:262–7.
Heyman A , Wilkinson W , Stafford J , et al. Alzheimer's disease: a study of epidemiological aspects. Ann Neurol. 1984;15:335–41.
Amaducci L , Fratiglioni L , Rocca WA , et al. Risk factors for clinically diagnosed Alzheimer's disease: a case-control study of an Italian population. Neurology. 1986;36:922–31.
Paganini-Hill A , Henderson VW . Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol. 1994;140:256–61.
Tang MX , Jacobs D , Stern Y , et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 1996;348:429–32.
Kawas C , Resnick S , Morrison A , et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology. 1997;48:1517–21.
Waring SC , Rocca WA , Petersen RC , et al. Postmenopausal estrogen replacement therapy and risk of AD: a population-based study. Neurology. 1999;52:965–70.
Zandi PP , Carlson MC , Plassman BL , et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County study. JAMA. 2002;288:2123–9.
Yaffe K , Sawaya G , Lieberburg I , Grady D . Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA. 1998;279:688–95.
Nelson HD , Humphrey LL , Nygren P , Teutsch SM , Allan JD . Postmenopausal hormone replacement therapy: scientific review. JAMA. 2002;288:872–81.

Reference Title: References

Reference Type: reference-list

Petersen RC , Doody R , Kurz A , et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58:1985–92.
Henderson VW . Hormone Therapy and the Brain: a Clinical Perspective on the Role of Estrogen. New York: Parthenon Publishing, 2000.
Burger HG . The endocrinology of the menopause. Maturitas. 1996;23:129–36.
Edwards DP . Regulation of signal transduction pathways by estrogen and progesterone. Annu Rev Physiol. 2005;67:335–76.
Behl C , Skutella T , Lezoualch F , et al. Neuroprotection against oxidative stress by estrogens: structure–activity relationship. Mol Pharmacol. 1997;51:535–41.
Shughrue PJ , Scrimo PJ , Merchenthaler I . Estrogen binding and estrogen receptor characterization (ERα and ERβ) in the cholinergic neurons of the rat basal forebrain. Neuroscience. 2000;96:41–9.
Luine V . Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol. 1985;89:484–90.
Maki PM , Resnick SM . Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol Aging. 2000;21:373–83.
Shaywitz SE , Shaywitz BA , Pugh KR , et al. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA. 1999;281:1197–202.
Joffe H , Hall JE , Gruber S , et al. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Menopause. 2006;13:411–22.
Petanceska SS , Nagy G , Frail D , Gandy S . Ovariectomy and 17β-estradiol modulate the levels of Alzheimer's amyloid β peptides in brain. Neurology. 2000;54:2212–17.
Zheng H , Xu H , Uljon SN , et al. Modulation of Aβ peptides by estrogen in mouse models. J Neurochem. 2002;80:191–6.
Alvarez-De-La-Rosa M , Silva I , Nilsen J , et al. Estradiol prevents neural tau hyperphosphorylation characteristic of Alzheimer's disease. Ann N Y Acad Sci. 2005;1052:210–24.
Carroll JC , Rosario ER , Chang L , et al. Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci. 2007;27:13357–65.
Stone DJ , Rozovsky I , Morgan TE , et al. Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro . Exp Neurol. 1997;143:313–18.
Farrer LA , Cupples LA , Haines JL , et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. JAMA. 1997;278:1349–56.
Gibbs RB . Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats. Neurobiol Aging. 2000;21:107–16.
Zandi PP , Carlson MC , Plassman BL , et al. Hormone replacement therapy and incidence of Alzheimer's disease on older women: the Cache County study. JAMA. 2002;288:2123–9.
Paganini-Hill A , Henderson VW . Estrogen replacement therapy and risk of Alzheimer's disease. Arch Intern Med. 1996;156:2213–17.
Tang M-X , Jacobs D , Stern Y , et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 1996;348:429–32.
Resnick SM , Henderson VW . Hormone therapy and risk of Alzheimer disease: a critical time. JAMA. 2002;288:2170–2.
Brinton RD . Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Ann N Y Acad Sci. 2005;1052:57–74.
Jezierski MK , Sohrabji F . Neurotrophin expression in the reproductively senescent forebrain is refractory to estrogen stimulation. Neurobiol Aging. 2001;22:309–19.
Leranth C , Roth RH , Elswoth JD , et al. Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson's disease and memory. J Neurosci. 2000;20:8604–9.
Silva I , Mello LEAM , Freymüller E , Haidar MA , Baracat EC . Onset of estrogen replacement has a critical effect on synaptic density of CA1 hippocampus in ovariectomized adult rats. Menopause. 2003;10:406–11.
Suzuki S , Brown CM , Dela Cruz CD , et al. Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions. Proc Natl Acad Sci USA. 2007;104:6013–18.
Savonenko AV , Markowska AL . The cognitive effects of ovariectomy and estrogen replacement are modulated by aging. Neuroscience. 2003;119:821–30.
Daniel JM , Hulst JL , Berbling JL . Estradiol replacement enhances working memory in middle-aged rats when initiated immediately after ovariectomy but not after a long-term period of ovarian hormone deprivation. Endocrinology. 2006;147:607–14.
Stampfer MJ . Cardiovascular disease and Alzheimer's disease: common links. J Intern Med. 2006;260:211–23.
Schneider JA , Arvanitakis Z , Bang W , Bennett DA . Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007;69:2197–204.
Herrington DM , Espeland MA , Crouse JR, 3rd , et al. Estrogen replacement and brachial artery flow-mediated vasodilation in older women. Arterioscler Thromb Vasc Biol. 2001;21:1955–61.
Hodis HN , Mack WJ , Lobo RA , et al. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2001;135:939–53.
Hodis HN , Mack WJ , Azen SP , et al. Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. N Engl J Med. 2003;349:535–45.
Clarkson TB . Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression. Menopause. 2007;14:373–84.
Umetani M , Domoto H , Gormley AK , et al. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat Med. 2007;13:1185–92.
Rossouw JE , Prentice RL , Manson JE , et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007;297:1465–77.
Sherwin BB , Tulandi T . “Add-back” estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J Clin Endocrinol Metab. 1996;81:2545–9.
Resnick SM , Maki PM , Golski S , Kraut MA , Zonderman AB . Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance. Horm Behav. 1998;34:171–82.
Hogervorst E , Williams J , Budge M , Riedel W , Jolles J . The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience. 2000;101:485–512.
LeBlanc ES , Janowsky J , Chan BKS , Nelson HD . Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA. 2001;285:1489–99.
Brett KM , Chong Y . Hormone Replacement Therapy: Knowledge and Use in the United States. Hyattsville, MD: National Center for Health Statistics, 2001.
Henderson VW , Paganini-Hill A , Miller BL , et al. Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology. 2000;54:295–301.
Mulnard RA , Cotman CW , Kawas C , et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. JAMA. 2000;283:1007–15.
Asthana S , Baker LD , Craft S , et al. High-dose estradiol improves cognition for women with AD: results of a randomized study. Neurology. 2001;57:605–12.
Shumaker SA , Legault C , Kuller L , et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study. JAMA. 2004;291:2947–58.
Rapp SR , Espeland MA , Shumaker SA , et al. The effect of estrogen with progestin treatment on global cognitive function in postmenopausal women: results from the Women's Health Initiative Memory Study. JAMA. 2003;289:2663–72.
Espeland MA , Rapp SR , Shumaker SA , et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study. JAMA. 2004;291:2959–68.
Henderson VW , Espeland MA , Hogan PE , et al. Prior use of hormone therapy and incident Alzheimer's disease in the Women's Health Initiative Memory Study. Neurology. 2007;68(suppl. 1):A205.
Henderson VW . Hormone therapy and Alzheimer's disease: benefit or harm? Expert Opin Pharmacother. 2004;5:389–406.
Henderson VW . Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research. Neuroscience. 2006;138:1031–9.
Matthews KA , Kuller LH , Wing RR , Meilahn EN , Plantinga P . Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol. 1996;143:971–8.
Henderson VW , Benke KS , Green RC , Cupples LA , Farrer LA . Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. J Neurol Neurosurg Psychiatry. 2005;76:103–5.
Brenner DE , Kukull WA , Stergachis A , et al. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am J Epidemiol. 1994;140:262–7.
Seshadri S , Zomberg GL , Derby LE , et al. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease. Arch Neurol. 2001;58:435–40.
Kang JH , Weuve J , Grodstein F . Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women. Neurology. 2004;63:101–7.
Carlson MC , Zandi PP , Plassman BL , et al. Hormone replacement therapy and reduced cognitive decline in older women: the Cache County study. Neurology. 2001;57:2210–16.
Henderson VW , Sherwin BB . Surgical versus natural menopause: cognitive issues. Menopause. 2007;14:572–9.
Resnick SM , Maki PM , Rapp SR , et al. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab. 2006;91:1802–10.
Grady D , Yaffe K , Kristof M , et al. Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/Progestin Replacement Study. Am J Med. 2002;113:543–8.
Viscoli CM , Brass LM , Kernan WN , et al. Estrogen therapy and risk of cognitive decline: results from the Women's Estrogen for Stroke Trial (WEST). Am J Obstet Gynecol. 2005;192:387–93.
Almeida OP , Lautenschlager NT , Vasikaran S , et al. 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life. Neurobiol Aging. 2006;27:141–9.
Yaffe K , Vittinghoff E , Ensrud KE , et al. Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life. Arch Neurol. 2006;63:945–50.
Xu J , Bartoces M , Neale AV , et al. Natural history of menopause symptoms in primary care patients: a MetroNet study. J Am Board Fam Pract. 2005;18:374–82.
Henderson VW , Dudley EC , Guthrie JR , Burger HG , Dennerstein L . Estrogen exposures and memory at midlife: a population-based study of women. Neurology. 2003;60:1369–71.
Herlitz A , Thilers P , Habib R . Endogenous estrogen is not associated with cognitive performance before, during, or after menopause. Menopause. 2007;14:425–31.
Luetters C , Huang MH , Seeman T , et al. Menopause transition stage and endogenous estradiol and follicle-stimulating hormone levels are not related to cognitive performance: cross-sectional results from the study of women's health across the nation (SWAN). J Women's Health. 2007;16:331–44.
Fuh J-L , Wang S-J , Lee S-J , Lu S-R , Juang K-D . A longitudinal study of cognition change during early menopausal transition in a rural community. Maturitas. 2006;53:447–53.
Kok HS , Kuh D , Cooper R , et al. Cognitive function across the life course and the menopausal transition in a British birth cohort. Menopause. 2006;13:19–27.
Maki PM , Gast MJ , Vieweg A , Burriss SW , Yaffe K . Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial. Neurology. 2007;69:1322–30.
Woods NF , Mitchell ES , Adams C . Memory functioning among midlife women: observations from the Seattle Midlife Women's Health Study. Menopause. 2000;7:257–65.
Shaywitz SE , Naftolin F , Zelterman D , et al. Better oral reading and short-term memory in midlife, postmenopausal women taking estrogen. Menopause. 2003;10:420–6.
Phillips SM , Sherwin BB . Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology. 1992;17:485–95.
Rocca WA , Bower JH , Ahlskog JE , et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology. 2007;69:1074–83.
MacLennan AH , Henderson VW , Paine BJ , et al. Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study. Menopause. 2006;13:28–36.
Bagger YZ , Tankó LB , Alexandersen P , Qin G , Christiansen C . Early postmenopausal hormone replacement therapy may prevent cognitive impairment later in life. Menopause. 2005;12:12–17.
Toran-Allerand CD . Estrogen as treatment for Alzheimer disease [letter]. JAMA. 2000;284:307–8.
Karim R , Hodis HN , Stanczyk FZ , Lobo RA , Mack WJ . Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women. J Clin Endocrinol Metab. 2008;93:131–8.
Kritz-Silverstein D , Barrett-Connor E . Hysterectomy, oophorectomy, and cognitive function in older women. J Am Geriatr Soc. 2002;50:55–61.

Reference Title: References

Reference Type: reference-list

Suzuki S , Brown CM , Wise PM . Mechanisms of neuroprotection by estrogen. Endocrine. 2006;29(2): 209–15.
Daniel JM . Effects of oestrogen on cognition: what have we learned from basic research? J Neuroendocrinol. 2006;18(10):787–95.
Gibbs R . Preclinical data relating to estrogen's effects on cognitive performance. In Rasgon NL , ed. The Effects of Estrogen on Brain Function. Baltimore, MD: Johns Hopkins Press, 2006, pp. 9–45.
Genazzani AR , Pluchino N , Luisi S , et al. Estrogen, cognition and female ageing. Hum Reprod Update. 2007;13(2):175–87.
Sherwin BB . Estrogen and cognitive aging in women. Neuroscience. 2006;138(3):1021–6.
Henderson VW . Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research. Neuroscience. 2006;138(3): 1031–9.
Shumaker SA , Legault C , Rapp SR , et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289(20):2651–62.
Shumaker SA , Legault C , Kuller L , et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study. JAMA. 2004;291(24):2947–58.
Gibbs RB , Gabor R . Estrogen and cognition: applying preclinical findings to clinical perspectives. J Neurosci Res. 2003;74:637–43.
Maki PM . Hormone therapy and cognitive function: is there a critical period for benefit? Neuroscience. 2006;138(3):1027–30.
Sherwin BB , Henry JF . Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review. Front Neuroendocrinol. 2008;29(1):88–113.
Dohanich GP . Gonadal steroids, learning and memory. In Pfaff DW , Arnold AP , Etgen AM , et al., eds. Hormones, Brain and Behavior. San Diego, CA: Academic Press, 2002, pp. 265–327.
Gibbs RB , Johnson DA . Sex specific effects of gonadectomy and hormone treatment on acquisition of a 12-arm radial maze task by Sprague-Dawley rats. Endocrinology. 2008;149(6):3176–83.
Bimonte HA , Denenberg VH . Estradiol facilitates performance as working memory load increases. Psychoneuroendocrinology. 1999;24(2):161–73.
Packard MG . Posttraining estrogen and memory modulation. Horm Behav. 1998;34(2):126–39.
Bimonte HA , Hyde LA , Hoplight BJ , et al. In two species, females exhibit superior working memory and inferior reference memory on the water radial-arm maze. Physiol Behav. 2000;70(3/4):311–17.
Luine VN , Jacome LF , Maclusky NJ . Rapid enhancement of visual and place memory by estrogens in rats. Endocrinology. 2003;144(7):2836–44.
Li C , Brake WG , Romeo RD , et al. Estrogen alters hippocampal dendritic spine shape and enhances synaptic protein immunoreactivity and spatial memory in female mice. Proc Natl Acad Sci USA. 2004;101(7):2185–90.
Fernandez SM , Lewis MC , Pechenino AS , et al. Estradiol-induced enhancement of object memory consolidation involves hippocampal extracellular signal-regulated kinase activation and membrane-bound estrogen receptors. J Neurosci. 2008;28(35):8660–7.
Jasnow AM , Schulkin J , Pfaff DW . Estrogen facilitates fear conditioning and increases corticotropin-releasing hormone mRNA expression in the central amygdala in female mice. Horm Behav. 2006;49(2):197–205.
Korol DL . Role of estrogen in balancing contributions from multiple memory systems. Neurobiol Learn Mem. 2004;82(3):309–23.
Fader AJ , Johnson PEM , Dohanich GP . Estrogen improves working but not reference memory and prevents amnestic effects of scopolamine on a radial-arm maze. Pharmacol Biochem Behav. 1999;62(4):711–17.
Gibbs RB , Johnson DA . Sex-specific effects of gonadectomy and hormone treatment on acquisition of a 12-arm radial maze task by Sprague-Dawley rats. Endocrinology. 2008;149(6):3176–83.
Chesler EJ , Juraska JM . Acute administration of estrogen and progesterone impairs the acquisition of the spatial Morris water maze in ovariectomized rats. Horm Behav. 2000;38(4):234–42.
Voytko ML . Estrogen and the cholinergic system modulate visuospatial attention in monkeys (Macaca fascicularis). Behav Neurosci. 2002;116(2):187–97.
Lacreuse A , Wilson ME , Herndon JG . Estradiol, but not raloxifene, improves aspects of spatial working memory in aged ovariectomized rhesus monkeys. Neurobiol Aging. 2002;23(4):589–600.
Lacreuse A , Chhabra RK , Hall MJ , et al. Executive function is less sensitive to estradiol than spatial memory: performance on an analog of the card sorting test in ovariectomized aged rhesus monkeys. Behav Processes. 2004;67(2):313–19.
Markham JA , Pych JC , Juraska JM . Ovarian hormone replacement to aged ovariectomized female rats benefits acquisition of the Morris water maze. Horm Behav. 2002;42(3):284–93.
Rapp PR , Morrison JH , Roberts JA . Cyclic estrogen replacement improves cognitive function in aged ovariectomized rhesus monkeys. J Neurosci. 2003;23(13):5708–14.
Gibbs RB . Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats. Neurobiol Aging. 2000;21:107–16.
Markowska AL , Savonenko AV . Effectiveness of estrogen replacement in restoration of cognitive function after long-term estrogen withdrawal in aging rats. J Neurosci. 2002;22(24):10985–95.
Daniel JM , Hulst JL , Berbling JL . Estradiol replacement enhances working memory in middle-aged rats when initiated immediately after ovariectomy but not after a long-term period of ovarian hormone deprivation. Endocrinology. 2006;147(1):607–14.
Talboom JS , Williams BJ , Baxley ER , et al. Higher levels of estradiol replacement correlate with better spatial memory in surgically menopausal young and middle-aged rats. Neurobiol Learn Mem. 2008;90(1):155–63.
Sherwin BB . The critical period hypothesis: can it explain discrepancies in the oestrogen-cognition literature? J Neuroendocrinol. 2007;19(2):77–81.
Zandi PP , Carlson MC , Plassman BL , et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County study. JAMA. 2002;288(17):2123–9.
Bagger YZ , Tanko LB , Alexandersen P , et al. Early postmenopausal hormone therapy may prevent cognitive impairment later in life. Menopause. 2005;12(1):12–17.
Henderson VW , Benke KS , Green RC , et al. Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. J Neurol Neurosurg Psychiatry. 2005;76(1):103–5.
Mesulam MM . The systems-level organization of cholinergic innervation in the human cerebral cortex and its alterations in Alzheimer's disease. Prog Brain Res. 1996;109:285–97.
Woolf NJ . Cholinergic systems in mammalian brain and spinal cord. Prog Neurobiol. 1991;37:475–524.
Baxter MG , Chiba AA . Cognitive functions of the basal forebrain. Curr Opin Neurobiol. 1999;9(2): 178–83.
Everitt BJ , Robbins TW . Central cholinergic systems and cognition. Annu Rev Psychol. 1997;48:649–84.
Linstow EV , Platt B . Biochemical dysfunction and memory loss: the case of Alzheimer's dementia. Cell Mol Life Sci. 1999;55:601–16.
Lanari A , Amenta F , Silvestrelli G , et al. Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease. Mech Ageing Dev. 2006;127(2):158–65.
Schliebs R , Arendt T . The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J Neural Transm. 2006;113(11): 1625–44.
Gibbs RB . Effects of estrogen on basal forebrain cholinergic neurons and cognition: implications for brain aging and dementia in women. In Morrison M , ed. Hormones, Aging, and Mental Disorders. Cambridge: Cambridge University Press, 2000, pp. 183–222.
Moore H , Stuckman S , Sarter M , et al. Potassium, but not atropine-stimulated cortical acetylcholine efflux, is reduced in aged rats. Neurobiol Aging. 1996;17(4): 565–71.
Quirion R , Wilson A , Rowe W , et al. Facilitation of acetylcholine release and cognitive performance by an M(2)-muscarinic receptor antagonist in aged memory-impaired. J Neurosci. 1995;15(2): 1455–62.
Bartus RT , Dean RL , Pontecorvo MJ , et al. The cholinergic hypothesis: a historical overview, current perspective, and future directions. Ann N Y Acad Sci. 1985;444:332–58.
Lleo A , Greenberg SM , Growdon JH . Current pharmacotherapy for Alzheimer's disease. Annu Rev Med. 2006;57:513–33.
Winkler J , Thal LJ , Gage FH , et al. Cholinergic strategies for Alzheimer's disease. J Mol Med. 1998;76(8):555–67.
Gibbs RB . Effects of gonadal hormone replacement on measures of basal forebrain cholinergic function. Neuroscience. 2000;101(4):931–8.
O'Malley CA , Hautamaki RD , Kelley M , et al. Effects of ovariectomy and estradiol benzoate on high affinity choline uptake, ACh synthesis, and release from rat cerebral cortical synaptosomes. Brain Research. 1987;403:389–92.
Marriott LK , Korol DL . Short-term estrogen treatment in ovariectomized rats augments hippocampal acetylcholine release during place learning. Neurobiol Learn Mem. 2003;80(3):315–22.
Gabor R , Nagle R , Johnson DA , et al. Estrogen enhances potassium-stimulated acetylcholine release in the rat hippocampus. Brain Research. 2003;962:244–7.
Kritzer MF , Kohama SG . Ovarian hormones differentially influence immunoreactivity for dopamine beta-hydroxylase, choline acetyltransferase, and serotonin in the dorsolateral prefrontal cortex of adult rhesus monkeys. J Comp Neurol. 1999;409(3):438–51.
Tinkler GP , Tobin JR , Voytko ML . Effects of two years of estrogen loss or replacement on nucleus basalis cholinergic neurons and cholinergic fibers to the dorsolateral prefrontal and inferior parietal cortex of monkeys. J Comp Neurol. 2004;469(4):507–21.
Fader AJ , Hendricson AW , Dohanich GP . Estrogen improves performance of reinforced T-maze alternation and prevents the amnestic effects of scopolamine administered systemically or intrahippocampally. Neurobiol Learn Mem. 1998;69(3):225–40.
Gibbs RB , Burke AM , Johnson DA . Estrogen replacement attenuates effects of scopolamine and lorazepam on memory acquisition and retention. Horm Behav. 1998;34:112–25.
Dumas J , Hancur-Bucci C , Naylor M , et al. Estrogen treatment effects on anticholinergic-induced cognitive dysfunction in normal postmenopausal women. Neuropsychopharmacology. 2006;31(9):2065–78.
Dumas J , Hancur-Bucci C , Naylor M , et al. Estradiol interacts with the cholinergic system to affect verbal memory in postmenopausal women: evidence for the critical period hypothesis. Horm Behav. 2008;53(1):159–69.
Gibbs RB . Estradiol enhances DMP acquisition via a mechanism not mediated by turning strategy but which requires intact basal forebrain cholinergic projections. Horm Behav. 2007;52(3):352–9.
Daniel JM , Hulst JL , Lee CD . Role of hippocampal M2 muscarinic receptors in the estrogen-induced enhancement of working memory. Neuroscience. 2005;132(1):57–64.
Gibbs RB . Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function. Exp Neurol. 1998;151:289–302.
Gibbs RB . Effects of aging, ovariectomy, and long-term hormone replacement on cholinergic neurons in the medial septum and nucleus basalis magnocellularis. J Neuroendocrinol. 2003;15:477–85.
Spencer JL , Waters EM , Romeo RD , et al. Uncovering the mechanisms of estrogen effects on hippocampal function. Front Neuroendocrinol. 2007;29(2):219–37.
Woolley CS . Acute effects of estrogen on neuronal physiology. Annu Rev Pharmacol Toxicol. 2007;47:657–80.
Rudick CN , Woolley CS . Estrogen regulates functional inhibition of hippocampal CA1 pyramidal cells in the adult female rat. J Neurosci. 2001;21(17): 6532–43.
Rudick CN , Gibbs RB , Woolley CS . A role for the basal forebrain cholinergic system in estrogen-induced disinhibition of hippocampal pyramidal cells. J Neurosci. 2003;23(11):4479–90.
Parducz A , Hajszan T , Maclusky NJ , et al. Synaptic remodeling induced by gonadal hormones: neuronal plasticity as a mediator of neuroendocrine and behavioral responses to steroids. Neuroscience. 2006;138(3):977–85.
McLaughlin KJ , Bimonte-Nelson H , Neisewander JL , et al. Assessment of estradiol influence on spatial tasks and hippocampal CA1 spines: evidence that the duration of hormone deprivation after ovariectomy compromises 17beta-estradiol effectiveness in altering CA1 spines. Horm Behav. 2008;54(3):386–95.
Lam TT , Leranth C . Role of the medial septum diagonal band of Broca cholinergic neurons in oestrogen-induced spine synapse formation on hippocampal CA1 pyramidal cells of female rats. Eur J Neurosci. 2003;17(10):1997–2005.
Daniel JM , Dohanich GP . Acetylcholine mediates the estrogen-induced increase in NMDA receptor binding in CA1 of the hippocampus and the associated improvement in working memory. J Neurosci. 2001;21(17):6949–56.
Wallace M , Luine V , Arellanos A , et al. Ovariectomized rats show decreased recognition memory and spine density in the hippocampus and prefrontal cortex. Brain Res. 2006;1126(1):176–82.
Wallace M , Frankfurt M , Arellanos A , et al. Impaired recognition memory and decreased prefrontal cortex spine density in aged female rats. Ann N Y Acad Sci. 2007;1097:54–7.
LeBlanc A . Estrogen and Alzheimer's disease. Curr Opin Investig Drugs. 2002;3(5):768–73.

Reference Title: References

Reference Type: reference-list

Brinton RD. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Ann N Y Acad Sci. 2005; 1052:57–74.
Morrison JH , Brinton RD , Schmidt PJ , Gore AC. Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women. J Neurosci. 2006; 26(41):10332–48.
Wise PM. Estrogen therapy: does it help or hurt the adult and aging brain? Insights derived from animal models. Neuroscience. 2006;138(3):831–5.
Singh M , Sumien N , Kyser C , Simpkins JW. Estrogens and progesterone as neuroprotectants: what animal models teach us. Front Biosci. 2008;13:1083–9.
Nilsen J , Brinton RD. Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology. 2002;143(1):205–12.
Zandi PP , Carlson MC , Plassman BL , et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County study. JAMA. 2002;288(17):2123–9.
Resnick SM , Henderson VW. Hormone therapy and risk of Alzheimer disease: a critical time. JAMA. 2002;288(17):2170–2.
Yaffe K. Hormone therapy and the brain: deja vu all over again? JAMA. 2003;289(20):2717–19.
Sohrabji F. Estrogen: a neuroprotective or proinflammatory hormone? Emerging evidence from reproductive aging models. Ann N Y Acad Sci. 2005;1052:75–90.
Chen S , Nilsen J , Brinton RD. Dose and temporal pattern of estrogen exposure determines neuroprotective outcome in hippocampal neurons: therapeutic implications. Endocrinology. 2006;147(11):5303–13.
Sherwin BB , Henry JF. Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review. Front Neuroendocrinol. 2008;29(1):88–113.
Shumaker SA , Legault C , Kuller L , et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study. JAMA. 2004;291(24):2947–58.
Shumaker SA , Legault C , Rapp SR , et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289(20):2651–62.
Sherwin BB. Estrogen and cognitive functioning in women. Endocr Rev. 2003;24(2):133–51.
Yaffe K , Sawaya G , Lieberburg I , Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA. 1998;279(9):688–95.
Petitti DB , Crooks VC , Chiu V , Buckwalter JG , Chui HC. Incidence of dementia in long-term hormone users. Am J Epidemiol. 2008;167(6):692–700.
Fillit H , Weinreb H , Cholst I , et al. Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type. Psychoneuroendocrinology. 1986;11(3):337–45.
Mulnard RA , Cotman CW , Kawas C , et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA. 2000;283(8):1007–15.
Henderson VW , Paganini-Hill A , Miller BL , et al. Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology. 2000;54(2):295–301.
Henderson VW , Hogan PE , Rapp SR , et al. Prior use of hormone therapy and incident Alzheimer's disease in the Women's Health Initiative Memory Study. Neurology. 2007;68(suppl.1):A205.
Shi J , Simpkins JW. 17 beta-estradiol modulation of glucose transporter 1 expression in blood-brain barrier. Am J Physiol. 1997;272(6 Pt 1):E1016–22.
Cheng CM , Cohen M , Wang J , Bondy CA. Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex. FASEB J. 2001;15(6):907–15.
Bishop J , Simpkins JW. Estradiol enhances brain glucose uptake in ovariectomized rats. Brain Res Bull. 1995;36(3):315–20.
Nilsen J , Brinton RD. Mechanism of estrogen-mediated neuroprotection: regulation of mitochondrial calcium and Bcl-2 expression. Proc Natl Acad Sci USA. 2003;100(5):2842–7.
Nilsen J , Brinton RD. Mitochondria as therapeutic targets of estrogen action in the central nervous system. Curr Drug Targets CNS Neurol Disord. 2004;3(4):297–313.
Simpkins JW , Wang J , Wang X , et al. Mitochondria play a central role in estrogen-induced neuroprotection. Curr Drug Targets CNS Neurol Disord. 2005;4(1):69–83.
Nilsen J , Chen S , Irwin RW , Iwamoto S , Brinton RD. Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function. BMC Neurosci. 2006;7:74.
Simpkins JW , Dykens JA. Mitochondrial mechanisms of estrogen neuroprotection. Brain Res Rev. 2008;57(2):421–30.
Kostanyan A , Nazaryan K. Rat brain glycolysis regulation by estradiol-17 beta. Biochim Biophys Acta. 1992;1133(3):301–6.
Mannella P , Brinton RD. Estrogen receptor protein interaction with phosphatidylinositol 3-kinase leads to activation of phosphorylated Akt and extracellular signal-regulated kinase 1/2 in the same population of cortical neurons: a unified mechanism of estrogen action. J Neurosci. 2006;26(37):9439–47.
Gottlob K , Majewski N , Kennedy S , et al. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev. 2001;15(11):1406–18.
Miyamoto S , Murphy AN , Brown JH. Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II. Cell Death Differ. 2008;15(3): 521–9.
Singh M. Ovarian hormones elicit phosphorylation of Akt and extracellular-signal regulated kinase in explants of the cerebral cortex. Endocrine Journal-UK. 2001;14(3):407–15.
Znamensky V , Akama KT , McEwen BS , Milner TA. Estrogen levels regulate the subcellular distribution of phosphorylated Akt in hippocampal CA1 dendrites. J Neurosci. 2003;23(6):2340–7.
Mendez P , Wandosell F , Garcia-Segura LM. Cross-talk between estrogen receptors and insulin-like growth factor-I receptor in the brain: cellular and molecular mechanisms. Front Neuroendocrinol. 2006;27(4):391–403.
Mendez P , Garcia-Segura LM. Phosphatidylinositol 3-kinase and glycogen synthase kinase 3 regulate estrogen receptor-mediated transcription in neuronal cells. Endocrinology. 2006;147(6):3027–39.
Cardona-Gomez GP , Mendez P , DonCarlos LL , Azcoitia I , Garcia-Segura LM. Interactions of estrogen and insulin-like growth factor-I in the brain: molecular mechanisms and functional implications. J Steroid Biochem Mol Biol. 2002;83(1/5):211–17.
Garcia-Segura LM , Cardona-Gomez GP , Chowen JA , Azcoitia I. Insulin-like growth factor-I receptors and estrogen receptors interact in the promotion of neuronal survival and neuroprotection. J Neurocytol. 2000;29(5/6):425–37.
Mendez P , Azcoitia I , Garcia-Segura LM. Estrogen receptor alpha forms estrogen-dependent multimolecular complexes with insulin-like growth factor receptor and phosphatidylinositol 3-kinase in the adult rat brain. Brain Res Mol Brain Res. 2003;112(1/2):170–6.
Carro E , Trejo JL , Gomez-Isla T , LeRoith D , Torres-Aleman I. Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat Med. 2002;8(12):1390–7.
Maki PM , Resnick SM. Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol Aging. 2000;21(2):373–83.
Rasgon NL , Silverman D , Siddarth P , et al. Estrogen use and brain metabolic change in postmenopausal women. Neurobiol Aging. 2005;26(2):229–35.
Liang WS , Reiman EM , Valla J , et al. Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc Natl Acad Sci USA. 2008;105(11):4441–6.
Nilsen J , Brinton RD. Mechanism of estrogen-mediated neuroprotection: regulation of mitochondrial calcium and Bcl-2 expression. Proc Natl Acad Sci USA. 2003;100(5):2842–7.
Brinton RD , Chen S , Montoya M , et al. The Women's Health Initiative estrogen replacement therapy is neurotrophic and neuroprotective. Neurobiol Aging. 2000;21(3):475–96.
Nilsen J , Irwin RW , Gallaher TK , Brinton RD. Estradiol in vivo regulation of brain mitochondrial proteome. J Neurosci. 2007;27(51):14069–77.
Holmquist L , Stuchbury G , Berbaum K , et al. Lipoic acid as a novel treatment for Alzheimer's disease and related dementias. Pharmacol Ther. 2007;113(1):154–64.
Bettini E , Maggi A. Estrogen induction of cytochrome c oxidase subunit III in rat hippocampus. J Neurochem. 1992;58(5):1923–9.
Stirone C , Duckles SP , Krause DN , Procaccio V. Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels. Mol Pharmacol. 2005;68(4):959–65.
Lin M , Beal M. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443(7113):787–95.
Bubber P , Haroutunian V , Fisch G , Blass JP , Gibson GE. Mitochondrial abnormalities in Alzheimer brain: mechanistic implications. Ann Neurol. 2005;57(5):695–703.
Moreira PI , Santos MS , Seica R , Oliveira CR. Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes. J Neurol Sci. 2007;257(1–2):206–14.
Cadenas E. Mitochondrial free radical production and cell signaling. Mol Aspects Med. 2004;25(1/2):17–26.
Yao J , Petanceska SS , Montine TJ , et al. Aging, gender and APOE isotype modulate metabolism of Alzheimer's A-beta peptides and F-isoprostanes in the absence of detectable amyloid deposits. J Neurochem. 2004;90(4):1011–18.
Borras C , Gambini J , Vina J. Mitochondrial oxidant generation is involved in determining why females live longer than males. Front Biosci. 2007;12:1008–13.
Vina J , Borras C , Gambini J , Sastre J , Pallardo FV. Why do females live longer than males? Importance of the upregulation of longevity-associated genes by oestrogenic compounds. FEBS Lett. 2005;579(12):2541–5.
Vina J , Sastre J , Pallardo FV , Gambini J , Borras C. Role of mitochondrial oxidative stress to explain the different longevity between genders: protective effect of estrogens. Free Radic Res. 2006;40(12):1359–65.
Duckles SP , Krause DN , Stirone C , Procaccio V. Estrogen and mitochondria: a new paradigm for vascular protection? Mol Interv. 2006;6(1):26–35.
Razmara A , Sunday L , Stirone C , et al. Mitochondrial effects of estrogen are mediated by ERα in brain endothelial cells. J Pharmacol Exp Ther. 2008;325(3):782–90.
Yang SH , Liu R , Perez EJ , et al. Mitochondrial localization of estrogen receptor beta. Proc Natl Acad Sci USA. 2004;101(12):4130–5.
Milner TA , Ayoola K , Drake CT , et al. Ultrastructural localization of estrogen receptor beta immunoreactivity in the rat hippocampal formation. J Comp Neurol. 2005;491(2):81–95.
Yager JD , Chen JQ. Mitochondrial estrogen receptors – new insights into specific functions. Trends Endocrinol Metab. 2007;18(3):89–91.
McEwen B , Akama K , Alves S , et al. Tracking the estrogen receptor in neurons: implications for estrogen-induced synapse formation. Proc Natl Acad Sci USA. 2001;98(13):7093–100.
Levin ER. Cell localization, physiology, and nongenomic actions of estrogen receptors. J Appl Physiol. 2001;91(4):1860–7.
Wu TW , Brinton RD. Estrogen membrane receptor imaging coupled with estradiol activation of intracellular calcium rise and ERK activation in single neurons. Society for Neuroscience Abstracts; 2004.
Zhao L , Chen S , Ming Wang J , Brinton RD. 17beta-estradiol induces Ca2+ influx, dendritic and nuclear Ca2+ rise and subsequent cyclic AMP response element-binding protein activation in hippocampal neurons: a potential initiation mechanism for estrogen neurotrophism. Neuroscience. 2005;132(2):299–311.
Wagner BK , Kitami T , Gilbert TJ , et al. Large-scale chemical dissection of mitochondrial function. Nat Biotechnol. 2008;26(3):343–51.
Milner TA , Lubbers LS , Alves SE , McEwen BS. Nuclear and extranuclear estrogen binding sites in the rat forebrain and autonomic medullary areas. Endocrinology. 2008;149(7):3306–12.
Milner TA , McEwen BS , Hayashi S , et al. Ultrastructural evidence that hippocampal alpha estrogen receptors are located at extranuclear sites. J Comp Neurol. 2001;429(3):355–71.
Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet. 2005;39:359–407.
Murphy AN , Fiskum G , Beal MF. Mitochondria in neurodegeneration: bioenergetic function in cell life and death. J Cereb Blood Flow Metab. 1999;19(3):231–45.
Mattson MP. Pathways towards and away from Alzheimer's disease. Nature. 2004;430(7000):631–9.
Melov S. Modeling mitochondrial function in aging neurons. Trends Neurosci. 2004;27(10):601–6.
Martins IJ , Hone E , Foster JK , et al. Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease. Mol Psychiatry. 2006;11(8):721–36.
Mosconi L , Sorbi S , de Leon MJ , et al. Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. J Nucl Med. 2006;47(11):1778–86.
Reiman EM , Chen K , Caselli RJ , et al. Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regions. Neuroimage. 2008;40(3):1214–21.
Mosconi L , Tsui WH , Herholz K , et al. Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nucl Med. 2008;49(3):390–8.
Blalock EM , Chen KC , Sharrow K et al. Gene microarrays in hippocampal aging: statistical profiling identifies novel processes correlated with cognitive impairment. J Neurosci. 2003;23(9):3807–19.
Blalock EM , Geddes JW , Chen KC , et al. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci USA. 2004;101(7):2173–8.
Reiman EM , Chen K , Alexander GE , et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci USA. 2004;101(1):284–9.
Rowe WB , Blalock EM , Chen KC , et al. Hippocampal expression analyses reveal selective association of immediate-early, neuroenergetic, and myelinogenic pathways with cognitive impairment in aged rats. J Neurosci. 2007;27(12):3098–110.
Miller JA , Oldham MC , Geschwind DH. A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging. J Neurosci. 2008;28(6):1410–20.
Alexander GE , Chen K , Pietrini P , Rapoport SI , Reiman EM. Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer's disease treatment studies. Am J Psychiatry. 2002;159(5):738–45.
Craft S. Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment. Curr Alzheimer Res. 2007;4(2):147–52.
Ishii K , Kitagaki H , Kono M , Mori E. Decreased medial temporal oxygen metabolism in Alzheimer's disease shown by PET. J Nucl Med. 1996;37(7):1159–65.
Magistretti PJ , Pellerin L. Cellular bases of brain energy metabolism and their relevance to functional brain imaging: evidence for a prominent role of astrocytes. Cereb Cortex. 1996;6(1):50–61.
Randle PJ. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev. 1998;14(4):263–83.
Ishii K , Minoshima S. PET is better than perfusion SPECT for early diagnosis of Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2005;32(12):1463–5.
Blass J , Sheu R , Gibson G. Inherent abnormalities in energy metabolism in Alzheimer disease. Interaction with cerebrovascular compromise. Ann N Y Acad Sci. 2000;903:204–21.
Hoyer S , Nitsch R , Oesterreich K. Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient early-onset cases. J Neural Transm Park Dis Dement Sect. 1991;3(1):1–14.
Toescu EC , Verkhratsky A , Landfield PW. Ca2+ regulation and gene expression in normal brain aging. Trends Neurosci. 2004;27(10):614–20.
Asthana S , Brinton RD , Henderson VW , et al. Frontiers Proposal. National Institute on Aging. Bench to Bedside: Estrogen as a Case Study. AGE. 2009; in press.

Reference Title: References

Reference Type: reference-list

Shumaker SA , et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289(20):2651–62.
Espeland MA , et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study. JAMA. 2004;291(24):2959–68.
Rapp SR , et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289(20):2663–72.
Shumaker SA , et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study. JAMA. 2004;291(24):2947–58.
Hogervorst E , et al. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience. 2000;101(3):485–512.
Fillit HM . The role of hormone replacement therapy in the prevention of Alzheimer disease. Arch Intern Med. 2002;162(17):1934–42.
Henderson VW , et al. Prior use of hormone therapy and incident Alzheimer's disease in the Women's Health Initiative Memory Study. In American Academy of Neurology Annual Meeting. Boston, MA, 2007.
Gleason CE , et al. Hormone effects on fMRI and cognitive measures of encoding: importance of hormone preparation. Neurology. 2006;67(11):2039–41.
Yonker JE , et al. Verified hormone therapy improves episodic memory performance in healthy postmenopausal women. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2006;13(3/4):291–307.
Zandi PP , et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County study. JAMA. 2002;288(17):2123–9.
Hu L , et al. Evaluation of neuroprotective effects of long-term low dose hormone replacement therapy on postmenopausal women brain hippocampus using magnetic resonance scanner. Chin Med Sci J. 2006;21(4):214–18.
Yue Y , et al. Effects of long-term, low-dose sex hormone replacement therapy on hippocampus and cognition of postmenopausal women of different apoE genotypes. Acta Pharmacol Sin. 2007;28(8):1129–35.
Manson JE , et al. Postmenopausal hormone therapy: new questions and the case for new clinical trials. Menopause. 2006;13(1):139–47.
Guay MP , et al. Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication. Pharmacoepidemiol Drug Saf. 2007;16(1):17–27.
Iadecola C . Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci. 2004;5(5):347–60.
de la Torre JC. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol. 2004;3(3):184–90.
Nagata K , et al. Hemodynamic aspects of Alzheimer's disease. Ann N Y Acad Sci. 2002;977:391–402.
Iadecola C , et al. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat Neurosci. 1999;2(2):157–61.
Girouard H , Iadecola C. Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease. J Appl Physiol. 2006;100(1):328–35.
Zhao L , Brinton RD. Estrogen receptor alpha and beta differentially regulate intracellular Ca(2+) dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons. Brain Res. 2007;1172:48–59.
Stirone C , et al. Estrogen receptor activation of phosphoinositide-3 kinase, akt, and nitric oxide signaling in cerebral blood vessels: rapid and long-term effects. Mol Pharmacol. 2005;67(1):105–13.
Chen DB , et al. Membrane estrogen receptor-dependent extracellular signal-regulated kinase pathway mediates acute activation of endothelial nitric oxide synthase by estrogen in uterine artery endothelial cells. Endocrinology. 2004;145(1):113–25.
Salom JB , et al. Relaxant effects of 17-beta-estradiol in cerebral arteries through Ca(2+) entry inhibition. J Cereb Blood Flow Metab. 2001;21(4):422–9.
Florian M , et al. Estrogen induced changes in Akt-dependent activation of endothelial nitric oxide synthase and vasodilation. Steroids. 2004;69(10):637–45.
Stirone C , Duckles SP , Krause DN . Multiple forms of estrogen receptor-alpha in cerebral blood vessels: regulation by estrogen. Am J Physiol Endocrinol Metab. 2003;284(1):E184–92.
Kublickiene K , et al. Small artery endothelial dysfunction in postmenopausal women: in vitro function, morphology, and modification by estrogen and selective estrogen receptor modulators. J Clin Endocrinol Metab. 2005;90(11):6113–22.
Ospina JA , Duckles SP , Krause DN . 17beta-estradiol decreases vascular tone in cerebral arteries by shifting COX-dependent vasoconstriction to vasodilation. Am J Physiol Heart Circ Physiol. 2003;285(1):H241–50.
Grohe C , et al. 17 Beta-estradiol regulates nNOS and eNOS activity in the hippocampus. Neuroreport. 2004;15(1):89–93.
Pelligrino DA , et al. Cerebral vasodilating capacity during forebrain ischemia: effects of chronic estrogen depletion and repletion and the role of neuronal nitric oxide synthase. Neuroreport. 1998;9(14):3285–91.
Chrissobolis S , et al. Evidence that estrogen suppresses rho-kinase function in the cerebral circulation in vivo. Stroke. 2004;35(9):2200–5.
Zhang F , et al. 17 beta-estradiol attenuates voltage-dependent Ca2+ currents in A7r5 vascular smooth muscle cell line. Am J Physiol. 1994;266(4 Pt 1):C975–80.
Nilsen J , et al. Estrogen protects neuronal cells from amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function. BMC Neurosci. 2006;7:74.
Stirone C , et al. Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels. Mol Pharmacol. 2005;68(4):959–65.
Ono H , et al. Cerebral thrombosis and microcirculation of the rat during the oestrous cycle and after ovariectomy. Clin Exp Pharmacol Physiol. 2002;29(1–2):73–8.
Sunday L , et al. Age alters cerebrovascular inflammation and effects of estrogen. Am J Physiol Heart Circ Physiol. 2007;292(5):H2333–40.
Sano M . Noncholinergic treatment options for Alzheimer's disease. J Clin Psychiatry. 2003;64 (Suppl 9):23–8.
Brinton RD. Impact of estrogen therapy on Alzheimer's disease: a fork in the road? CNS Drugs. 2004;18(7):405–22.
McEwen B. Estrogen actions throughout the brain. Recent Prog Horm Res. 2002;57:357–84.
McAsey ME , et al. Time course of response to estradiol replacement in ovariectomized mice: brain apolipoprotein E and synaptophysin transiently increase and glial fibrillary acidic protein is suppressed. Exp Neurol. 2006;197(1):197–205.
Thomas T , et al. Estrogen and raloxifene activities on amyloid-beta-induced inflammatory reaction. Microvasc Res. 2001;61(1):28–39.
Li R , et al. Estrogen enhances uptake of amyloid beta-protein by microglia derived from the human cortex. J Neurochem. 2000;75(4):1447–54.
Greenfield JP , et al. Estrogen lowers Alzheimer beta-amyloid generation by stimulating trans-Golgi network vesicle biogenesis. J Biol Chem. 2002;277(14):12128–36.
Hao J , et al. Estrogen increases the number of spinophilin-immunoreactive spines in the hippocampus of young and aged female rhesus monkeys. J Comp Neurol. 2003;465(4):540–50.
Tang Y , et al. Estrogen replacement increases spinophilin-immunoreactive spine number in the prefrontal cortex of female rhesus monkeys. Cereb Cortex. 2004;14(2):215–23.
Prokai L , et al. Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection. Proc Natl Acad Sci USA. 2003;100(20):11741–6.
Thibodeau PA , et al. In vitro pro- and antioxidant properties of estrogens. J Steroid Biochem Mol Biol. 2002;81(3):227–36.
Day M , Good M . Ovariectomy-induced disruption of long-term synaptic depression in the hippocampal CA1 region in vivo is attenuated with chronic estrogen replacement. Neurobiol Learn Mem. 2005;83(1):13–21.
Kim JS , et al. Enhancement of rat hippocampal long-term potentiation by 17 beta-estradiol involves mitogen-activated protein kinase-dependent and -independent components. Neurosci Lett. 2002;332(1):65–9.
El-Bakri NK , et al. Effects of estrogen and progesterone treatment on rat hippocampal NMDA receptors: relationship to Morris water maze performance. J Cell Mol Med. 2004;8(4):537–44.
Blum I , et al. The effect of estrogen replacement therapy on plasma serotonin and catecholamines of postmenopausal women. Isr J Med Sci. 1996;32(12):1158–62.
Tinkler GP , Voytko ML . Estrogen modulates cognitive and cholinergic processes in surgically menopausal monkeys. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(3):423–31.
Matsuda Y , Hirano H , Watanabe Y . Effects of estrogen on acetylcholine release in frontal cortex of female rats: involvement of serotonergic neuronal systems. Brain Res. 2002;937(1/2):58–65.
Daniel JM , Dohanich GP . Acetylcholine mediates the estrogen-induced increase in NMDA receptor binding in CA1 of the hippocampus and the associated improvement in working memory. J Neurosci. 2001;21(17):6949–56.
Gibbs RB. Basal forebrain cholinergic neurons are necessary for estrogen to enhance acquisition of a delayed matching-to-position T-maze task. Horm Behav. 2002;42(3):245–57.
Luine V , et al. Immunochemical demonstration of increased choline acetyltransferase concentration in rat preoptic area after estradiol administration. Brain Research. 1980;191:273–7.
Daniel JM , Hulst JL , Lee CD . Role of hippocampal M2 muscarinic receptors in the estrogen-induced enhancement of working memory. Neuroscience. 2005;132(1):57–64.
Sawada H , Shimohama S . Neuroprotective effects of estradiol in mesencephalic dopaminergic neurons. Neurosci Biobehav Rev. 2000;24(1):143–7.
Kim YJ , et al. Nongenomic inhibition of catecholamine secretion by 17beta-estradiol in PC12 cells. J Neurochem. 2000;74(6):2490–6.
Nilsen J , Brinton RD . Mechanism of estrogen-mediated neuroprotection: regulation of mitochondrial calcium and Bcl-2 expression. Proc Natl Acad Sci USA. 2003;100(5):2842–7.
Guerra B , et al. Plasma membrane oestrogen receptor mediates neuroprotection against beta-amyloid toxicity through activation of Raf-1/MEK/ERK cascade in septal-derived cholinergic SN56 cells. J Neurochem. 2004;91(1):99–109.
Zhao L , Wu TW , Brinton RD . Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain Res. 2004;1010(1/2):22–34.
Toran-Allerand CD . Estrogen and the brain: beyond ER-alpha and ER-beta. Exp Gerontol. 2004;39(11–12): 1579–86.
Dubal DB , et al. Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J Neurosci. 1999;19(15):6385–93.
Rozovsky I , et al. Equine estrogens induce apolipoprotein E and glial fibrillary acidic protein in mixed glial cultures. Neurosci Lett. 2002;323(3):191–4.
Jezierski MK , Sohrabji F . Estrogen enhances retrograde transport of brain-derived neurotrophic factor in the rodent forebrain. Endocrinology. 2003;144(11):5022–9.
Sakamoto H , et al. Dendritic growth and spine formation in response to estrogen in the developing Purkinje cell. Endocrinology. 2003;144(10):4466–77.
Rune GM , et al. Estrogen up-regulates estrogen receptor alpha and synaptophysin in slice cultures of rat hippocampus. Neuroscience. 2002;113(1):167–75.
Giltay EJ , et al. Oral and transdermal estrogens both lower plasma total homocysteine in male-to-female transsexuals. Atherosclerosis. 2003;168(1):139–46.
Cetinkaya MB , et al. Tibolone versus four estrogen replacement therapy protocols and plasma lipid levels in postmenopausal women. Int J Gynaecol Obstet. 2002;79(1):17–23.
Gruber C , et al. Production and actions of estrogens. N Engl J Med. 2002;346:340–52.
Kuiper GGJM , et al. Comparison of the ligand binding specificity and transcription tissue distribution of estrogen receptors alpha and beta. Endocrinology. 1997;138(3):863–70.
Miro F , et al. Relationship between follicle-stimulating hormone levels at the beginning of the human menstrual cycle, length of the follicular phase and excreted estrogens: the FREEDOM study. J Clin Endocrinol Metab. 2004;89(7):3270–5.
Michaud DS , et al. Reproducibility of plasma and urinary sex hormone levels in premenopausal women over a one-year period. Cancer Epidemiol Biomarkers Prev. 1999;8(12):1059–64.
Romani W , et al. The correlations between estradiol, estrone, estriol, progesterone, and sex hormone-binding globulin and anterior cruciate ligament stiffness in healthy, active females. J Womens Health (Larchmt). 2003;12(3):287–98.
Hankinson SE , et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 1998;90(17):1292–9.
Rannevik G , et al. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas. 1995;21(2):103–13.
Jellinck PH , Lee SJ , McEwen BS . Metabolism of dehydroepiandrosterone by rat hippocampal cells in culture: possible role of aromatization and 7-hydroxylation in neuroprotection. J Steroid Biochem Mol Biol. 2001;78(4):313–7.
Bhavnani BR . Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's. J Steroid Biochem Mol Biol. 2003;85(2–5):473–82.
Scarabin P , et al. Differential association of oral and transdermal oestrogen replacement therapy with venous thromboembolism risk. Lancet. 2003; 362:428–32.
Shifren JL , et al. A comparison of the short-term effects of oral conjugated equine estrogens versus transdermal estradiol on C-reactive protein, other serum markers of inflammation and other hepatic proteins in naturally menopausal women. J Clin Endocrinol Metab. 2008;93(5):1702–10.
Coelingh Bennink HJ. Are all estrogens the same? Maturitas. 2004;47(4):269–75.
Koh KK , et al. Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women. Circulation. 1999;99(3):354–60.
Nachtigall LE , et al. Serum estradiol-binding profiles in postmenopausal women undergoing three common estrogen replacement therapies: associations with sex hormone-binding globulin, estradiol, and estrone levels. Menopause. 2000;7(4):243–50.
Schindler AE . Climacteric symptoms and hormones. Gynecol Endocrinol. 2006;22(3):151–4.
Girdler SS , et al. Transdermal versus oral estrogen therapy in postmenopausal smokers: hemodynamic and endothelial effects. Obstet Gynecol. 2004;103(1):169–80.
Vigna GB , et al. Simvastatin, transdermal patch, and oral estrogen-progestogen preparation in early-postmenopausal hypercholesterolemic women: a randomized, placebo-controlled clinical trial. Metabolism. 2002;51(11):1463–70.
de Kraker AT , et al. The effects of 17 beta-oestradiol plus dydrogesterone compared with conjugated equine oestrogens plus medroxyprogesterone acetate on lipids, apolipoproteins and lipoprotein (a). Maturitas. 2004;49(3):253–63.
Rauramo L , Punnonen R , Gronroos M . Serum concentrations of oestrone, oestradiol and oestriol during various oestrogen treatments. Maturitas. 1981;3(2):183–6.
Gleason CE , et al. Clinical pharmacology and differential cognitive efficacy of estrogen preparations. Ann N Y Acad Sci. 2005;1052:93–115.
Deecher DC , et al. Characterization of a membrane-associated estrogen receptor in a rat hypothalamic cell line (D12). Endocrine. 2003;22(3):211–23.
Modena MG , et al. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits. Maturitas. 2005;52(1):1–10.
Garza-Meilandt A , Cantu RE , Claiborne BJ . Estradiol's effects on learning and neuronal morphology vary with route of administration. Behav Neurosci. 2006;120(4):905–16.
Akwa Y , et al. Neurosteroid metabolism. 7 Alpha-hydroxylation of dehydroepiandrosterone and pregnenolone by rat brain microsomes. Biochem J. 1992;288(Pt 3):959–64.
Skouby SO , et al. A comparative study of the effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on blood coagulability. Hum Reprod. 2007;22(4):1186–91.
Scarabin PY , et al. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial. Arterioscler Thromb Vasc Biol. 1997;17(11):3071–8.
Decensi A , et al. Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women. Circulation. 2002;106(10):1224–8.
Lethaby A , et al. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding. Cochrane Database Syst Rev. 2004;(3):CD000402.
Paganini-Hill A , Dworsky R , Krauss RM . Hormone replacement therapy, hormone levels, and lipoprotein cholesterol concentrations in elderly women. Am J Obstet Gynecol. 1996;174(3):897–902.
Soderpalm AH , et al. Administration of progesterone produces mild sedative-like effects in men and women. Psychoneuroendocrinology. 2004;29(3):339–54.
Freeman EW , et al. A placebo-controlled study of effects of oral progesterone on performance and mood. Br J Clin Pharmacol. 1992;33(3):293–8.
Rice MM , et al. Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women: the Kame Project. Arch Intern Med. 2000;160(11): 1641–9.
McEwen B , Woolley C . Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain. Exp Gerontol. 1994;29:431–6.
Woolley CS . Estrogen-mediated structural and functional synaptic plasticity in the female rat hippocampus. Horm Behav. 1998;34(2):140–8.
Nilsen J , Brinton RD . Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology. 2002;143(1):205–12.
de Lignieres B. Oral micronized progesterone. Clin Ther. 1999;21(1):41–60; discussion 1–2.
Thal LJ , et al. Estrogen levels do not correlate with improvement in cognition. Arch Neurol. 2003;60(2):209–12.
Asthana S , et al. Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study. Psychoneuroendocrinology. 1999;24(6):657–77.
Asthana S , et al. High-dose estradiol improves cognition for women with AD: results of a randomized study. Neurology. 2001;57(4):605–12.
Harman SM , et al. KEEPS: the Kronos Early Estrogen Prevention Study. Climacteric. 2005;8(1):3–12.
Resnick SM , et al. The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline. Clin Trials. 2004;1(5):440–50.
Wilson JR , et al. Cognitive abilities: use of family data as a control to assess sex and age differences in two ethnic groups. Int J Aging Hum Dev. 1975;6(3):261–76.
Bravo G , Hebert R . Age- and education-specific reference values for the Mini-Mental and modified Mini-Mental State Examinations derived from a non-demented elderly population. Int J Geriatr Psychiatry. 1997;12(10):1008–18.
Delis DC , et al. California Verbal Learning Test-II, 2nd edn. San Antonio, TX: The Psychological Corporation, 2000.
Kluger A , et al. Neuropsychological prediction of decline to dementia in nondemented elderly. J Geriatr Psychiatry Neurol. 1999;12(4):168–79.
Benton A , et al. Contributions to Neuropsychological Assessment. New York: Oxford University Press, 1983.
Spreen O , Strauss E . A Compendium of Neuropsychological Tests, 2nd edn. New York: Oxford University Press, 1998.
Golden C. The Stroop Color and Word Test: A Manual for Clinical and Experimental Uses. Chicago: Stoetling, 1978.
Wechsler D. Wechsler Memory Scales. 3rd edn. San Antonio, TX: The Psychological Corporation, 1997.
Wechsler D. WAIS-R Wechsler Adult Intelligence Scale-III, 3rd ed. New York, NY: Psychological Corporation, 1991. 4 puzzles (object assembly), 9 plastic cubes (block design), 2 spiral booklets, 1 object assembly layout shield, 1 digit symbol scoring stencil, 1 supplementary sheet, 1 word list, 25 record forms, 1 manual.
Hogervorst E , Bandelow S . Hogervorst–Bandelow Cognitive Test Battery (HBC Test). Unpublished manual, 2003.
McNair DM , Lorr M , Droppleman LF . POMS Manual. San Diego, CA: EdITS, 1981.
Beck AT , et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.
Spitzer RL , et al. Validity and utility of the PRIME-MD patient health questionnaire in assessment of 3000 obstetric-gynecologic patients: the PRIME-MD Patient Health Questionnaire Obstetrics-Gynecology Study. Am J Obstet Gynecol. 2000;183(3):759–69.
Gilewski MJ , Zelinski EM , Schaie KW . The Memory Functioning Questionnaire for assessment of memory complaints in adulthood and old age. Psychol Aging. 1990;5(4):482–90.
Resnick SM , et al. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab. 2006;91(5):1802–10.
Hickey M , Davis SR , Sturdee DW . Treatment of menopausal symptoms: what shall we do now? Lancet. 2005;366(9483):409–21.

Reference Title: References

Reference Type: reference-list

Rossouw JE , Anderson GL , Prentice RL , et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321–33.
Shumaker SA , Legault C , Kuller L , et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study. JAMA. 2004;291:2947–58.
Resnick SM , Maki PM , Rapp SR , et al. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab. 2006;91:1802–10.
Gleason CE , Carlsson CM , Johnson S , Atwood C , Asthana S. Clinical pharmacology and differential cognitive efficacy of estrogen preparations. Ann N Y Acad Sci. 2005;1052:93–115.
Shughrue PJ , Merchenthaler I. Estrogen is more than just a ‘sex hormone’: novel sites for estrogen action in the hippocampus and cerebral cortex. Front Neuroendocrinol. 2000;21:95–101.
Shughrue PJ , Merchenthaler I. Distribution of estrogen receptor beta immunoreactivity in the rat central nervous system. J Comp Neuro. 2001;436:64–81.
Bhavnani BR . Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's. J Steroid Biochem Mol Biol. 2003;85:473–82.
Kuiper GGJM , Carlsson BO , Grandien K , et al. Comparison of the ligand binding specificity and transcription tissue distribution of estrogen receptors alpha and beta. Endocrinology. 1997;138:863–70.
Deecher DC , Swiggard P , Frail DE , et al. Characterization of a membrane associated estrogen receptor in a rat hypothalamic cell line (D12). Endocrine. 2003;22:211–23.
Yaffe K. Hormone therapy and the brain: deja vu all over again. JAMA. 2003;289:2717–19.
Hogervorst E , Williams J , Budge M , et al. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience. 2000;101(3):485–512.
Cunningham C , Synncot M , Rowan M , et al. Oestrogen levels in demented and nondemented postmenopausal women. UK Dementia Research Group, Annual Meeting, University of Leicester, Gilbert Murray Hall, Leicester, 1994, pp. 5–6.
Yue X , Lu M , Lancaster T , et al. Brain estrogen deficiency accelerates A-beta plaque formation in an Alzheimer's disease animal model. Proc Natl Acad Sci. 2005;102:19198–203.
McEwen B , Alves S , Bulloch K , et al. Ovarian steroids and the brain: implications for cognition and aging. Neurology. 1997;48(7):S8–S15.
Yaffe K , Sawaya G , Lieberburg I , et al. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. J Am Med Assoc. 1998;279:688–95.
Fillit H , Weiner H , Cholst I , et al. Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type. Psychoneuroendocrinology. 1986;11:337–45.
Honjo H , Ogino Y , Naitoh K , et al. In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer's type). J Steroid Biochem. 1989;34:521–5.
Ohkura T , Isse K , Akazawa K , et al. Low-dose estrogen replacement therapy for Alzheimer disease in women. Menopause. 1994;1:125–30.
Ohkura T , Isse K , Akazawa K , et al. Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocr J. 1994;41:361–71.
Ohkura T , Isse K , Akazawa K , et al. Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type: 7 case reports. Dementia. 1995;6:99–107.
Henderson VW , Watt L , Buckwalter JG. Cognitive skills associated with estrogen replacement in women with Alzheimer's disease. Psychoneuroendocrinology. 1996;21(4):421–30.
Hu L , Yue Y , Zuo PP , et al. Evaluation of neuroprotective effects of long-term low dose hormone replacement therapy on postmenopausal women brain hippocampus using magnetic resonance scanner. Chin Med Sci J. 2006;21:214–18.
Yue Y , Hu L , Tian QJ , et al. Effects of long-term, low-dose sex hormone replacement therapy on hippocampus and cognition of postmenopausal women of different apoE genotypes. Acta Pharmacologica Sinica. 2007;28:1129–35.
Asthana S , Baker LD , Craft S , et al. Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study. Psychoneuroendocrinology. 1999;24:657–77.
Asthana S , Baker LD , Craft S , et al. High-dose estradiol improves cognition for women with AD: results of a randomized study. Neurology. 2001;57:605–12.
Honjo H , Ogino Y , Tanaka K , et al. An effect of conjugated estrogen to cognitive impairment in women with senile dementia-Alzheimer's type: a placebo-controlled, double-blind study. J Jap Menop Soc. 1993;1:167–71.
Hogervorst E. The short-lived effect of hormone therapy on cognition function. In Rasgon NL , ed. The Effects of Estrogen on Brain Function. Baltimore, MD: John Hopkins Press, 2006, pp. 46–79.
Wang P , Liao S , Liu R , et al. Effects of estrogen on cognition, mood, and cerebral blood flow in AD. Neurology. 2000;54:2061–6.
Henderson VW , Paganini-Hill A , Miller BL , et al. Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology. 2000;54:295–301.
Mulnard RA , Cotman CW , Kawas C , et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA. 2000;283:1007–15.
Hogervorst E. The short-lived effect of HRT on cognition function. In N Rasgon. Estrogen's effects on brain function. What's next? The AlzGene Database. Alzheimer Research Forum. Available at: http://www.alzgene.org. Accessed 2006.
Brookmeyer R , Gray S , Kawas C . Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health. 1998;88:1337–42.
Morrison JH , Brinton RD , Schmidt PJ , et al. Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women. Neuroscience. 2006;26(41):10332–48.

Reference Title: References

Reference Type: reference-list

McDonnell DP , Norris JD . Connections and regulation of the human estrogen receptor. Science. 2002;296:1642–4.
Chen DB , Bird IM , Zheng J , et al. Membrane estrogen receptor-dependent extracellular signal-regulated kinase pathway mediates acute activation of endothelial nitric oxide synthase by estrogen in uterine artery endothelial cells. Endocrinology. 2004;145:113–25.
Haas E , Meyer MR , Schurr U , et al. Differential effects of 17beta-estradiol on function and expression of estrogen receptor alpha, estrogen receptor beta, and GPR30 in arteries and veins of patients with atherosclerosis. Hypertension. 2007;49:1358–63.
Girdler SS , Hinderliter AL , Wells EC , et al. Transdermal versus oral estrogen therapy in postmenopausal smokers: hemodynamic and endothelial effects. Obstet Gynecol. 2004;103:169–80.
Ashraf MS , Vongpatanasin W . Estrogen and hypertension. Curr Hypertens Rep. 2006;8:368–76.
Albertsson PA , Emanuelsson H , Milsom I . Beneficial effect of treatment with transdermal estradiol-17-beta on exercise-induced angina and ST segment depression in syndrome X. Int J Cardiol. 1996;54:13–20.
Scarabin PY , Alhenc-Gelas M , Plu-Bureau G , et al. Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial. Arterioscler Thromb Vasc Biol. 1997;17:3071–8.
Mattsson LA , Christiansen C , Colau JC , et al. Clinical equivalence of intranasal and oral 17beta-estradiol for postmenopausal symptoms. Am J Obstet Gynecol. 2000;182:545–52.
Devissaguet JP , Brion N , Lhote O , et al. Pulsed estrogen therapy: pharmacokinetics of intranasal 17-beta-estradiol (S21400) in postmenopausal women and comparison with oral and transdermal formulations. Eur J Drug Metab Pharmacokinet. 1999;24:265–71.
Studd J , Pornel B , Marton I , et al. Efficacy and acceptability of intranasal 17 beta-oestradiol for menopausal symptoms: randomised dose-response study. Aerodiol Study Group. Lancet. 1999;353:1574–8.
Nielsen TF , Ravn P , Pitkin J , et al. Pulsed estrogen therapy improves postmenopausal quality of life: a 2-year placebo-controlled study. Maturitas. 2006;53:184–90.
Kuiper GG , Enmark E , Pelto-Huikko M , et al. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA. 1996;93:5925–30.
Paige LA , Christensen DJ , Gron H , et al. Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta. Proc Natl Acad Sci USA. 1999;96:3999–4004.
Norris JD , Paige LA , Christensen DJ , et al. Peptide antagonists of the human estrogen receptor. Science. 1999;285:744–6.
McDonnell DP . Mechanism-based discovery as an approach to identify the next generation of estrogen receptor modulators. FASEB J. 2006;20:2432–4.
Hall JM , McDonnell DP . The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology. 1999;140:5566–78.
Brzozowski AM , Pike AC , Dauter Z , et al. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature. 1997;389:753–8.
Shiau AK , Barstad D , Loria PM , et al. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell. 1998;95:927–37.
McDonnell DP , Dana SL , Hoener PA , et al. Cellular mechanisms which distinguish between hormone- and antihormone-activated estrogen receptor. Ann N Y Acad Sci. 1995;761:121–37.
Wijayaratne AL , Nagel SC , Paige LA , et al. Comparative analyses of mechanistic differences among antiestrogens. Endocrinology. 1999;140:5828–40.
Harris HA , Albert LM , Leathurby Y , et al. Evaluation of an estrogen receptor-beta agonist in animal models of human disease. Endocrinology. 2003;144:4241–9.
McDonnell DP . The molecular pharmacology of estrogen receptor modulators: implications for the treatment of breast cancer. Clin Cancer Res. 2005;11:871s–7s.
Dauvois S , Danielian PS , White R , et al. Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc Natl Acad Sci USA. 1992;89:4037–41.
Eckert RL , Mullick A , Rorke EA , et al. Estrogen receptor synthesis and turnover in MCF-7 breast cancer cells measured by a density shift technique. Endocrinology. 1984;114:629–37.
Monsma FJ, Jr. , Katzenellenbogen BS , Miller MA , et al. Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogen. Endocrinology. 1984;115:143–53.
Nardulli AM , Katzenellenbogen BS . Dynamics of estrogen receptor turnover in uterine cells in vitro and in uteri in vivo. Endocrinology. 1986;119:2038–46.
Scholl S , Lippman ME . The estrogen receptor in MCF-7 cells: evidence from dense amino acid labeling for rapid turnover and a dimeric model of activated nuclear receptor. Endocrinology. 1984;115:1295–301.
Ciechanover A . The ubiquitin-proteasome proteolytic pathway. Cell. 1994;79:13–21.
Alarid ET , Bakopoulos N , Solodin N . Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation. Mol Endocrinol. 1999;13:1522–34.
El Khissiin A , Leclercq G . Implication of proteasome in estrogen receptor degradation. FEBS Lett. 1999;448:160–6.
Cavailles V , Gompel A , Portois MC , et al. Comparative activity of pulsed or continuous estradiol exposure on gene expression and proliferation of normal and tumoral human breast cells. J Mol Endocrinol. 2002;28:165–75.
Yager JD , Davidson NE . Estrogen carcinogenesis in breast cancer. N Engl J Med. 2006;354:270–82.
Stefanick ML , Anderson GL , Margolis KL , et al. Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA. 2006;295:1647–57.
Simoncini T , Fornari L , Mannella P , et al. Differential estrogen signaling in endothelial cells upon pulsed or continuous administration. Maturitas. 2005;50:247–58.
Li J , Wang H , Johnson SM , et al. Differing transcriptional responses to pulsed or continuous estradiol exposure in human umbilical vein endothelial cells. J Steroid Biochem Mol Biol. 2008; 111(1/2):41–9.
Lopes P , Merkus HM , Nauman J , et al. Randomized comparison of intranasal and transdermal estradiol. Obstet Gynecol. 2000;96:906–12.
Frasor J , Danes JM , Komm B , et al. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology. 2003;144:4562–74.
Inoue A , Yoshida N , Omoto Y , et al. Development of cDNA microarray for expression profiling of estrogen-responsive genes. J Mol Endocrinol. 2002;29:175–92.
Pedram A , Razandi M , Aitkenhead M , et al. Integration of the non-genomic and genomic actions of estrogen. Membrane-initiated signaling by steroid to transcription and cell biology. J Biol Chem. 2002;277:50768–75.
Li J , Wang H , Johnson SM , et al. Differing transcriptional responses to pulsed or continuous estradiol exposure in human umbilical vein endothelial cells. J Steroid Biochem Mol Biol. 2008;111:41–9.
Li C , Briggs MR , Ahlborn TE , et al. Requirement of Sp1 and estrogen receptor alpha interaction in 17beta-estradiol-mediated transcriptional activation of the low density lipoprotein receptor gene expression. Endocrinology. 2001;142:1546–53.
Zhou J , Ng S , Adesanya-Famuiya O , et al. Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression. FASEB J. 2000;14:1725–30.
Cappelletti V , Saturno G , Miodini P , et al. Selective modulation of ER-beta by estradiol and xenoestrogens in human breast cancer cell lines. Cell Mol Life Sci. 2003;60:567–76.
Porter W , Wang F , Duan R , et al. Transcriptional activation of heat shock protein 27 gene expression by 17beta-estradiol and modulation by antiestrogens and aryl hydrocarbon receptor agonists. J Mol Endocrinol. 2001;26:31–42.
Dunn SE , Ehrlich M , Sharp NJ , et al. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer. Cancer Res. 1998;58:3353–61.
Kahlert S , Nuedling S , van Eickels M , et al. Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway. J Biol Chem. 2000;275:18447–53.
Lawler J . Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J Cell Mol Med. 2002;6:1–12.
Neufeld G , Cohen T , Gengrinovitch S , et al. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999;13:9–22.
Ferrara N , Davis-Smyth T . The biology of vascular endothelial growth factor. Endocr Rev. 1997;18:4–25.

Reference Title: References

Reference Type: reference-list

Shumaker SA , Legault C , Rapp SR , et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289:2651–62.
Shumaker SA , Legault C , Kuller LH , et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study. JAMA. 2004;291:2947–58.
Espeland MA , Rapp SR , Shumaker SA , et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study. JAMA. 2004;291: 2959–68.
Rapp SR , Espeland MA , Shumaker SA , et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289:2663–72.
American Academy of Neurology . Estrogen use before 65 linked to reduced risk of Alzheimer's disease. Available at: http://www.aan.com/press/indexcfm?fuseaction=releaseview&release=471. Accessed July 3, 2008.
Manson JE , Allison MA , Rossouw JE , et al. Estrogen therapy and coronary-artery calcification. N Engl J Med. 2007;356:2591–602.
Rossouw JE , Prentice RL , Manson JE , et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007;297:1465–77.
Zandi PP , Anthony JC , Hayden KM , et al. Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study. Neurology. 2002;59:880–6.
MacLennan AH , Henderson VW , Paine BJ , et al. Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study. Menopause. 2006;13:28–36.
Brinton RD . Estrogen therapy for prevention of Alzheimer's disease not for rehabilitation following onset of disease: the healthy cell bias of estrogen action. In Baudry M , Bi R , Schreiber SS , eds. Synaptic Plasticity: Basic Mechanisms to Clinical Applications. New York: Taylor & Francis Group, 2004, pp. 131–57.
Brinton RD . Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Ann N Y Acad Sci. 2005;1052:57–74.
Prewitt AK , Wilson ME . Changes in estrogen receptor-alpha mRNA in the mouse cortex during development. Brain Res. 2007;1134:62–9.
Zhang JQ , Cai WQ , Zhou de S , et al. Distribution and differences of estrogen receptor beta immunoreactivity in the brain of adult male and female rats. Brain Res. 2002;935:73–80.
Yaden BC , Krishnan GV , Bryant HU , et al. Discovery and characterization of selective ERbeta agonist. The Endocrine Society 87th Annual Meeting, San Diego. 2005, pp. 3–295.
Corrieri L , Della Seta D , Canoine V , et al. Developmental exposure to xenoestrogen enhances spatial learning in male rats. Horm Behav. 2007;51:620–5.
Toung TJ , Traystman RJ , Hurn PD . Estrogen-mediated neuroprotection after experimental stroke in male rats. Stroke. 1998;29:1666–70.
McCullough LD , Alkayed NJ , Traystman RJ , et al. Postischemic estrogen reduces hypoperfusion and secondary ischemia after experimental stroke. Stroke. 2001;32:796–802.
Hogervorst E , De Jager C , Budge M , et al. Serum levels of estradiol and testosterone and performance in different cognitive domains in healthy elderly men and women. Psychoneuroendocrinology. 2004;29:405–21.
Cherrier MM , Matsumoto AM , Amory JK , et al. The role of aromatization in testosterone supplementation: effects on cognition in older men. Neurology. 2005;64:290–6.
Beer TM , Bland LB , Bussiere JR , et al. Testosterone loss and estradiol administration modify memory in men. J Urol. 2006;175:130–5.
Sayed Y , Taxel P . The use of estrogen therapy in men. Curr Opin Pharmacol. 2003;3:650–4.
Zhao L , O'Neill K , Brinton RD . Selective estrogen receptor modulators (SERMs) for the brain: current status and remaining challenges for developing NeuroSERMs. Brain Res Brain Res Rev. 2005;49:472–93.
Taxel P , Stevens MC , Trahiotis M , et al. The effect of short-term estradiol therapy on cognitive function in older men receiving hormonal suppression therapy for prostate cancer. J Am Geriatr Soc. 2004;52:269–73.
Ravdin PM , Cronin KA , Howlader N , et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med. 2007;356:1670–4.
Wassertheil-Smoller S , Hendrix SL , Limacher M , et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA. 2003;289:2673–84.
Hendrix SL , Wassertheil-Smoller S , Johnson KC , et al. Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation. 2006;113:2425–34.
Littleton-Kearney MT , Ostrowski NL , Cox DA , et al. Selective estrogen receptor modulators: tissue actions and potential for CNS protection. CNS Drug Rev. 2002; 8:309–30.
Dhandapani KM , Brann DW . Protective effects of estrogen and selective estrogen receptor modulators in the brain. Biol Reprod. 2002;67:1379–85.
LaFerla FM . Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat Rev Neurosci. 2002;3:862–72.
Yaffe K , Krueger K , Sarkar S , et al. Cognitive function in postmenopausal women treated with raloxifene. N Engl J Med. 2001;344:1207–13.
Yaffe K , Krueger K , Cummings SR , et al. Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. Am J Psychiatry. 2005;162:683–90.
Buckwalter JG , Geiger AM , Parsons TD , et al. Cognitive effects of short-term use of raloxifene: a randomized clinical trial. Int J Neurosci. 2007;117: 1579–90.
Haskell SG , Richardson ED . The effect of raloxifene on cognitive function in postmenopausal women: a randomized clinical trial. Conn Med. 2004;68:355–8.
Goekoop R , Duschek EJ , Knol DL , et al. Raloxifene exposure enhances brain activation during memory performance in healthy elderly males; its possible relevance to behavior. Neuroimage. 2005;25:63–75.
Goekoop R , Barkhof F , Duschek EJ , et al. Raloxifene treatment enhances brain activation during recognition of familiar items: a pharmacological fMRI study in healthy elderly males. Neuropsychopharmacology. 2006;31:1508–18.
Zhao L , Jin C , Mao Z , et al. Design, synthesis, and estrogenic activity of a novel estrogen receptor modulator – a hybrid structure of 17beta-estradiol and vitamin E in hippocampal neurons. J Med Chem. 2007;50:4471–81.
Zhao L , O'Neill K , Brinton RD . Estrogenic agonist activity of ICI 182,780 (Faslodex) in hippocampal neurons: implications for basic science understanding of estrogen signaling and development of estrogen modulators with a dual therapeutic profile. J Pharmacol Exp Ther. 2006;319:1124–32.
Howell A , Osborne CK , Morris C , et al. ICI 182,780 (Faslodex): development of a novel, “pure” antiestrogen. Cancer. 2000;89:817–25.
Zhao L , Brinton RD . Estrogen receptor beta as a therapeutic target for promotion of neurogenesis and prevention of neurodegeneration. Drug Dev Res. 2006;66:103–17.
Zhao L , Brinton RD . Estrogen receptor alpha and beta differentially regulate intracellular Ca(2+) dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons. Brain Res. 2007;1172:48–59.
Zhao L , Wu T-W , Brinton RD . Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain Res. 2004;1010:22–34.
Simpkins JW , Yang SH , Sarkar SN , et al. Estrogen actions on mitochondria – physiological and pathological implications. Mol Cell Endocrinol. 2008; 290(1/2):51–9.
Simpkins JW , Dykens JA . Mitochondrial mechanisms of estrogen neuroprotection. Brain Res Rev. 2008;57:421–30.
Nilsen J , Brinton RD . Mitochondria as therapeutic targets of estrogen action in the central nervous system. Curr Drug Targets CNS Neurol Disord. 2004;3:297–313.
Wang L , Andersson S , Warner M , et al. Estrogen receptor (ER) beta knockout mice reveal a role for ERbeta in migration of cortical neurons in the developing brain. Proc Natl Acad Sci USA. 2003; 100:703–8.
Wang L , Andersson S , Warner M , et al. Morphological abnormalities in the brains of estrogen receptor beta knockout mice. Proc Natl Acad Sci USA. 2001;98:2792–6.
Rissman EF , Heck AL , Leonard JE , et al. Disruption of estrogen receptor beta gene impairs spatial learning in female mice. Proc Natl Acad Sci USA. 2002;99:3996–4001.
Day M , Sung A , Logue S , et al. Beta estrogen receptor knockout (BERKO) mice present attenuated hippocampal CA1 long-term potentiation and related memory deficits in contextual fear conditioning. Behav Brain Res. 2005;164:128–31.
Liu F , Day M , Muniz LC , et al. Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory. Nat Neurosci. 2008;11:334–43.
Fan X , Warner M , Gustafsson JA . Estrogen receptor beta expression in the embryonic brain regulates development of calretinin-immunoreactive GABAergic interneurons. Proc Natl Acad Sci USA. 2006;103:19338–43.
Walf AA , Frye CA . Rapid and estrogen receptor beta mediated actions in the hippocampus mediate some functional effects of estrogen. Steroids. 2008; 73:997–1007.
Wang JM , Irwin RW , Brinton RD . Activation of estrogen receptor alpha increases and estrogen receptor beta decreases apolipoprotein E expression in hippocampus in vitro and in vivo. Proc Natl Acad Sci USA. 2006;103:16983–8.
Rice MM , LaCroix AZ , Lampe JW , et al. Dietary soy isoflavone intake in older Japanese American women. Public Health Nutr. 2001;4:943–52.
Maskarinec S . The effect of phytoestrogens on hot flashes. Nutrition Bytes. 2003;9:Article 5.
Ziegler RG . Phytoestrogens and breast cancer. Am J Clin Nutr. 2004;79:183–4.
Henderson BE , Bernstein L . The international variation in breast cancer rates: an epidemiological assessment. Breast Cancer Res Treat. 1991;18(Suppl 1):S11–7.
Goetzl MA , Van Veldhuizen PJ , Thrasher JB . Effects of soy phytoestrogens on the prostate. Prostate Cancer Prostatic Dis. 2007;10:216–23.
de Kleijn MJ , van der Schouw YT , Wilson PW , et al. Intake of dietary phytoestrogens is low in postmenopausal women in the United States: the Framingham study. J Nutr. 2001;131:1826–32.
Zhao L , Brinton RD . WHI and WHIMS follow-up and human studies of soy isoflavones on cognition. Expert Rev Neurother. 2007;7:1549–64.
Zhao L , Chen Q , Brinton RD . Neuroprotective and neurotrophic efficacy of phytoestrogens in cultured hippocampal neurons. Exp Biol Med. 2002;227:509–19.
Zhao L , Mao Z , Brinton RD . A select combination of clinically relevant phytoestrogens enhances estrogen receptor beta-binding selectivity and neuroprotective activities in vitro and in vivo. Endocrinology. 2009;150:770–83.
Setchell KD , Brown NM , Desai P , et al. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr. 2001;131(4 Suppl):1362S–75S.
Setchell KD , Borriello SP , Hulme P , et al. Nonsteroidal estrogens of dietary origin: possible roles in hormone-dependent disease. Am J Clin Nutr. 1984;40:569–78.
Morito K , Hirose T , Kinjo J , et al. Interaction of phytoestrogens with estrogen receptors alpha and beta. Biol Pharm Bull. 2001;24:351–6.
Setchell KD , Brown NM , Lydeking-Olsen E . The clinical importance of the metabolite equol – a clue to the effectiveness of soy and its isoflavones. J Nutr. 2002;132:3577–84.
Atkinson C , Frankenfeld CL , Lampe JW . Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med. 2005;230:155–70.
Frankenfeld CL , McTiernan A , Thomas WK , et al. Postmenopausal bone mineral density in relation to soy isoflavone-metabolizing phenotypes. Maturitas. 2006;53:315–24.
Niculescu MD , Pop EA , Fischer LM , et al. Dietary isoflavones differentially induce gene expression changes in lymphocytes from postmenopausal women who form equol as compared with those who do not. J Nutr Biochem. 2007;18:380–90.
Wu J , Oka J , Ezaki J , et al. Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controlled trial. Menopause. 2007;14:866–74.
Akaza H , Miyanaga N , Takashima N , et al. Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American residents. Jpn J Clin Oncol. 2004;34:86–9.
Arai Y , Uehara M , Sato Y , et al. Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J Epidemiol. 2000;10:127–35.

Reference Title: References

Reference Type: reference-list

Henderson VW , Paganini-Hill A , Miller BL , et al. Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology. 2000;54(2):295–301.
Simpkins JW , Yang SH , Wen Y , Singh M . Estrogens, progestins, menopause and neurodegeneration: basic and clinical studies. Cell Mol Life Sci. 2005;62(3):271–80.
Shumaker SA , Legault C , Rapp SR , et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289(20): 2651–62.
Wise PM . Estrogens and neuroprotection. Trends Endocrinol Metab. 2002;13(6):229–30.
Sherwin BB , Henry JF . Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review. Front Neuroendocrinol. 2008;29(1):88–113.
Woolley CS , McEwen BS . Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism. J Neurosci. 1994;14(12):7680–7.
Wong M , Moss RL . Long-term and short-term electrophysiological effects of estrogen on the synaptic properties of hippocampal CA1 neurons. J Neurosci. 1992;12(8):3217–25.
Bi R , Broutman G , Foy MR , Thompson RF , Baudry M . The tyrosine kinase and mitogen-activated protein kinase pathways mediate multiple effects of estrogen in hippocampus. Proc Natl Acad Sci USA. 2000;97(7):3602–7.
Gibbs RB. Oestrogen and the cholinergic hypothesis: implications for oestrogen replacement therapy in postmenopausal women. Novartis Found Symp. 2000;230:94–107; discussion 107–11.
Galea LA , Spritzer MD , Barker JM , Pawluski JL . Gonadal hormone modulation of hippocampal neurogenesis in the adult. Hippocampus. 2006;16(3):225–32.
Struble RG , Nathan BP , Cady C , Cheng X , McAsey M . Estradiol regulation of astroglia and apolipoprotein E: an important role in neuronal regeneration. Exp Gerontol. 2007;42(1/2):54–63.
Goodenough S , Schleusner D , Pietrzik C , Skutella T , Behl C . Glycogen synthase kinase 3beta links neuroprotection by 17beta-estradiol to key Alzheimer processes. Neuroscience. 2005;132(3):581–9.
Green PS , Simpkins JW . Neuroprotective effects of estrogens: potential mechanisms of action. Int J Dev Neurosci. 2000;18(4/5):347–58.
Gandy S , Petanceska S . Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism. Adv Exp Med Biol. 2001;487:85–100.
Petanceska SS , Nagy V , Frail D , Gandy S . Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. Exp Gerontol. 2000;35(9/10):1317–25.
Carroll JC , Rosario ER , Chang L , et al. Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci. 2007;27(48):13357–65.
Levin-Allerhand JA , Lominska CE , Wang J , Smith JD . 17Alpha-estradiol and 17beta-estradiol treatments are effective in lowering cerebral amyloid-beta levels in AbetaPPSWE transgenic mice. J Alzheimers Dis. 2002;4(6):449–57.
Zheng H , Xu H , Uljon SN , et al. Modulation of A(beta) peptides by estrogen in mouse models. J Neurochem. 2002;80(1):191–6.
Green PS , Bales K , Paul S , Bu G . Estrogen therapy fails to alter amyloid deposition in the PDAPP model of Alzheimer's disease. Endocrinology. 2005;146(6): 2774–81.
Heikkinen T , Kalesnykas G , Rissanen A , et al. Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation. Exp Neurol. 2004;187(1):105–17.
Yue X , Lu M , Lancaster T , et al. Brain estrogen deficiency accelerates A-beta plaque formation in an Alzheimer's disease animal model. Proc Natl Acad Sci USA. 2005;102(52):19198–203.
Baulieu EE , Robel P , Schumacher M . Neurosteroids: beginning of the story. Int Rev Neurobiol. 2001;46:1–32.
Brinton RD , Thompson RF , Foy MR , et al. Progesterone receptors: form and function in brain. Front Neuroendocrinol. 2008;29(2):313–39.
Schumacher M , Guennoun R , Stein DG , De Nicola AF . Progesterone: therapeutic opportunities for neuroprotection and myelin repair. Pharmacol Ther. 2007;116(1):77–106.
Nilsen J , Brinton RD . Impact of progestins on estradiol potentiation of the glutamate calcium response. Neuroreport. 2002;13(6):825–30.
Singh M . Ovarian hormones elicit phosphorylation of Akt and extracellular-signal regulated kinase in explants of the cerebral cortex. Endocrine. 2001;14(3):407–15.
Nilsen J , Brinton RD . Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling. Proc Natl Acad Sci USA. 2003;100(18): 10506–11.
Roof RL , Duvdevani R , Braswell L , Stein DG . Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp Neurol. 1994;129(1):64–9.
Stein DG , Wright DW , Kellermann AL . Does progesterone have neuroprotective properties? Ann Emerg Med. 2008;51(2):164–72.
Labombarda F , Gonzalez SL , Deniselle MC , et al. Effects of injury and progesterone treatment on progesterone receptor and progesterone binding protein 25-Dx expression in the rat spinal cord. J Neurochem. 2003;87(4):902–13.
Gibson CL , Constantin D , Prior MJ , Bath PM , Murphy SP . Progesterone suppresses the inflammatory response and nitric oxide synthase-2 expression following cerebral ischemia. Exp Neurol. 2005;193(2):522–30.
Murphy SJ , Littleton-Kearney MT , Hurn PD . Progesterone administration during reperfusion, but not preischemia alone, reduces injury in ovariectomized rats. J Cereb Blood Flow Metab. 2002;22(10):1181–8.
Rhodes ME , Frye CA . Progestins in the hippocampus of female rats have antiseizure effects in a pentylenetetrazole seizure model. Epilepsia. 2004;45(12):1531–8.
Singh M . Progestins and neuroprotection: are all progestins created equal? Minerva Endocrinol. 2007;32(2):95–102.
Rice MM , Graves AB , McCurry SM , et al. Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women: the Kame Project. Arch Intern Med. 2000;160(11):1641–9.
Azcoitia I , Fernandez-Galaz C , Sierra A , Garcia-Segura LM . Gonadal hormones affect neuronal vulnerability to excitotoxin-induced degeneration. J Neurocytol. 1999;28(9):699–710.
Bimonte-Nelson HA , Nelson ME , Granholm AC . Progesterone counteracts estrogen-induced increases in neurotrophins in the aged female rat brain. Neuroreport. 2004;15(17):2659–63.
Bimonte-Nelson HA , Francis KR , Umphlet CD , Granholm AC . Progesterone reverses the spatial memory enhancements initiated by tonic and cyclic oestrogen therapy in middle-aged ovariectomized female rats. Eur J Neurosci. 2006;24(1):229–42.
Woolley CS , McEwen BS . Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol. 1993;336(2):293–306.
Murphy DD , Segal M . Progesterone prevents estradiol-induced dendritic spine formation in cultured hippocampal neurons. Neuroendocrinology. 2000;72(3):133–43.
Silva I , Mello LE , Freymuller E , Haidar MA , Baracat EC . Estrogen, progestogen and tamoxifen increase synaptic density of the hippocampus of ovariectomized rats. Neurosci Lett. 2000;291(3):183–6.
Frankfurt M , Gould E , Woolley CS , McEwen BS . Gonadal steroids modify dendritic spine density in ventromedial hypothalamic neurons: a Golgi study in the adult rat. Neuroendocrinology. 1990;51(5):530–5.
Gibbs RB . Effects of gonadal hormone replacement on measures of basal forebrain cholinergic function. Neuroscience. 2000;101(4):931–8.
Brinton RD . Requirements of a brain selective estrogen: advances and remaining challenges for developing a NeuroSERM. J Alzheimers Dis. 2004;6(6 Suppl):S27–35.
Yaffe K , Krueger K , Cummings SR , et al. Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. Am J Psychiatry. 2005;162(4):683–90.
Zhao L , Wu TW , Brinton RD . Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain Res. 2004;1010(1/2):22–34.
Cordey M , Pike CJ . Neuroprotective properties of selective estrogen receptor agonists in cultured neurons. Brain Res. 2005;1045(1/2):217–23.
Carroll JC , Pike CJ. Selective estrogen receptor modulators differentially regulate Alzheimer-like changes in female 3xTg-AD mice. Endocrinology. 2008;149(5):2607–11.
Garcia-Segura LM , Cardona-Gomez P , Naftolin F , Chowen JA . Estradiol upregulates Bcl-2 expression in adult brain neurons. Neuroreport. 1998;9(4):593–7.
Rosario ER , Ramsden M , Pike CJ . Progestins inhibit the neuroprotective effects of estrogen in rat hippocampus. Brain Res. 2006;1099(1):206–10.
Harburger LL , Bennett JC , Frick KM . Effects of estrogen and progesterone on spatial memory consolidation in aged females. Neurobiol Aging. 2007;28(4):602–10.
Carroll JC , Rosario ER , Pike CJ . Progesterone blocks estrogen neuroprotection from kainate in middle-aged female rats. Neurosci Lett. 2008;445(3):229–32.
Jayaraman A , Pike CJ . Progesterone attenuates oestrogen neuroprotection via downregulation of oestrogen receptor expression in cultured neurones. J Neuroendocrinol. 2009;21(1):77–81.

Reference Title: References

Reference Type: reference-list

Stoppe G , Doren M . Critical appraisal of effects of estrogen replacement therapy on symptoms of depressed mood. Arch Women Ment Health. 2002;5(2):39–47.
Cone RI , Davis GA , Goy RW . Effects of ovarian steroids on serotonin metabolism within grossly dissected and microdissected brain regions of the ovariectomized rat. Brain Res Bull. 1981;7:639–44.
Biegnon A . Effects of steroid hormones on the serotonergic system. In Whitaker-Azmida PM , Peroutka SJ , eds. The Neuropharmacology of Serotonin. New York Academy of Sciences, 1990, pp. 427–31.
Sherwin BB , Suranyi-Cadotte BE . Up-regulatory effect of estrogen on platelet 3H-imipramine binding sites in surgically menopausal women. Biol Psychiatry. 1990;28(4):339–48.
Guicheney P , Leger D , Barrat J , et al. Platelet serotonin content and plasma tryptophan in peri- and postmenopausal women: variations with plasma oestrogen levels and depressive symptoms. Eur J Clin Invest. 1988;18(3):297–304.
Rehavi M , Sepcuti H , Weizman A . Upregulation of imipramine binding and serotonin uptake by estradiol in female rat brain. Brain Res. 1987;410:135–9.
McQueen JK , Wilson H , Fink G . Estradiol-17 beta increases serotonin transporter (SERT) mRNA levels and the density of SERT-binding sites in female rat brain. Brain Res Mol Brain Res. 1997;45(1):13–23.
Moses-Kolko EL , Greer PJ , Smith G , et al. Widespread increases of cortical serotonin type 2A receptor availability after hormone therapy in euthymic postmenopausal women. Fertil Steril. 2003;80:554–9.
Kuyaga A , Epperson N , Zoghbi S , et al. Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am J Psych. 2003;160:1522–4.
Ball P , Knuppen R , Haupt M , Breuer H . Interactions between estrogens and catechol amines. 3. Studies on the methylation of catechol estrogens, catechol amines and other catechols by the catechol-O-methyltransferases of human liver. J Clin Endocrinol Metab. 1972;34(4):736–46.
Biegnon A , Reches A , Synder L , et al. Serotonergic and noradrenergic receptor in the rat brain: modulation by chronic exposure to ovarian hormones. Life Sci. 1983;32:2015–21.
Petrovic SI , McDonald JK , DeCastro G , et al. Regulation of anterior pituitary and brain beta-adrenergic receptors by ovarian steroids. Life Sci. 1983;37:1563–70.
Etgen AM , Karkanias GB . Estrogen regulation of noradrenergic signaling in the hypothalamus. Psychoneuroendocrinology. 1994;19(5/7):603–10.
Mamounas LA , Blue ME , Siuciak JA , et al. Estradiol-17β increases serotonin transporter (SERT) mRNA levels and the density of SERT-biding sites in female rat brain. Molecular Brain Res. 1997;45:13–23.
Mamounas LA , Altar CA , Blue ME , et al. BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J Neurosci. 2000;20(2):771–82.
Siuciak JA , Clark MS , Rind HB , et al. BDNF induction of tryptophan hydroxylase mRNA levels in the rat brain. J Neurosci Res. 1998;52(2):149–58.
Cavus I , Duman RS . Influence of estradiol, stress, and 5-HT2A agonist treatment on brain-derived neurotrophic factor expression in female rats. Biol Psychiatry. 2003;54(1):59–69.
Frank RT . Hormonal causes of premenstrual tension. Arch Neurol Psychiatry. 1931;26:1053–7.
Severino SK , Moline ML . Premenstrual Syndrome. A Clinicians Guide. New York: Guilford Press, 1989.
Watts JF , Butts WR , Edwards RI , et al. Hormonal studies in women with premenstrual tension. Br J Obstet Gynecol. 1985;92:247–55.
Rubinow DR , Hoban MC , Grover GN , et al. Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. Am J Obstet Gynecol. 1988;158:5–11.
Dennerstein L , Brown JB , Gotts G , et al. Menstrual cycle hormonal profiles of women with and without premenstrual syndrome. J Psychosom Obstet Gynecol. 1993;14:259–68.
Schmidt PJ , Nieman LK , Danaceau MA , et al. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med. 1998;338:209–16.
Hammarback S , Damber JF , Backstrom T . Relationship between symptom severity and hormone changes in women with premenstrual syndrome. J Clin Endocrinol Metab. 1989;68:125–30.
Dhar V , Murphy GE . Double blind randomized crossover trial of luteal phase estrogens (Premarin) in the premenstrual syndrome (PMS). Psychoneuroendocrinology. 1990;15:489–93.
Smith RN , Studd JW , Zamblera D , et al. A randomized comparison over 8 months of 100 micrograms and 200 micrograms twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndrome. Br J Obstet Gynaecol. 1995;102(6):475–84.
Backstrom T , Hansson-Malmstrom Y , Lindhe BA , et al. Oral contraceptive in premenstrual syndrome: a randomized comparison of triphasic and monophasic preparations. Contraception. 1992;46(3):253–68.
Watson NR , Studd JW , Savvas M , et al. Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone. Lancet. 1989;23:730–2.
Rapkin AJ , Mikacich JA , Moatakef-Imani B , et al. The clinical nature and formal diagnosis of premenstrual, postpartum, and perimenopausal affective disorders. Curr Psychiatry Rep. 2002;4(6):419–28.
Freeman EW , Kroll R , Rapkin A , et al. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder. J Womens Health Gend Based Med. 2001;20:561–96.
Pearlstein TB , Bachmann GA , Zacur HA , Yonkers KA . Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation. Contraception. 2005;72(6):414–21.
Yonkers KA , Brown C , Pearlstein TB , et al. Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstet Gynecol. 2005;106:492–501.
Hendrick V , Altshuler L , Suri R . Hormonal chanages in the postpartum and implications for postpartum depression. Psychosomatics. 1998;39:93–101.
Bloch M , Schmidt PJ , Danaceau M , et al. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psych. 2000;157:924–30.
Galea LA , Wide JK , Alasdair MB . Estradiol alleviates depressive-like symptoms in a novel animal model of post-partum depression. Behav Brain Res. 2001;122:1–9.
Ahokas A , Kaukoranta J , Wahlbeck K , Aito M . Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17beta-estradiol: a preliminary study. J Clin Psychiatry. 2001;62(5):332–6.
Gregoire AJP , Kumar R , Everitt B , et al. Transdermal oestrogen for treatment of severe postnatal depression. Lancet. 1996;347:930–3.
Soules MR , Sherman S , Parrott E et al. Stages of Reproductive Aging workshop (STRAW). J Womens Health Gend Based Med. 2001;10(9):843–8.
Steiner M , Dunn E , Born L. Hormones and mood: from menarche to menopause and beyond. J Affect Disord. 2003;74(1):67–83.
Judd HL . Transdermal estradiol. A potentially improved method of hormone replacement. J Reprod Med. 1994;39(5):343–52.
Nelson HD , Vesco KK , Haney E et al. Nonhormonal therapies for menopausal hot flashes systematic review and meta-analysis. JAMA. 2006;295:2057.
Schmidt PJ , Roca CA , Bloch M , et al. The perimenopause and affective disorders. Semin Reprod Endocrinol. 1997;15(1):91–100.
Banger M . Affective syndrome during perimenopause. Maturitas. 2002;41(Suppl 1):S13–8.
Novaes C , Almeida OP , de Melo NR . Mental health among perimenopausal women attending a menopause clinic: possible association with premenstrual syndrome? Climacteric. 1998;1(4):264–70.
Avis NE , Brambilla D , McKinlay SM , et al. A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women's Health Study. Ann Epidemiol. 1994;4(3):214–20.
Freeman EW , Sammel MD , Liu L , Gracia , et al. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry. 2004;61(1):62–70.
Schmidt PJ , Haq N , Rubinow DR . A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women. Am J Psychiatry. 2004;161(12):2238–44.
Harlow BL , Wise LA , Otto MW , et al. Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard Study of Moods and Cycles. Arch Gen Psychiatry. 2003;60(1):29–36.
Klaiber EL , Broverman DM , Vogel W , et al. Estrogen therapy for severe persistent depressions in women. Arch Gen Psychiatry. 1979;36(5):550–4.
Amsterdam J , Garcia-Espana F , Fawcett J , et al. Fluoxetine efficacy in menopausal women with and without estrogen replacement. J Affect Disord. 1999;55(1):11–7.
Shapira B , Oppenheim G , Zohar J , et al. Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives. Biol Psychiatry. 1985;20(5):576–9.
Pearce J , Hawton K , Blake F . Psychological and sexual symptoms associated with the menopause and the effects of hormone replacement therapy. Br J Psychiatry. 1995;167(2):163–73.
Miller KJ . The other side of estrogen replacement therapy: outcome study results of mood improvement in estrogen users and nonusers. Curr Psychiatry Rep. 2003;5(6):439–44.
Zweifel JE , O'Brien WH . A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology. 1997;22(3):189–212. Erratum in: Psychoneuroendocrinology. 1997;22(8):655.
Schmidt PJ , Nieman L , Danaceau MA , et al. Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol. 2000;183(2):414–20.
Soares CN , Almeida OP , Joffe H , et al. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry. 2001;58(6):529–34.
Canada SA , Hofkamp M , Gall EP , et al. Estrogen replacement therapy, subsyndromal depression, and orthostatic blood pressure regulation. Behav Med. 2003;29(3):101–6.
Cohen LS , Soares CN , Poitras JR , et al. Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report. Am J Psychiatry. 2003;160(8):1519–22.
Altshuler LL . The use of SSRIs in depressive disorders specific to women. J Clin Psychiatry. 2002;63(Suppl 7):3–8.
Halbreich U , Rojansky N , Palter S , et al. Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry. 1995;37(7):434–41.
Grigoriadis S , Kennedy SH , Bagby RM . A comparison of antidepressant response in younger and older women. J Clin Psychopharmacol. 2003;23(4):405–7.
Kornstein SG , Schatzberg AF , Thase ME , et al. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry. 2000;157(9):1445–52.
Oppenheim G . A case of rapid mood cycling with estrogen: implications for therapy. J Clin Psychiatry. 1984;45(1):34–5.
Young RC , Moline M , Kleyman F . Hormone replacement therapy and late-life mania. Am J Geriatr Psychiatry. 1997;5(2):179–81.
Schneider LS , Small GW , Hamilton SH , et al. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. Am J Geriatr Psychiatry. 1997;5(2):97–106.
Schneider LS , Small GW , Clary CM . Estrogen replacement therapy and antidepressant response to sertraline in older depressed women. Am J Geriatr Psychiatry. 2001;9(4):393–9.
Rasgon NL , Altshuler LL , Fairbanks LA , et al. Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women. J Clin Psychiatry. 2002;63(Suppl 7):45–8.
Rasgon NL , Dunkin J , Fairbanks L , et al. Estrogen and response to sertraline in postmenopausal women with major depressive disorder: a pilot study. J Psychiatr Res. 2007;41(3/4):338–43.

Reference Title: References

Reference Type: reference-list

FDA . Soy: health claims for soy protein, questions about other components, 2000. Available at: http://www.fda.gov/fdac/features/2000/300_soy.html. Accessed 2008.
Kris-Etherton PM , Hecker KD , Bonanome A , et al. Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med. 2002;113(Suppl 9B):71S–88S.
Zhao L , Brinton RD . WHI and WHIMS follow-up and human studies of soy isoflavones on cognition. Expert Rev Neurother. 2007;7(11):1549–64.
Hogervorst E . The short-lived effects of hormone therapy on cognitive function. In Rasgun NL , ed. Effects of Estrogen on Brain Function. Baltimore, MD: John Hopkins University Press, 2006, pp. 46–78.
Hogervorst E , Ribeiro HM , Molyneux A , Budge M , Smith AD . Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol. 2002;59(5):787–93.
Budge MM , de Jager C , Hogervorst E , Smith AD , Oxford Project to Investigate Memory and Ageing (OPTIMA). Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people. J Am Geriatr Soc. 2002;50(12):2014–18.
Zaccai J , Ince P , Brayne C . Population-based neuropathological studies of dementia: design, methods and areas of investigation – a systematic review. BMC Neurol. 2006;6:2.
Gibbs RB . Preclinical data relating to estrogen's effects on cognitive performance. In Rasgon NL , ed. Effects of Estrogen on Brain Function. Baltimore, MD: John Hopkins University Press, 2006, pp. 9–45.
Henderson VW . Hormone therapy and Alzheimer's disease: benefit or harm? Expert Opin Pharmacother. 2004;5(2):389–406.
Sonee M , Sum T , Wang C , Mukherjee SK . The soy isoflavone, genistein, protects human cortical neuronal cells from oxidative stress. Neurotoxicology. 2004;25(5):885–91.
Azcoitia I , Moreno A , Carrero P , Palacios S , Garcia-Segura LM . Neuroprotective effects of soy phytoestrogens in the rat brain. Gynecol Endocrinol. 2006;22(2):63–9.
Zhao L , Chen Q , Diaz Brinton R . Neuroprotective and neurotrophic efficacy of phytoestrogens in cultured hippocampal neurons. Exp Biol Med. 2002;227(7):509–19.
Fitzpatrick LA . Soy isoflavones: hope or hype? Maturitas. 2003;44(Suppl 1):S21–9.
Grodstein F , Mayeux R , Stampfer MJ . Tofu and cognitive function: food for thought. J Am Coll Nutr. 2000;19(2):207–9.
Hogervorst E , Williams J , Budge M , Riedel W , Jolles J . The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience. 2000;101(3):485–512.
File SE , Hartley DE , Elsabagh S , Duffy R , Wiseman H . Cognitive improvement after 6 weeks of soy supplements in postmenopausal women is limited to frontal lobe function. Menopause. 2005;12(2):193–201.
Duffy R , Wiseman H , File SE . Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones. Pharmacol Biochem Behav. 2003;75(3):721–9.
Casini ML , Marelli G , Papaleo E , et al. Psychological assessment of the effects of treatment with phytoestrogens on postmenopausal women: a randomized, double-blind, crossover, placebo-controlled study. Fertil Steril. 2006;85(4):972–8.
Kritz-Silverstein D , Von Muhlen D , Barrett-Connor E , Bressel MA . Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health In Aging (SOPHIA) Study. Menopause. 2003;10(3):196–202.
Howes JB , Bray K , Lorenz L , Smerdely P , Howes LG . The effects of dietary supplementation with isoflavones from red clover on cognitive function in postmenopausal women. Climacteric. 2004;7(1):70–7.
Kreijkamp-Kaspers S , Kok L , Grobbee DE , et al. Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA. 2004;292(1):65–74.
Ho SC , Chan AS , Ho YP , et al. Effects of soy isoflavone supplementation on cognitive function in Chinese postmenopausal women: a double-blind, randomized, controlled trial. Menopause. 2007;14(3 Pt 1):489–99.
Fournier LR , Ryan Borchers TA , Robison LM , et al. The effects of soy milk and isoflavone supplements on cognitive performance in healthy, postmenopausal women. J Nutr Health Aging. 2007;11(2):155–64.
White LR , Petrovitch H , Ross GW , et al. Brain aging and midlife tofu consumption. J Am Coll Nutr. 2000;19(2):242–55.
Rice MM , Graves AB , McCurry SM , et al. Tofu consumption and cognition in older Japanese American men and women. J Nutr. 2000;130(3):676S.
Huang MH , Luetters C , Buckwalter GJ , et al. Dietary genistein intake and cognitive performance in a multiethnic cohort of midlife women. Menopause. 2006;13(4):621–30.
Kreijkamp-Kaspers S , Kok L , Grobbee DE , et al. Dietary phytoestrogen intake and cognitive function in older women. J Gerontol A Biol Sci Med Sci. 2007;62(5):556–62.
Wu AH , Ziegler RG , Nomura AM , et al. Soy intake and risk of breast cancer in Asians and Asian Americans. Am J Clin Nutr. 1998;68(6 Suppl):1437S–1443S.
Mulligan AA , Welch AA , McTaggart AA , Bhaniani A , Bingham SA . Intakes and sources of soya foods and isoflavones in a UK population cohort study (EPIC-Norfolk). Eur J Clin Nutr. 2007;61(2):248–54.
Murkies AL , Wilcox G , Davis SR . Clinical review 92: Phytoestrogens. J Clin Endocrinol Metab. 1998;83(2):297–303.
Wibowo S , Boedhi-Darmojo R , Kreager P , et al. Indonesia's Elderly: Problem and Potential. Indonesia: University of Indonesia Center for Health Research and University of Oxford, Oxford Institute of Aging, 2004.
Launer LJ , Andersen K , Dewey ME , et al. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology. 1999;52(1):78–84.
Kalache A , Aboderin I , Hoskins I . Compression of morbidity and active ageing: key priorities for public health policy in the 21st century. Bull World Health Organ. 2002;80(3):243–4.
Kreager P . Migration, social structure and old-age support networks: a comparison of three Indonesian communities. Ageing Soc. 2006;26:37–60.
Biswas A , Chakraborty D , Dutt A , Roy T . Dementia in India – a critical appraisal. J Indian Med Assoc. 2005;103(3):154–8.
Hogervorst E , Sadjimim T , Yesufu A , Kreager P , Rahardjo TB . High tofu intake is associated with worse memory in elderly Indonesian men and women. Dement Geriatr Cogn Disord. 2008;26(1):50–7.
Frankenfeld CL , Lampe JW , Shannon J , et al. Frequency of soy food consumption and serum isoflavone concentrations among Chinese women in Shanghai. Public Health Nutr. 2004;7(6):765–72.
Barberger-Gateau P , Raffaitin C , Letenneur L , et al. Dietary patterns and risk of dementia: the Three-City cohort study. Neurology. 2007;69(20):1921–30.
Brandt J . The Hopkins Verbal Learning Test: development of a new memory test with six equivalent forms. Clin Neuropsychol. 1991;5:125–42.
Folstein MF , Folstein SE , McHugh PR . ‘Mini-mental State’: a practical method for grading the cognitive state of patients for the clinician. J Psychiat Res. 1975;12:189–98.
Ganguli M , Ratcliff G , Chandra V , et al. A Hindi version of the MMSE: the development of a cognitive screening instrument for a largely illiterate rural elderly population in India. Int J Geriatr Psychiatry. 1995;10:367–77.
Schrijnemaekers AM , de Jager CA , Hogervorst E , Budge MM . Cases with mild cognitive impairment and Alzheimer's disease fail to benefit from repeated exposure to episodic memory tests as compared with controls. J Clin Exp Neuropsychol. 2006;28(3):438–55.
De Jager CA , Hogervorst E , Combrinck M , Budge MM . Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer's disease. Psychol Med. 2003;33(6):1039–50.
Hogervorst E , Combrinck M , Lapuerta P , et al. The Hopkins Verbal Learning Test and screening for dementia. Dement Geriatr Cogn Disord. 2002;13(1):13–20.
Sherwin BB . Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology. 1988;13(4):345–57.
Lawton MP , Brody EM . Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179–86.
Ellis RJ , Jan K , Kawas C , et al. Diagnostic validity of the dementia questionnaire for Alzheimer disease. Arch Neurol. 1998;55(3):360–5.
American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, 1994.
Griffith AP , Collison MW . Improved methods for the extraction and analysis of isoflavones from soy-containing foods and nutritional supplements by reversed-phase high-performance liquid chromatography and liquid chromatography-mass spectrometry. J Chromatogr A. 2001;913(1/2):397–413.
Gamache PH , Acworth IN . Analysis of phytoestrogens and polyphenols in plasma, tissue, and urine using HPLC with coulometric array detection. Proc Soc Exp Biol Med. 1998;217(3):274–80.
Wu Q , Wang M , Simon JE . Analytical methods to determine phytoestrogenic compounds. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;812(1/2):325–55.
Wilkinson AP , Wahala K , Williamson G . Identification and quantification of polyphenol phytoestrogens in foods and human biological fluids. J Chromatogr B Analyt Technol Biomed Life Sci. 2002; 777(1/2):93–109.
Laboratorytalk . Determination of xenoestrogens. 2003. Available at: http://www.laboratorytalk.com/news/esa/esa134.html. Accessed June 30, 2008.
Petitti DB , Buckwalter JG , Crooks VC , Chiu V . Prevalence of dementia in users of hormone replacement therapy as defined by prescription data. J Gerontol A Biol Sci Med Sci. 2002;57(8):M532–8.
Karp A , Kareholt I , Qiu C , et al. Relation of education and occupation-based socioeconomic status to incident Alzheimer's disease. Am J Epidemiol. 2004;159(2):175–83.
Chen WH , Lin CC , Chen TS , Misra TK , Liu CY . Capillary electrochromatographic analysis of aliphatic mono- and polycarboxylic acids. Electrophoresis. 2003;24(6):970–7.
Hogervorst E , Yaffe K , Richards M , Huppert FA. Hormone replacement therapy for cognitive function in postmenopausal women with dementia. Cochrane Database Syst Rev. 2009;21(1): CD003799. Review.
Hogervorst E , Combrinck M , Dowsett M , Smith AD . Methodological and conceptual difficulties in assessing the association between sex hormone levels and Alzheimer's disease. The Graylyn Conference on Women's Health. Poster Women's Cognitive Health, Graylyn International Conference Centre of Wake Forest University, Winston-Salem, North Carolina, Nov 8–10, 2001. (Won best poster award.)
Paoletti AM , Lello S , Fratta S , et al. Psychological effect of the oral contraceptive formulation containing 3 mg of drospirenone plus 30 microg of ethinyl estradiol. Fertil Steril. 2004;81(3):645–51.
Cunningham CJ , Sinnott M , Denihan A , et al. Endogenous sex hormone levels in postmenopausal women with Alzheimer's disease. J Clin Endocrinol Metab. 2001;86(3):1099–103.
den Heijer T , Geerlings MI , Hofman A , et al. Higher estrogen levels are not associated with larger hippocampi and better memory performance. Arch Neurol. 2003;60(2):213–20.
Smith AD , Jobst KA . Use of structural imaging to study the progression of Alzheimer's disease. Br Med Bull. 1996;52(3):575–86.
Hogervorst E , Williams J , Combrinck M , Smith AD . Measuring serum estradiol in women with Alzheimer's disease: the importance of the sensitivity of the assay method. Eur J Endocrinol. 2003;148:67–72.
Henderson VW . Only a matter of time? Hormone therapy and cognition. Menopause. 2005;12(1):1–3.
Hogervorst E , Bandelow S , Moffat SD . Increasing testosterone levels and effects on cognitive functions in elderly men and women: a review. Curr Drug Targets CNS Neurol Disord. 2005;4(5):531–40.
Hogervorst E , De Jager C , Budge M , Smith AD . Serum levels of estradiol and testosterone and performance in different cognitive domains in healthy elderly men and women. Psychoneuroendocrinology. 2004;29(3):405–21.
Muller M , Aleman A , Grobbee DE , de Haan EH , van der Schouw YT . Endogenous sex hormone levels and cognitive function in aging men: is there an optimal level? Neurology. 2005;64(5):866–71.
Hogervorst E , Combrinck M , Smith AD . Testosterone and gonadotropin levels in men with dementia. Neuro Endocrinol Lett. 2003;24(3/4):203–8.
Moffat SD , Zonderman AB , Metter EJ , et al. Free testosterone and risk for Alzheimer disease in older men. Neurology. 2004;62(2):188–93.
Irie F , Strozyk D , Peila R , et al. Brain lesions on MRI and endogenous sex hormones in elderly men. Neurobiol Aging 2006;27(8):1137–44.
Cherrier MM , Matsumoto AM , Amory JK , et al. The role of aromatization in testosterone supplementation: effects on cognition in older men. Neurology. 2005;64(2):290–6.
Wang H , Murphy PA . Isoflavone content in commercial soybean products. J Agric Food Chem. 1994;42:1666–73.
Ginting E , Arcot J . High-performance liquid chromatographic determination of naturally occurring folates during tempe preparation. J Agric Food Chem. 2004;52(26):7752–8.
Smith AD . Homocysteine, B vitamins, and cognitive deficit in the elderly. Am J Clin Nutr. 2002;75(5):785–6.
Yesufu A , Rahardjo T , Bandelow S , Hogervorst E. Soy , tofu and brain function in the elderly. In Martin C ed., The Handbook of Behavior, Diet and Nutrition. London: Karger, 2010.

Reference Title: References

Reference Type: reference-list

De Kloet ER , Joels M , Holsboer F . Stress and the brain: from adaptation to disease. Nat Rev Neurosci. 2005;6:463–75.
McEwen BS . Protective and damaging effects of stress mediators. New Engl J Med. 1998;338(3):171–9.
Ursin H , Eriksen HR . The cognitive activation theory of stress. Psychoneuroendocrinology. 2004;29(5):567–92.
Lazarus RS . Coping theory and research: past, present, and future. Psychosom Med. 1993;55(3):234–47.
Mendel CM . The free hormone hypothesis: a physiologically based mathematical model. Endocr Rev. 1989;10(3):232–74.
Dickerson SS , Kemeny ME . Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. Psychol Bull. 2004;130(3):355–91.
Herbert J , Goodyer IM , Grossman AB , et al. Do corticosteroids damage the brain? J Neuroendocrinol. 2006;18(6):393–411.
Wolf OT . Effects of stress hormones on the structure and function of the human brain. Expert Rev Endocrinol Metabol. 2006;1(5):623–32.
Wolf OT . The influence of stress hormones on emotional memory: relevance for psychopathology. Acta Psychol. (Amst) 2008;127(3):513–31.
LaBar KS , Cabeza R . Cognitive neuroscience of emotional memory. Nat Rev Neurosci. 2006;7(1):54–64.
Roozendaal B , Okuda S , de Quervain DJ , McGaugh JL . Glucocorticoids interact with emotion-induced noradrenergic activation in influencing different memory functions. Neuroscience. 2006;138:901–10.
Neupert SD , Almeida DM , Mroczek DK , Spiro A, III. Daily stressors and memory failures in a naturalistic setting: findings from the VA Normative Aging Study. Psychol Aging. 2006;21(2):424–9.
McEwen BS . Sex, stress and the hippocampus: allostasis, allostatic load and the aging process. Neurobiol Aging. 2002;23(5):921–39.
Radley JJ , Morrison JH . Repeated stress and structural plasticity in the brain. Ageing Res Rev. 2005;4(2):271–87.
McEwen BS . Mood disorders and allostatic load. Biol Psychiatry. 2003;54(3):200–7.
Radley JJ , Rocher AB , Janssen WG , et al. Reversibility of apical dendritic retraction in the rat medial prefrontal cortex following repeated stress. Exp Neurol. 2005;196:199–203.
Gould E , Tanapat P , Rydel T , Hastings N . Regulation of hippocampal neurogenesis in adulthood. Biol Psychiatry. 2000;48(8):715–20.
Bodnoff SR , Humphreys AG , Lehman JC , et al. Enduring effects of chronic corticosterone treatment on spatial learning, synaptic plasticity, and hippocampal neuropathology in young and mid-aged rats. J Neurosci. 1995;15(1 Pt 1):61–9.
Conrad CD , Galea LA , Kuroda Y , McEwen BS . Chronic stress impairs rat spatial memory on the Y-maze, and this effect is blocked by tianeptine pretreatment. Behav Neurosci. 1996;110(6):1321–34.
Sapolsky RM . Stress and plasticity in the limbic system. Neurochem Res. 2003;28(11):1735–42.
Schulkin J , Gold PW , McEwen BS . Induction of corticotropin-releasing hormone gene expression by glucocorticoids: implication for understanding the states of fear and anxiety and allostatic load. Psychoneuroendocrinology. 1998;23(3):219–43.
Conrad CD , LeDoux JE , Magarinos AM , McEwen BS . Repeated restraint stress facilitates fear conditioning independently of causing hippocampal CA3 dendritic atrophy. Behav Neurosci. 1999;113(5):902–13.
Luine V . Sex differences in chronic stress effects on memory in rats. Stress. 2002;5(3):205–16.
Galea LA , McEwen BS , Tanapat P , et al. Sex differences in dendritic atrophy of CA3 pyramidal neurons in response to chronic restraint stress. Neuroscience. 1997;81(3):689–97.
Conrad CD , Jackson JL , Wieczorek L , et al. Acute stress impairs spatial memory in male but not female rats: influence of estrous cycle. Pharmacol Biochem Behav. 2004;78(3):569–79.
Shansky RM , Rubinow K , Brennan A , Arnsten AF . The effects of sex and hormonal status on restraint-stress-induced working memory impairment. Behav Brain Funct. 2006;2:8.
Shors TJ . Learning during stressful times. Learn Mem. 2004;11(2):137–44.
Cho K . Chronic ‘jet lag’ produces temporal lobe atrophy and spatial cognitive deficits. Nat Neurosci. 2001;4(6):567–8.
Morgan CA, III , Doran A , Steffian G , Hazlett G , Southwick SM . Stress-induced deficits in working memory and visuo-constructive abilities in Special Operations soldiers. Biol Psychiatry. 2006;60(7):722–9.
Newcomer JW , Selke G , Melson AK , et al. Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch Gen Psychiatry. 1999;56(6):527–33.
Wolkowitz OM , Reus VI , Canick J , Levin B , Lupien S . Glucocorticoid medication, memory and steroid psychosis in medical illness. Ann N Y Acad Sci. 1997;823:81–96.
Coluccia D , Wolf OT , Kollias S , et al. Glucocorticoid therapy-induced memory deficits: acute versus chronic effects. J Neurosci. 2008;28(13):3474–8.
Starkman MN , Gebarski SS , Berent S , Schteingart DE . Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol Psychiatry. 1992;32(9):756–65.
Starkman MN , Giordani B , Gebarski SS , et al. Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease. Biol Psychiatry. 1999;46(12):1595–602.
Van Cauter E , Leproult R , Kupfer DJ . Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab. 1996;81(7):2468–73.
Otte C , Hart S , Neylan TC , et al. A meta-analysis of cortisol response to challenge in human aging: importance of gender. Psychoneuroendocrinology. 2005;30(1):80–91.
Kudielka BM , Schmidt-Reinwald AK , Hellhammer DH , Kirschbaum C . Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment. Neuroendocrinology. 1999;70(6):422–30.
Issa AM , Rowe W , Gauthier S , Meaney MJ . Hypothalamic-pituitary-adrenal activity in aged, cognitively impaired and cognitively unimpaired rats. J Neurosci. 1990;10(10):3247–54.
Lee BK , Glass TA , McAtee MJ , et al. Associations of salivary cortisol with cognitive function in the Baltimore memory study. Arch Gen Psychiatry. 2007;64(7):810–8.
MacLullich AM , Deary IJ , Starr JM , et al. Plasma cortisol levels, brain volumes and cognition in healthy elderly men. Psychoneuroendocrinology. 2005;30(5):505–15.
Greendale GA , Kritz-Silverstein D , Seeman T , Barrett-Connor E . Higher basal cortisol predicts verbal memory loss in postmenopausal women: Rancho Bernardo Study. J Am Geriatr Soc. 2000;48(12):1655–8.
Li G , Cherrier MM , Tsuang DW , et al. Salivary cortisol and memory function in human aging. Neurobiol Aging. 2006;27(11):1705–14.
Karlamangla AS , Singer BH , Chodosh J , McEwen BS , Seeman TE . Urinary cortisol excretion as a predictor of incident cognitive impairment. Neurobiol Aging. 2005;26(Suppl 1):80–4.
Lupien SJ , de Leon M , De Santi S , et al. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci. 1998;1(1):69–73.
Seeman TE , McEwen BS , Singer BH , Albert MS , Rowe JW . Increase in urinary cortisol excretion and memory declines: MacArthur studies of successful aging. J Clin Endocrinol Metab. 1997;82(8):2458–65.
Wolf OT , Convit A , de Leon MJ , Caraos C , Quadri SF . Basal hypothalamo-pituitary-adrenal axis activity and corticotropin feedback in young and older men: relationship to magnetic resonance imaging derived hippocampus and cingulate gyrus volumes. Neuroendocrinology. 2002;75:241–9.
de Leon MJ , McRae T , Tsai JR , et al. Abnormal cortisol response in Alzheimer's disease linked to hippocampal atrophy. Lancet. 1988;2(8607):391–2.
O'Brien JT , Ames D , Schweitzer I , Mastwyk M , Colman P . Enhanced adrenal sensitivity to adrenocorticotrophic hormone (ACTH) is evidence of HPA axis hyperactivity in Alzheimer's disease. Psychol Med. 1996;26(1):7–14.
Csernansky JG , Dong H , Fagan AM , et al. Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia. Am J Psychiatry. 2006;163(12):2164–9.
Kang JE , Cirrito JR , Dong H , Csernansky JG , Holtzman DM . Acute stress increases interstitial fluid amyloid-beta via corticotropin-releasing factor and neuronal activity. Proc Natl Acad Sci USA. 2007;104(25):10673–8.
Rissman RA , Lee KF , Vale W , Sawchenko PE . Corticotropin-releasing factor receptors differentially regulate stress-induced tau phosphorylation. J Neurosci. 2007;27(24):6552–62.
Aisen PS , Davis KL , Berg JD , et al. A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study. Neurology. 2000;54(3):588–93.
de Quervain DJ , Poirier R , Wollmer MA , et al. Glucocorticoid-related genetic susceptibility for Alzheimer's disease. Hum Mol Genet. 2004;13(1):47–52.
Wilson RS , Evans DA , Bienias JL , et al. Proneness to psychological distress is associated with risk of Alzheimer's disease. Neurology. 2003;61(11):1479–85.
Woods NF , Carr MC , Tao EY , Taylor HJ , Mitchell ES . Increased urinary cortisol levels during the menopause transition. Menopause. 2006;13(2):212–21.
Qureshi AC , Bahri A , Breen LA , et al. The influence of the route of oestrogen administration on serum levels of cortisol-binding globulin and total cortisol. Clin Endocrinol. (Oxf) 2007;66(5):632–5.
Shifren JL , Desindes S , McIlwain M , Doros G , Mazer NA . A randomized, open-label, crossover study comparing the effects of oral versus transdermal estrogen therapy on serum androgens, thyroid hormones, and adrenal hormones in naturally menopausal women. Menopause. 2007;14(6):985–94.
Wolf OT , Heinrich AB , Hanstein B , Kirschbaum C . Estradiol or estradiol/progesterone treatment in older women: no strong effects on cognition. Neurobiol Aging. 2005;26:1029–32.
Patacchioli FR , Simeoni S , Monnazzi P , et al. Menopause, mild psychological stress and salivary cortisol: influence of long-term hormone replacement therapy (HRT). Maturitas. 2006;55(2):150–5.
Komesaroff PA , Esler MD , Sudhir K . Estrogen supplementation attenuates glucocorticoid and catecholamine responses to mental stress in perimenopausal women. J Clin Endocrinol Metab. 1999;84(2):606–10.
Lindheim SR , Legro RS , Bernstein L , et al. Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen. Am J Obstet Gynecol. 1992;167(6):1831–6.
Lindheim SR , Legro RS , Morris RS , et al. The effect of progestins on behavioral stress responses in postmenopausal women. J Soc Gynecol Investig. 1994;1(1):79–83.
Puder JJ , Freda PU , Goland RS , Wardlaw SL . Estrogen modulates the hypothalamic-pituitary-adrenal and inflammatory cytokine responses to endotoxin in women. J Clin Endocrinol Metab. 2001;86(6):2403–8.
Kajantie E , Phillips DI . The effects of sex and hormonal status on the physiological response to acute psychosocial stress. Psychoneuroendocrinology. 2006;31(2):151–78.
Bowman RE , MacLusky NJ , Diaz SE , Zrull MC , Luine VN . Aged rats: sex differences and responses to chronic stress. Brain Res. 2006;1126:156–66.
Behl C , Moosmann B , Manthey D , Heck S . The female sex hormone oestrogen as neuroprotectant: activities at various levels. Novartis Found Symp. 2000;230:221–34.
Wolf OT . Stress, memory and aging: relevance for the peri- and postmenopausal women. Menopause Management 2007;16:22–30.
Ising M , Kunzel HE , Binder EB , et al. The combined dexamethasone/CRH test as a potential surrogate marker in depression. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(6):1085–93.
Wilson RS , Barnes LL , Mendes De Leon CF , et al. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology. 2002;59(3):364–70.
Convit A . Links between cognitive impairment in insulin resistance: an explanatory model. Neurobiol Aging. 2005;26(Suppl. 1):31–5.
Dallman MF , Pecoraro N , Akana SF , et al. Chronic stress and obesity: a new view of “comfort food”. Proc Natl Acad Sci USA. 2003;100(20):11696–701.
Rosmond R . Stress induced disturbances of the HPA axis: a pathway to Type 2 diabetes? Med Sci Monit. 2003;9(2):RA35–RA39.
Seckl JR , Walker BR . 11beta-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memory. Trends Endocrinol Metab. 2004;15(9):418–24.
Yau JL , Noble J , Kenyon CJ , et al. Lack of tissue glucocorticoid reactivation in 11beta-hydroxysteroid dehydrogenase type 1 knockout mice ameliorates age-related learning impairments. Proc Natl Acad Sci USA. 2001;98(8):4716–21.
Sandeep TC , Yau JL , MacLullich AM , et al. 11β-Hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics. Proc Natl Acad Sci USA. 2004; 101:6734–9.

Reference Title: References

Reference Type: reference-list

Hogervorst E . The short-lived effect of hormone therapy on cognition function. In Rasgon N , ed. The Effects of Estrogen on Brain Function. Baltimore: Johns Hopkins Press, 2006, pp. 46–78.
Yesufu A , Bandelow S , Hogervorst E . Meta-analyses of the effect of hormone treatment on cognitive function in postmenopausal women. Women's Health. 2007;3(2):173–95.
Henderson VW , Paganini-Hill A , Miller BL , et al. Estrogen for Alzheimer's disease in women. Neurology. 2000;54(January 2):295–301.
Wang PN , Liao SQ , Liu RS , et al. Effects of estrogen on cognition, mood, and cerebral blood flow in AD. Neurology. 2000;54(January 1):2061–66.
Mulnard RA , Cotman CW , Kawas C. et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer's disease. JAMA. 2000;283:1007–15.
Shumaker SA , Legault C , Rapp SR , et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. JAMA. 2003;289:2651–62.
Shumaker SA , Legault C , Kuller L , et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study. JAMA. 2004;291(24):2947–58.
Rapp SR , Espeland MA , Shumaker SA , et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289(20):2663–72.
Espeland MA , Rapp SR , Shumaker SA , et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study. JAMA. 2004;291(24):2959–68.
Hersh AL , Stefanick ML , Stafford RS . National use of postmenopausal hormone therapy. JAMA. 2004;291(1):47–53.
Henderson VW , Benke KS , Green RC , et al. Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. JNNP. 2005;76(1):103–5.
Zandi PP , Carlson MC , Plassman BL , et al. Hormone replacement therapy and incidence of Alzheimer disease in older women the Cache County Study. JAMA. 2002;288(17):2123–9.
Sherwin BB . Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology. 1988;13:345–57.
Nappi RE , Sinforiani E , Mauri M , et al. Memory functioning at menopause impact of age in ovariectomized women. Gynecol Obstet Invest. 1999;47:29–36.
Rocca WA , Bower JH , Maraganore DM , et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology. 2007;69(11): 1074–83.
Szklo M , Cerhan J , Diez-Roux AV , et al. Estrogen replacement therapy and cognitive functioning in the artherosclerotic risk in communities (ARIC) study. Am J Epidemiol. 1996;144:1048–57.
Caldwell BM . An evaluation of psychological effects of sex hormone administration in aged women II. Results of therapy after 18 months. J Gerontol. 1954;9(2):168–74.
Honjo H , Ogino Y , Tanaka K , et al. An effect of conjugated estrogen to cognitive impairment in women with senile dementia-Alzheimer's type: a placebo-controlled double-blind study. J Jpn Menopause Soc. 1993;1:161–71.
Birge SJ . The role of estrogen in the treatment of Alzheimer's disease. Neurology. 1997;48:S36–S41.
Zhang YX , Luo G , Guo ZJ , Wang LQ , Zhou CL . Quantitative evaluation of the intervention of estrogen on Alzheimer's disease. Chin J Clin Rehab. 2006;10(30):37–91.
Asthana S , Craft S , Baker LD , et al. Cognitive and neuroedocrine response to transdermal estrogen in postmenopausal women with AD: results of a placebo-controlled, double-blind pilot study. Psychoneuroendocrinology. 1999;24:657–77.
Asthana S , Baker LD , Craft S , et al. High-dose estradiol improves cognition for women with AD: results of a randomized study. Neurology. 2001;57(4):605–12.
Asthana S , Craft S , Baker LD , et al. Transdermal estrogen improves memory in women with Alzheimer's Disease. Soc Neurosci Abstr. 1996;22:A200.
Hogervorst E , Williams J , Budge M , Riedel W , Jolles J . The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience. 2000;101(3):485–512.
Hogervorst E , Boshuisen M , Riedel WJ , Willekes C , Jolles J. The effect of hormone replacement therapy on cognitive function in elderly women. Psychoneuroendocrinology. 1999;24:43–68.
File SE , Heard JE , Rymer J . Trough oestradiol levels associated with cognitive impairment in post-menopausal women after 10 years of oestradiol implants. Psychopharmacology (Berl). 2002;161(1):107–12.
Hogervorst E , Bandelow S . Should surgically menopausal women be treated with estrogens to decrease the risk for dementia? Invited Editorial. Neurology. 2007;69(11):1070–1.
Hogervorst E , Bandelow S , Combrinck M , Irani M , Smith AD . The validity and reliability of 6 sets of clinical criteria to classify Alzheimer's disease and vascular dementia in post-mortem confirmed cases: added value of a decision-tree approach. Dementia. 2003;16(3):170–80.
McKhann G , Drachmann D , Folstein M , et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939–44.
Mirra SS , Heyman A , McKeel D , et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991;41:479–86.
Roth M , Huppert FA , Tym E , Mountjoy CQ . CAMDEX: The Cambridge Examination for Mental Disorders of the Elderly. Cambridge: Cambridge University Press, 1988.
Hogervorst E , Williams J , Combrinck M , Smith AD . Measuring serum oestradiol in women with Alzheimer's disease: the importance of the sensitivity of the assay method. Eur J Endocrinol. 2003;148(1):67–72.
Hogervorst E , Barnetson L , Williams J , et al. Women with dementia of Alzheimer's type have higher levels of estradiol than healthy controls: prize winning poster. Paper presented at the 5th Annual Graylyn Conference on Women's Health, 1999; Winston-Salem.
Paoletti AM , Congia S , Lello S , et al. Low androgenization index in elderly women and elderly men with Alzheimer's disease. Neurology. 2004;62(2):301–3.
Cunningham CJ , Sinnott M , Denihan A , et al. Endogenous sex hormone levels in postmenopausal women with AD. J Clin Endocrinol Metab. 2001;86(3):1099–103.
Ravaglia G , Forti P , Maiolo F , et al. Endogenous sex hormones as risk factors for dementia in elderly men and women. J Gerontol A Biol Sci Med Sci. 2007;62(9):1035–41.
Den Heijer T , Geerlings MI , Hofman A , et al. Higher estrogen levels are not associated with larger hippocampi and better memory performance. Arch Neurol. 2003;60(2):213–20.
Rees M . Gynaecological oncology perspective on management of the menopause. Eur J Surg Oncol. 2006;32(8):892–7.
Berstein L , Zimarina T , Imyanitov E , et al. Hormonal imbalance in two types of endometrial cancer and genetic polymorphism of steroidogenic enzymes. Maturitas. 2006;54(4):352–5.
Szyllo K , Smolarz B , Romanowicz-Makowska H , Kulig A . The polymorphisms of the CYP17 and CYP19 genes in endometrial cancer patients. Pol J Pathol. 2006;57(1):35–40.
Aban M , Arslan M , Tok E , et al. CYP17 genetic polymorphism in patients with endometrial hyperplasia and cancer. Int J Gynecol Cancer. 2006;16(1):448–51.
Kruman R , Wersto F , Cardozo-Pelaez L , et al. Cycle activation linked to neuronal cell death initiated by DNA damage. Neuron. 2004;41(4):549–61.
Sharp L . CYP17 gene polymorphisms. A HuGE review. Am J Epid. 2004;160(8):729–40.
Huang CS , Chern HD , Chang KJ , et al. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res. 1999;59(19):4870–5.
Cecchin E . Lack of association of CYP1B1*3 polymorphism and ovarian cancer. Int J Biol Markers. 2004;19(2):160–3.
Tworoger SS , Chubak J , Aiello EJ , et al. Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2004;13(1):94–101.
Turnbridge EM , Harrison PJ , Warden DR , et al. Polymorphisms in the catechol-O-methyltransferase (COMT) gene influence plasma total homocysteine levels. Am J Med Genet B Neuropsychiatr Genet. 2008;147B(6): 996–9.
Wang PN . Estrogen-metabolizing gene COMT polymorphism synergistic APOE epsilon4 allele increases the risk of Alzheimer disease. Dementia. 2005;19(2/3):120–5.
Nicholl DJ , Bennett P , Hiller L , et al. A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. Neurology. 1999;53(7): 1415–21.
Borroni B , Agosti C , Archetti S , et al. COMT polymorphism is associated with risk for psychosis in AD. Neurosci Lett. 2004;370(2/3):127–9.
Wegienka G , Havstad S , Kelsey JL . Menopausal hormone therapy in a health maintenance organization before and after WHI hormone trials termination. J Women's Health. 2006;15(4):369–78.
Hogervorst E , Yaffe K , Richards M , Huppert FA . Hormone replacement therapy to maintain cognitive function in women with dementia. Cochrane Database Syst Rev. 2009;21(1):CD003799. Review.
Hogervorst E , Williams JW , Budge M , Barnetson L , Smith AD . Serum total testosterone is lower in men with Alzheimer's disease. Neuro Endocrinol Lett. 2001;22(3):163–8.
Moffat SD , Zonderman AB , Metter EJ , et al. Free testosterone and risk for Alzheimer disease in older men. Neurology. 2004;62(2):188–93.
Rosario ER , Chang L , Stanczyk FZ , Pike CJ . Age-related testosterone depletion and the development of Alzheimer disease. JAMA. 2004;292(12):1431–2.
Hogervorst E , Lehmann DJ , Warden DR , McBroom J , Smith AD . Apolipoprotein E ε4 and testosterone interact in the risk of Alzheimer's disease in men. Int J Geriatr Psychiatry. 2002;17(16):938–40.
Raber J , Bongers G , Le Fevour A , Buttini M , Mucke L . Androgens protect against apolipoprotein E4-induced cognitive deficits. Neurosci. 2002;22(12):5204–9.
Lehmann DJ , Hogervorst E , Warden DR , et al. The androgen receptor CAG repeat and serum testosterone in the risk of Alzheimer's disease in men. J Neurol Neurosurg Psychiatry. 2004;75(1):163–4.
Krithivas K , Yurgalevitch SM , Mohr BA , et al. Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men. J Endocrinol. 1999; 162(1):137–42.
Hogervorst E , Bandelow S , Moffat SD . Increasing testosterone levels and effects on cognitive function in elderly men and women: a review. Curr Drug Targets CNS Neurol Disord. 2005;4(5):531–40.

Reference Title: References

Reference Type: reference-list

Gatz M , Reynolds CA , Fratiglioni L , et al. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry. 2006;63(2):168–74.
Mayeux R , Sano M , Chen J , Tatemichi T , Stern Y . Risk of dementia in first-degree relatives of patients with Alzheimer's disease and related disorders. Arch Neurol. 1991;48(3):269–73.
Daw EW , Payami H , Nemens EJ , et al. The number of trait loci in late-onset Alzheimer disease. Am J Hum Genet. 2000;66(1):196–204.
Bertram L , McQueen M , Mullin K , Blacker D , Tanzi R . The AlzGene Database. Alzheimer Research Forum. 2008 [updated 2008; cited 08/07/08]; Available from: http://www.alzgene.org.
Coon KD , Myers AJ , Craig DW , et al. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clin Psychiatry. 2007;68(4):613–18.
Reiman EM , Webster JA , Myers AJ , et al. GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers. Neuron. 2007;54(5):713–20.
Grupe A , Abraham R , Li Y , et al. Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants. Hum Mol Genet. 2007;16(8):865–73.
Li H , Wetten S , Li L , et al. Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol. 2008;65(1):45–53.
Deroo BJ , Korach KS . Estrogen receptors and human disease. J Clin Invest. 2006;116(3):561–70.
Herrington DM , Howard TD , Brosnihan KB , et al. Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation. 2002;105(16):1879–82.
Schuit SC , Oei HH , Witteman JC , et al. Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction. JAMA. 2004;291(24):2969–77.
Schuit SC , de Jong FH , Stolk L , et al. Estrogen receptor alpha gene polymorphisms are associated with estradiol levels in postmenopausal women. Eur J Endocrinol. 2005;153(2):327–34.
McIntyre MH , Kantoff PW , Stampfer MJ , et al. Prostate cancer risk and ESR1 TA, ESR2 CA repeat polymorphisms. Cancer Epidemiol Biomarkers Prev. 2007;16(11):2233–6.
Lawlor DA , Timpson N , Ebrahim S , Day IN , Smith GD . The association of oestrogen receptor alpha-haplotypes with cardiovascular risk factors in the British Women's Heart and Health Study. Eur Heart J. 2006;27(13):1597–604.
Cox DG , Bretsky P , Kraft P , et al. Haplotypes of the estrogen receptor beta gene and breast cancer risk. Int J Cancer. 2008;122(2):387–92.
Brandi ML , Becherini L , Gennari L , et al. Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease. Biochem Biophys Res Commun. 1999;265(2):335–8.
Isoe-Wada K , Maeda M , Yong J , et al. Positive association between an estrogen receptor gene polymorphism and Parkinson's disease with dementia. Eur J Neurol. 1999;6(4):431–5.
den Heijer T , Schuit SC , Pols HA , et al. Variations in estrogen receptor alpha gene and risk of dementia, and brain volumes on MRI. Mol Psychiatry. 2004;9(12):1129–35.
Luckhaus C , Sand PG . Estrogen Receptor 1 gene (ESR1) variants in Alzheimer's disease. Results of a meta-analysis. Aging Clin Exp Res. 2007;19(2):165–8.
Usui C , Shibata N , Ohnuma T , et al. No genetic association between the myeloperoxidase gene-463 polymorphism and estrogen receptor-alpha gene polymorphisms and Japanese sporadic Alzheimer's disease. Dement Geriatr Cogn Disord. 2006;21(5/6): 296–9.
Forsell C , Enmark E , Axelman K , et al. Investigations of a CA repeat in the oestrogen receptor beta gene in patients with Alzheimer's disease. Eur J Hum Genet. 2001;9(10):802–4.
Lambert JC , Harris JM , Mann D , et al. Are the estrogen receptors involved in Alzheimer's disease? Neurosci Lett. 2001;306(3):193–7.
Pirskanen M , Hiltunen M , Mannermaa A , et al. Estrogen receptor beta gene variants are associated with increased risk of Alzheimer's disease in women. Eur J Hum Genet. 2005;13(9):1000–6.
Luckhaus C , Spiegler C , Ibach B , et al. Estrogen receptor beta gene (ESRbeta) 3′-UTR variants in Alzheimer disease. Alzheimer Dis Assoc Disord. 2006; 20(4):322–3.
Olson SH , Bandera EV , Orlow I . Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review. Am J Epidemiol. 2007;165(3):235–45.
Kastelan D , Grubic Z , Kraljevic I , et al. Decreased peak bone mass is associated with a 3-bp deletion/insertion of the CYP19 intron 4 polymorphism: preliminary data from the GOOS study. J Endocrinol Invest. 2007;30(6):465–9.
Redon R , Ishikawa S , Fitch KR , et al. Global variation in copy number in the human genome. Nature. 2006;444(7118):444–54.
Iivonen S , Corder E , Lehtovirta M , et al. Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease. Neurology. 2004;62(7): 1170–6.
Combarros O , Riancho JA , Infante J , et al. Interaction between CYP19 aromatase and butyrylcholinesterase genes increases Alzheimer's disease risk. Dement Geriatr Cogn Disord. 2005;20(2/3):153–7.
Combarros O , Sanchez-Juan P , Riancho JA , et al. Aromatase and interleukin-10 genetic variants interactively modulate Alzheimer's disease risk. J Neural Transm. 2008;115(6):863–7.
Huang R , Poduslo SE . CYP19 haplotypes increase risk for Alzheimer's disease. J Med Genet. 2006;43(8):e42.
Mukherjee N , Kidd KK , Pakstis AJ , et al. The complex global pattern of genetic variation and linkage disequilibrium at catechol-O-methyltransferase. Mol Psychiatry. 2008; doi:10.1038/mp.2008.64.
Tworoger SS , Chubak J , Aiello EJ , et al. Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2004;13(1):94–101.
Locke DP , Sharp AJ , McCarroll SA , et al. Linkage disequilibrium and heritability of copy-number polymorphisms within duplicated regions of the human genome. Am J Hum Genet. 2006;79(2):275–90.
Emahazion T , Feuk L , Jobs M , et al. SNP association studies in Alzheimer's disease highlight problems for complex disease analysis. Trends Genet. 2001;17(7):407–13.
Borroni B , Agosti C , Archetti S , et al. Catechol-O-methyltransferase gene polymorphism is associated with risk of psychosis in Alzheimer disease. Neurosci Lett. 2004;370(2/3):127–9.
Wang PN , Liu HC , Liu TY , et al. Estrogen-metabolizing gene COMT polymorphism synergistic APOE epsilon4 allele increases the risk of Alzheimer disease. Dement Geriatr Cogn Disord. 2005;19(2/3):120–5.
Forero DA , Benitez B , Arboleda G , et al. Analysis of functional polymorphisms in three synaptic plasticity-related genes (BDNF, COMT AND UCHL1) in Alzheimer's disease in Colombia. Neurosci Res. 2006;55(3):334–41.
Sweet RA , Devlin B , Pollock BG , et al. Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease. Mol Psychiatry. 2005;10(11):1026–36.
Sit D , Rothschild AJ , Wisner KL . A review of postpartum psychosis. J Womens Health (Larchmt). 2006;15(4):352–68.
Rasgon N , Shelton S , Halbreich U . Perimenopausal mental disorders: epidemiology and phenomenology. CNS Spectr. 2005;10(6):471–8.
Chua WL , de Izquierdo SA , Kulkarni J , Mortimer A . Estrogen for schizophrenia. Cochrane Database Syst Rev. 2005(4):CD004719.
Kulkarni J , Gurvich C , Gilbert H , et al. Hormone modulation: a novel therapeutic approach for women with severe mental illness. Aust NZ J Psychiatry. 2008;42(1):83–8.
Herrmann N , Lanctot KL . Pharmacologic management of neuropsychiatric symptoms of Alzheimer disease. Can J Psychiatry. 2007;52(10):630–46.
Sharp L , Cardy AH , Cotton SC , Little J . CYP17 gene polymorphisms: prevalence and associations with hormone levels and related factors. A HuGE review. Am J Epidemiol. 2004;160(8):729–40.
Feigelson HS , McKean-Cowdin R , Pike MC , et al. Cytochrome P450c17{{alpha}} gene (CYP17) polymorphism predicts use of hormone replacement therapy. Cancer Res. 1999;59(16):3908–10.
Masson LF , Sharp L , Cotton SC , Little J . Cytochrome P-450 1A1 gene polymorphisms and risk of breast cancer: a HuGE review. Am J Epidemiol. 2005;161(10):901–15.
Nicholl DJ , Bennett P , Hiller L , et al. A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on atypical Parkinsonism. Neurology. 1999;53(7):1415–21.
Grupe A , Li Y , Rowland C , et al. A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease. Am J Hum Genet. 2006;78(1):78–88.
Kanehisa M , Goto S , Hattori M , et al. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res. 2006;34(Database issue):D354–7.
O'Lone R , Frith MC , Karlsson EK , Hansen U . Genomic targets of nuclear estrogen receptors. Mol Endocrinol. 2004;18(8):1859–75.
Carroll JS , Meyer CA , Song J , et al. Genome-wide analysis of estrogen receptor binding sites. Nat Genet. 2006;38(11):1289–97.
Reynolds WF , Rhees J , Maciejewski D , et al. Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease. Exp Neurol. 1999;155(1):31–41.
Lendon CL , Talbot CJ , Craddock NJ , et al. Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population. Neurosci Lett. 1997;222(3):187–90.
Lamsa R , Helisalmi S , Herukka SK , et al. Genetic study evaluating LDLR polymorphisms and Alzheimer's disease. Neurobiol Aging. 2008;29(6):848–55.
Zou F , Gopalraj RK , Lok J , et al. Sex-dependent association of a common low-density lipoprotein receptor polymorphism with RNA splicing efficiency in the brain and Alzheimer's disease. Hum Mol Genet. 2008;17(7):929–35.
Li Y , Grupe A , Rowland C , et al. DAPK1 variants are associated with Alzheimer's disease and allele-specific expression. Hum Mol Genet. 2006;15(17):2560–8.
Burkhardt MS , Foster JK , Laws SM , et al. Oestrogen replacement therapy may improve memory functioning in the absence of APOE epsilon4. J Alzheimers Dis. 2004;6(3):221–8.
Rippon GA , Tang MX , Lee JH , et al. Familial Alzheimer disease in Latinos: interaction between APOE, stroke, and estrogen replacement. Neurology. 2006;66(1):35–40.
Lehmann DJ , Butler HT , Warden DR , et al. Association of the androgen receptor CAG repeat polymorphism with Alzheimer's disease in men. Neurosci Lett. 2003;340(2):87–90.
Corder EH , Beaumont H . Susceptibility groups for Alzheimer's disease (OPTIMA cohort): integration of gene variants and biochemical factors. Mech Ageing Dev. 2007;128(1):76–82.
Casadesus G , Garrett MR , Webber KM , et al. The estrogen myth: potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer's disease. Drugs R D. 2006;7(3):187–93.
Webber KM , Perry G , Smith MA , Casadesus G . The contribution of luteinizing hormone to Alzheimer disease pathogenesis. Clin Med Res. 2007;5(3):177–83.
Haasl RJ , Ahmadi MR , Meethal SV , et al. A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E epsilon4 allele. BMC Med Genet. 2008;9:37.

Reference Title: References

Reference Type: reference-list

Paganini-Hill A , Henderson V . Estrogen deficiency and risk of Alzheimer's disease in women. Am J Epidemiol. 1994;140:256–61.
Sicotte NL , Liva SM , Klutch R , et al. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol. 2002;52:421–8.
Saunders-Pullman R , Gordon-Elliott J , Parides M , et al. The effect of estrogen replacement on early Parkinson's disease. Neurology. 1999;52:1417–21.
Weisgraber KH . Apolipoprotein E: structure–function relationships. Adv Protein Chem. 1994;45:249–302.
Herz J , Bock HH . Lipoprotein receptors in the nervous system. Annu Rev Biochem. 2002;71:405–34.
Struble RG , Rosario ER , Kircher ML , et al. Regionally specific modulation of brain apolipoprotein E in the mouse during the estrous cycle and by exogenous 17β estradiol. Exp Neurol. 2003;183:638–44.
Struble RG , Nathan BP , Cady C , Cheng X , McAsey M . Estradiol regulation of astroglia and apolipoprotein E: an important role in neuronal regeneration. Exp Gerontol. 2007;42:54–63.
Nathan BP , Barsukova AG , Shen F , McAsey M , Struble RG . Estrogen facilitates neurite extension via apolipoprotein E in cultured adult mouse cortical neurons. Endocrinology. 2004;145:3065–73.
McAsey ME , Cady C , Jackson LM , et al. Time course of response to estradiol replacement in ovariectomized mice: brain apolipoprotein e and synaptophysin transiently increase and glial fibrillary acidic protein is suppressed. Exper Neurol. 2006;197:197–205.
Cheng X , McAsey ME , Li M , et al. Estradiol replacement increases the low-density lipoprotein receptor related protein (LRP) in the mouse brain. Neurosci Lett. 2007;417:50–4.
Yaffe K , Haan M , Byers A , Tangen C , Kuller L . Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction. Neurology. 2000;54:1949–54.
Burkhardt MS , Foster JK , Laws SM , et al. Oestrogen replacement therapy may improve memory functioning in the absence of APOE epsilon4. J Alzheimers Dis. 2004;6:221–8.
Hogervorst E , Lehmann DJ , Warden DR , McBroom J , Smith AD . Apolipoprotein E epsilon4 and testosterone interact in the risk of Alzheimer's disease in men. Int J Geriatr Psychiatry. 2002;17:938–40.
Mattila KM , Axelman K , Rinne JO , et al. Interaction between estrogen receptor 1 and the epsilon 4 allele of apolipoprotein E increases the risk of familial Alzheimer's disease in women. Neurosci Lett. 2000;282:45–8.
Horsburgh K , Macrae IM , Carswell H . Estrogen is neuroprotective via an apolipoprotein E-dependent mechanism in a mouse model of global ischemia. J Cereb Blood Flow Metab. 2002;22:1189–95.
Stone DJ , Rozovsky I , Morgan TE , Anderson CP , Finch CE Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: implications for Alzheimer's disease. J Neurosci. 1998;18:3180–5.
Corder EH , Saunders AM , Strittmatter WJ , et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261(5123):921–3.
Kolsch H , Ptok U , Mohamed I , et al. Association of the C766T polymorphism of the low-density lipoprotein receptor-related protein gene with Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet. 2003;121:128–30.
Tang G , Xie H , Xu L , et al. Genetic study of apolipoprotein E gene, alpha-1 antichymotrypsin gene in sporadic Parkinson disease. Am J Med Genet. 2002;114:446–9.
Zareparsi S , Camicioli R , Sexton G , et al. Age at onset of Parkinson disease and apolipoprotein E genotypes. Am J Med Genet. 2002;107:156–61.
Buchanan DD , Silburn PA , Prince JA , Mellick GD . Association of APOE with Parkinson disease age-at-onset in women. Neurosci Lett. 2007;411:185–8.
Jordan BD . Genetic influences on outcome following traumatic brain injury. Neurochem Res. 2007;32:905–15.
Fazekas F , Strasser-Fuchs S , Kollegger H , et al.Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis. Neurology. 2001;57:853–7.
Masterman T , Zhang Z , Hellgren D , et al. APOE genotypes and disease severity in multiple sclerosis. Mult Scler. 2002;8:98–103.
Li YJ , Pericak-Vance MA , Haines JL , et al. Apolipoprotein E is associated with age at onset of amyotrophic lateral sclerosis. Neurogenetics. 2004;5:209–13.
Briellmann RS , Torn-Broers Y , Busuttil BE , et al. APOE epsilon4 genotype is associated with an earlier onset of chronic temporal lobe epilepsy. Neurology. 2000;55:435–7.
Sheng H , Laskowitz DT , Bennett E , et al. Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice. J Cereb Blood Flow Metab. 1998;18:361–6.
Martínez-González NA , Sudlow CL . Effects of apolipoprotein E genotype on outcome after ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 2006;77:1329–35.
Nathan BP , Nisar R , Randall S , et al. Apolipoprotein E is upregulated in olfactory bulb glia following peripheral receptor lesion in mice. Exp Neurol. 2001;172:128–36.
Poirier J , Hess M , May PC , Finch CE . Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Brain Res Mol Brain Res. 1991;11:97–106.
Nathan BP , Nisar R , Short J , et al. Delayed olfactory nerve regeneration in APOE-deficient mice. Brain Res. 2005;1041:87–94.
Brown CM , Wright E , Colton CAM , et al. Apolipoprotein E isoform mediated regulation of nitric oxide release. Free Radic Biol Med. 2002; 32:1071–5.
Colton, CA , Brown CM , Vitek MP . Sex steroids, APOE genotype and the innate immune system. Neurobiol Aging. 2005;26:363–72.
Paganini-Hill A , Perez Barreto M . Stroke risk in older men and women: aspirin, estrogen, exercise, vitamins, and other factors. J Gend Specif Med. 2001;4:18–28.
LeBlanc ES , Janowsky J , Chan BK , Nelson HD . Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA. 2001;285:1489–99.
Henderson VW , Benke KS , Green RC , Cupples LA , Farrer LA . MIRAGE Study Group. Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. J Neurol Neurosurg Psychiatry. 2005;76:103–5.
Espeland MA , Rapp SR , Shumaker SA , et al. Women's Initiative Memory Study. Conjugated equine estrogens and global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study. JAMA. 2004;291:2959–68.
Asthana S , Baker LD , Craft S , et al. High-dose estradiol improves cognition for women with AD: results of a randomized study. Neurology. 2001;57:605–12.
Thal LJ , Thomas RG , Mulnard R , et al. Estrogen levels do not correlate with improvement in cognition. Arch Neurol. 2003;60:209–12.
Currie LJ , Harrison MB , Trugman JM , Bennett JP , Wooten GF . Postmenopausal estrogen use affects risk for Parkinson disease. Arch Neurol. 2004;61:886–8.
Holmqvist P , Wallberg M , Hammar M , Landtblom AM , Brynhildsen J . Symptoms of multiple sclerosis in women in relation to sex steroid exposure. Maturitas. 2006;54:149–53.
Simpkins JW , Yang SH , Wen Y , Singh M . Estrogens, progestins, menopause and neurodegeneration: basic and clinical studies. Cell Mol Life Sci. 2005;62:271–80.
Lehtimaki T , Dastidar P , Jokela H , et al. Effect of long-term hormone replacement therapy on atherosclerosis progression in postmenopausal women relates to functional apolipoprotein e genotype. J Clin Endocrinol Metab. 2002;87:4147–53.
von Muhlen D , Barrett-Connor E , Kritz-Silverstein D . Apolipoprotein E genotype and response of lipid levels to postmenopausal estrogen use. Atherosclerosis. 2002;161:209–14.
Qiu Z , Crutcher KA , Hyman BT , Rebeck GW . APOE isoforms affect neuronal N-methyl-D-aspartate calcium responses and toxicity via receptor-mediated processes. Neuroscience. 2003;122:291–303.
Drory VE , Birnbaum M , Korczyn AD , Chapman J . Association of APOE epsilon4 allele with survival in amyotrophic lateral sclerosis. J Neurol Sci. 2001;190:17–20.
Popat RA , Van Den Eeden SK , Tanner CM , et al. Effect of reproductive factors and postmenopausal hormone use on the risk of amyotrophic lateral sclerosis. Neuroepidemiology. 2006;27:117–21.
Harden CL , Pulver MC , Ravdin L , Jacobs AR . The effect of menopause and perimenopause on the course of epilepsy. Epilepsia. 1999;40:1402–7.
Joels M . Steroid hormones and excitability in the mammalian brain. Front Neuroendocrinol. 1997;18:2–48.
Khachaturian AS , Corcoran CD , Mayer LS , et al. Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: the Cache County Study. Arch Gen Psychiatry. 2004;61:518–24.
Wang JM , Irwin RW , Brinton RD . Activation of estrogen receptor alpha increases and estrogen receptor beta decreases apolipoprotein E expression in hippocampus in vitro and in vivo. Proc Natl Acad Sci USA. 2006;103:16983–8.

Reference Title: References

Reference Type: reference-list

Ahlbom E , Prins GS , Ceccatelli S . Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism. Brain Res. 2001;892:255–62.
Hammond J , Le Q , Goodyer C , et al. Testosterone mediated neuroprotection through the androgen receptor in human primary neurons. J Neurochem. 2001;77:1319–26.
Pike CJ . Testosterone attenuates b-amyloid toxicity in cultured hippocampal neurons. Brain Res. 2001; 919:160–5.
Lessov-Schlaggar CN , Reed T , Swan GE , et al. Association of sex steroid hormones with brain morphology and cognition in healthy elderly men. Neurology. 2005;65(10):1591–6.
Hogervorst E , Williams J , Budge M , et al. Serum total testosterone is lower in men with Alzheimer's disease. Neuroendocrinology Lett. 2001;22(3):163–8.
Roth M , Huppert FA , Tym E , Mountjoy C . CAMDEX: The Cambridge Examination for Mental Disorders of the Elderly. Cambridge: Cambridge University Press, 1988.
Hogervorst E , Bandelow S , Combrinck M , Smith AD . Low free testosterone is an independent risk factor for Alzheimer's disease. Exp Gerontol. 2004;39(11/12): 1633–9.
Moffat SD , Zonderman AB , Metter EJ , et al. Free testosterone and risk for Alzheimer disease in older men. Neurology. 2004;62(2):188–93.
Paoletti AM , Congia S , Lello S , et al. Low androgenization index in elderly women and elderly men with Alzheimer's disease. Neurology. 2004; 62(2):301–3.
Svartberg M , Midtby M , Bonaa KH , et al. The associations of age, lifestyle factors and chronic disease with testosterone in men: the Tromso Study. Eur J Endo. 2003;149(2):145–52.
Hoskin EK , Tang MX , Manly JJ , Mayeux R . Elevated sex-hormone binding globulin in elderly women with Alzheimer's disease. Neurobiol Aging. 2004;25(2):141–7.
Brenta G , Schnitman M , Gurfinkiel M , et al. Variations of sex hormone-binding globulin in thyroid dysfunction. Thyroid. 1999;9(3):273–7.
Skjoldebrand-Sparre L , Kollind M , Carlstrom K . Ovarian ultrasound and ovarian and adrenal hormones before and after treatment for hyperthyroidism. Gynecol Obstet Invest. 2002;54(1):50–5.
Zahringer S , Tomova A , von Werder K , et al. The influence of hyperthyroidism on the hypothalamic-pituitary-gonadal axis. Exp Clin Endocrinol Diabetes. 2002;108(4):282–9.
van Osch LA , Hogervorst E , Combrinck M , Smith AD . Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease. Neurology. 2004;62(11):1967–71.
Demers LM , Spencer CA . NACB, Biochemistry TNAoC, Laboratory Medicine Practice Guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Available at http://www.nacb.org/lmpg/thyroid_LMPG_PDF.stm.
Kalmijn S , Mehta KM , Pols HAP , et al. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin Endocrinol. 2000;53:733–7.
Wahlin A , Wahlin TBR , Small BJ , Backman L . Influences of thyroid stimulating hormone on cognitive functioning in very old age. J Gerontol Ser B Psychol Sci. 1998;53(4):P234–P239.
Wahlin A , Bunce D , Wahlin TB . Longitudinal evidence of the impact of normal thyroid stimulating hormone variations on cognitive functioning in very old age. Psychoneuroendocrinology. 2005;30(7):625–37.
Hogervorst E , Matthews F , Huppert FA , Brayne C . Thyroid function and cognitive decline in the MRC Cognitive Function & Ageing Study. Psychoneuroendocrinology. 2008;33(7):1013–22.
Tsitouras PD , Bulat T . The aging male reproductive system. Endocrinol Metab Clin North Am. 1995;24:297–315.
Bowen RL , Isley JP , Atkinson RL . An association of elevated serum gonadotropin concentrations and Alzheimer disease? J Neuroendocrinol. 2000;12(4):351–4.
Short RA , Bowen RL , O'Brien PC , Graff Radford NR . Elevated gonadotropin levels in patients with Alzheimer disease. Mayo Clin Proc. 2001;76(9):906–9.
Schrijnemaeckers AMC , De Jager CA , Hogervorst E , Budge MM . Cases with Mild Cognitive Impairment and Alzheimer's disease fail to benefit from repeated exposure to episodic memory tests as compared with controls. J Clin Exp Neuropsychol. 2006;28(3):438–55.
DeJager CA , Hogervorst E , Combrinck M , Budge MM . Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer's disease. Psychol Med. 2003;33(6):1039–50.
Almeida OP , Waterreus A , Spry N , Flicker L , Martins RN . One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men. Psychoneuroendocrinology. 2004;29(8):1071–81.
Green HJ , Pakenham KI , Headley BC , et al. Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: a randomized controlled trial. BJU Int. 2004;93(7):975–9.
Cherrier MM , Rose AL , Higano C . The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer. J Urol. 2003;170(5):1808–11.
Salminen EK , Portin RI , Koskinen A , Helenius H , Nurmi M . Associations between serum testosterone fall and cognitive function in prostate cancer patients. Clin Cancer Res. 2004;10(22):7575–82.
Grigorova M , Sherwin BB , Tulandi T . Effects of treatment with leuprolide acetate depot on working memory and executive functions in young premenopausal women. Psychoneuroendocrinology. 2006;31(8):935–47.
Sherwin BB , Tulandi T . “Add-back” estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J Clin Endocrinol Metab. 1996;81(7):2545–9.
Newton C , Slota D , Yuzpe AA , Tummon IS . Memory complaints associated with the use of gonadotropin-releasing hormone agonists: a preliminary study. Fertil Steril. 1996;65(6):1253–5.
Varney NR , Syrop C , Kubu CS , et al. Neuropsychologic dysfunction in women following leuprolide acetate induction of hypoestrogenism. J Assist Reprod Genet. 1993;10(1):53–7.
Cherrier MM , Matsumoto AM , Amory JK , et al. The role of aromatization in testosterone supplementation: effects on cognition in older men. Neurology. 2005;64(2):290–6.
Tworoger SS , Chubak J , Aiello EJ , et al. Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2004;13(1):94–101.
Iivonen S , Corder E , Lehtovirta M , et al. Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease. Neurology. 2004;62(7): 1170–6.
Rosario ER , Chang L , Stanczyk FZ , Pike CJ . Age-related testosterone depletion and the development of Alzheimer disease. JAMA. 2004;292(12):1431–2.
Hogervorst E , Lehmann DJ , Warden DR , McBroom J , Smith AD . Apolipoprotein E epsilon4 and testosterone interact in the risk of Alzheimer's disease in men. Int J Geriatr Psychiatry. 2002;17(10):938–40.
Burkhardt MS , Foster JK , Clarnette RM , et al. Interaction between testosterone and apolipoprotein E epsilon4 status on cognition in healthy older men. J Clin Endocrinol Metab. 2006;91(3):1168–72.
Raber J , Bongers G , LeFevour A , Buttini M , Mucke L . Androgens protect against apolipoprotein E4-induced cognitive deficits. J Neurosci. 2002;22(12):5204–9.
Yaffe K , Edwards ER , Lui LY , et al. Androgen receptor CAG repeat polymorphism is associated with cognitive function in older men. Biol Psychiatry. 2003;54(9):943–6.
Lehmann DJ , Butler HT , Warden DR , et al. Association of the androgen receptor CAG repeat polymorphism with Alzheimer disease in men. Neurosci Lett. 2003;340(2):87–90.
Lehmann DJ , Hogervorst E , Warden DR , et al. The androgen receptor CAG repeat and serum testosterone in the risk of Alzheimer's disease in men. J Neurol Neurosurg Psychiatry. 2004;75(1):163–4.
Beilin J , Ball EM , Favaloro JM , Zajac JD . Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines. J Mol Endocrinol. 2000;25(1):85–96.
Krithivas K , Yurgalevitch SM , Mohr BA , et al. Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men. J Endocrinol. 1999;162(1):137–42.

Reference Title: References

Reference Type: reference-list

Burger NZ , Johnson JV . Androgen production in women. In Tulandi T , Gelfand MM , eds. Androgens and Reproductive Aging. Boca Ratan, FL: Taylor & Francis, 2006, pp. 1–4.
Burger HG . Androgen production in women. Fertil Steril. 2002;77:S3–S5.
Davison SL , Davis SR . Androgens in women. J Steroid Biochem Mol Biol. 2003;85:363–6.
Zumoff B , Strain GW , Miller LK , et al. Twenty-four hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab. 1995;80:1429–30.
Adashi EY . The climacteric ovary as a functional gonadotropin-driven androgen-producing gland. Fertil Steril. 1994;62:20–7.
Judd H , Lucas WE , Yen SSC . Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol. 1974;118:793–8.
Labrie F , Belanger A , Cusan L , et al. Marked decline in serum concentrations of adrenal C-19 sex steroid precursors and conjugated androgen metabolism during aging. J Clin Endocrinol Metab. 1997;82:2396–402.
Clancy AN , Bonsall RW , Michael RP . Immunohistochemical labeling of androgen receptors in the brain of the rat and monkey. Life Sci. 1992;50:409–17.
Gibbs RB . Expression of estrogen receptor-like immunoreactivity by different subgroups of basal forebrain cholinergic neurons in gonadectomized male and female rats. Brain Res. 1996;720:61–8.
Kerr JE , Beck SG , Handa RJ . Androgens selectively modulate c-fos messenger RNA induction in the rat hippocampus following novelty. Neuroscience. 1996;70:757–66.
Simerly RB , Chang C , Muramatsu MS , et al. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in-situ hybridization study. J Comp Neurol. 1990;294:76–95.
Osterlund MK , Hurd YL . Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders. Prog Neurobiol. 2001;64:251–67.
Puy L , MacLusky NJ , Becker L , et al. Immunocytochemical detection of androgen receptor in human temporal cortex: characterization and application of polyclonal androgen receptor antibodies in frozen and paraffin-embedded tissues. J Steroid Biochem Mol Biol. 1995;55:197–209.
Sarrieau A , Mitchell JB , Lal S , et al. Androgen binding sites in human temporal cortex. Neuroendocrinology. 1990;51:713–16.
Taylor AH , Al-Azzawi F . Immunolocalisation of estrogen receptor beta in human tissues. J Clin Endocr Metab. 2000;24:145–55.
Beyenburg S , Watzka M , Clusmann H , et al. Androgen receptor mRNA expression in the human hippocampus. Neurosci Lett. 2000;294:25–8.
Tohgi H , Utsugisawa K , Yamagata M , et al. Effects of age on messenger RNA expression of glucocorticoid, thyroid hormone, androgen, and estrogen receptors in postmortem human hippocampus. Brain Res. 1995;700:245–53.
Donahue JE , Stopa EG , Chorsky RL , et al. Cells containing immunoreactive estrogen receptor-a in the human basal forebrain. Brain Res. 2000;856:142–51.
Fernández-Guasti A , Kruijver FPM , Fodor M , et al. Sex differences in the distribution of androgen receptors in the human hypothalamus. J Comp Neurol. 2000;425:422–35.
Luine VN , Khylchevskaya RI , McEwen BS . Effect of gonadal steroids on activities of monoamine oxidase and choline acetylase in rat brain. Brain Res. 1975; 86:293–306.
Fink G , Sumner B , Rosie R , et al. Androgen actions on central serotonin neurotransmitters: relevance for mood, mental state, and memory. Behav Brain Sci. 1999;211:311–52.
Bitar MS , Ota M , Linnoila M , et al. Modification of gonadectomy-induced increases in brain monoamine metabolism by steroid hormones in male and female rats. Psychoneuroendocrinology. 1991;16:547–57.
DeVoogd TJ , Nottebohm F . Gonadal hormones induce dendritic growth in the adult brain. Science. 1981;214:202–4.
Leranth C , Hajszan T , MacLusky NJ . Androgen increases spine synapse density in the CA1 hippocampal subfield of ovariectomized female rats. J Neurosci. 2004;24:495–9.
Archer JS , Love-Geffen TE , Herbst-Damm KL , et al. Effect of estradiol versus estradiol and testosterone on brain-activation patterns in postmenopausal women. Menopause. 2006;13:528–37.
Halpern DF . Sex Differences in Cognitive Abilities. Hillsdale: Lawrence Erlbaum Associates, 1992.
White PC , Speiser PW . Congenital adrenal hyperplasia due to 21-hydroxylase deficiencies. Endocr Rev. 2000;21:245–91.
Baker SW , Ehrhardt AA . Prenatal androgen, intelligence and cognitive sex differences. In Friedman RC , Richart RM , Wiele RLV , eds. Sex Differences in Behavior. New York: Wiley, 1974, pp. 53–76.
Perlman SM . Cognitive abilities of children with hormonal abnormalities: screening by psychoeducational tests. J Learn Disabil. 1973;6:22–9.
Resnick SM , Berenbaum SA , Gottesman II , et al. Early hormonal influences on cognitive functioning in congenital adrenal hyperplasia. Dev Psychol. 1986;22:191–8.
Nordenstrom A , Servin A , Bhlin G , et al. Sex-typed toy play behavior correlates with the degree of prenatal androgen exposure assessed by CYP21 genotype in girls with congenital adrenal hyperphasia. J Clin Endocrinol Metab. 2002;87:5119–24.
Bagger Y , Tanko L , Alexandersen G , et al. Early postmenopausal hormone therapy may prevent cognitive impairment later in life. Menopause. 2005;12:12–17.
Hampson E . Variations in sex-related cognitive abilities across the menstrual cycle. Brain Cognition. 1990;14:26–43.
Maki PM , Rich JB , Rosenbaum RS . Implicit memory varies across the menstrual cycle: estrogen effects in young women. Neuropsychologia. 2002;40:518–29.
Gouchie C , Kimura D . The relationship between testosterone levels and cognitive ability patterns. Psychoneuroendocrinology. 1991;16:323–34.
Hassler M , Gupta D , Wollmann H . Testosterone, estradiol, ACTH and musical, spatial and verbal performance. Int J Neurosci. 1992;65:45–60.
Moffat SD , Hampson E . A curvilinear relationship between testosterone and spatial cognition in humans: possible influence of hand preference. Psychoneuroendocrinology. 1996;21:323–37.
Silverman I , Kastuk D , Choi J , et al. Testosterone levels and spatial ability in men. Psychoneuroendocrinology. 1999;24:813–22.
Wolf OT , Kirschbaum C . Endogenous estradiol and testosterone levels are associated with cognitive performance in older women and men. Horm Behav. 2002;41:259–66.
Carlson LE , Sherwin BB . Higher levels of plasma estradiol and testosterone in healthy elderly men compared with age-matched women may protect aspects of explicit memory. Menopause. 2000;7:168–77.
Hogervorst E , De Jager C , Budge M , et al. Serum levels of estradiol and testosterone and performance in different cognitive domains in healthy elderly men and women. Psychoneuroendocrinology. 2004; 29:405–21.
Thilers PP , MacDonald SWS , Herlitz A . The association between endogenous free testosterone and cognitive performance: a population-based study in 35 to 90 year-old men and women. Psychoneuroendocrinology. 2006;31:565–76.
Sherwin BB . Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology. 1988;13:345–57.
Aleman A , Bronk E , Kessels RPC , et al. A single administration of testosterone improves visuospatial ability in young women. Psychoneuroendocrinology. 2004;29:612–17.
Shah S , Bell RJ , Savage G , et al. Testosterone aromatization and cognition in women: a randomized, placebo-controlled trial. Menopause. 2006;13:600–8.
Asuncion M , Calco RM , Millan JL , et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000;85:2434–8.
Lobo RA , Carmina E . Polycystic ovary syndrome. In Lobo RA , Mishell DR , Paulson RJ , eds. Infertility, Contraception and Reproductive Endocrinology, 4th edn. Malden, MA: Blackwell Science, 1997, pp. 363–83.
Schattmann L , Sherwin BB . Testosterone levels and cognitive functioning in women with polycystic ovary syndrome and in healthy young women. Horm Behav. 2007;51:587–96.
Barnard L , Balen AH , Ferriday D , et al. Cognitive functioning in polycystic ovary syndrome. Psychoneuroendocrinology. 2007;32:906–14.
Schattmann L , Sherwin BB . Effects of the pharmacologic manipulation of testosterone on cognitive functioning in women with polycystic ovary syndrome: a randomized, placebo-controlled treatment study. Horm Behav. 2007;51:579–86.

Reference Title: References

Reference Type: reference-list

Roselli CE , Klosterman S , Resko JA . Anatomic relationships between aromatase and androgen receptor mRNA expression in the hypothalamus and amygdala of adult male cynomolgus monkeys. J Comp Neurol. 2001;439(2):208–23.
Brown TJ , Adler GH , Sharma M , Hochberg RB , MacLusky NJ . Androgen treatment decreases estrogen receptor binding in the ventromedial nucleus of the rat brain: a quantitative in vitro autoradiographic analysis. Mol Cell Neurosci. 1994;5(6):549–55.
Lynch CS , Story AJ . Dihydrotestosterone and estrogen regulation of rat brain androgen-receptor immunoreactivity. Physiol Behav. 2000;69(4/5): 445–53.
Singh R , Pervin S , Shryne J , Gorski R , Chaudhuri G . Castration increases and androgens decrease nitric oxide synthase activity in the brain: physiologic implications. Proc Natl Acad Sci USA. 2000;97(7): 3672–7.
Kerr JE , Allore RJ , Beck SG , Handa RJ . Distribution and hormonal regulation of androgen receptor (AR) and AR messenger ribonucleic acid in the rat hippocampus. Endocrinology. 1995;136(8):3213–21.
Lieberherr M , Grosse B . Androgens increase intracellular calcium concentration and inositol 1,4,5-trisphosphate and diacylglycerol formation via a pertussis toxin-sensitive G-protein. J Biol Chem. 1994;269(10):7217–23.
Benten WP , Lieberherr M , Sekeris CE , Wunderlich F . Testosterone induces Ca2+ influx via non-genomic surface receptors in activated T cells. FEBS Lett. 1997;407(2):211–14.
Benten WP , Lieberherr M , Stamm O , et al. Testosterone signaling through internalizable surface receptors in androgen receptor-free macrophages. Mol Biol Cell. 1999;10(10):3113–23.
Benten WP , Lieberherr M , Giese G , et al. Functional testosterone receptors in plasma membranes of T cells. FASEB J. 1999;13(1):123–33.
Cyr M , Calon F , Morissette M , et al. Drugs with estrogen-like potency and brain activity: potential therapeutic application for the CNS. Curr Pharm Des. 2000;6(12):1287–312.
Gundlah C , Kohama SG , Mirkes SJ , et al. Distribution of estrogen receptor beta (ERbeta) mRNA in hypothalamus, midbrain and temporal lobe of spayed macaque: continued expression with hormone replacement. Brain Res Mol Brain Res. 2000;76(2):191–204.
Osterlund MK , Gustafsson JA , Keller E , Hurd YL . Estrogen receptor beta (ERbeta) messenger ribonucleic acid (mRNA) expression within the human forebrain: distinct distribution pattern to ERalpha mRNA. J Clin Endocrinol Metab. 2000;85(10):3840–6.
Michael RP , Rees HD , Bonsall RW . Sites in the male primate brain at which testosterone acts as an androgen. Brain Res. 1989;502(1):11–20.
Osterlund MK , Grandien K , Keller E , Hurd YL . The human brain has distinct regional expression patterns of estrogen receptor alpha mRNA isoforms derived from alternative promoters. J Neurochem. 2000;75(4):1390–7.
Ishunina TA , Fisser B , Swaab DF . Sex differences in androgen receptor immunoreactivity in basal forebrain nuclei of elderly and Alzheimer patients. Exp Neurol. 2002;176(1):122–32.
de Fougerolles Nunn E , Greenstein B , Khamashta M , Hughes GR . Evidence for sexual dimorphism of estrogen receptors in hypothalamus and thymus of neonatal and immature Wistar rats. Int J Immunopharmacol. 1999;21(12):869–77.
Nakamura N , Fujita H , Kawata M . Effects of gonadectomy on immunoreactivity for choline acetyltransferase in the cortex, hippocampus, and basal forebrain of adult male rats. Neuroscience. 2002;109(3):473–85.
Kritzer MF . Long-term gonadectomy affects the density of tyrosine hydroxylase- but not dopamine-beta-hydroxylase-, choline acetyltransferase- or serotonin-immunoreactive axons in the medial prefrontal cortices of adult male rats. Cereb Cortex. 2003;13(3):282–96.
Kritzer MF . Effects of acute and chronic gonadectomy on the catecholamine innervation of the cerebral cortex in adult male rats: insensitivity of axons immunoreactive for dopamine-beta-hydroxylase to gonadal steroids, and differential sensitivity of axons immunoreactive for tyrosine hydroxylase to ovarian and testicular hormones. J Comp Neurol. 2000;427(4):617–33.
Kritzer MF , Adler A , Marotta J , Smirlis T . Regionally selective effects of gonadectomy on cortical catecholamine innervation in adult male rats are most disruptive to afferents in prefrontal cortex. Cereb Cortex. 1999;9(5):507–18.
Kritzer MF . Perinatal gonadectomy exerts regionally selective, lateralized effects on the density of axons immunoreactive for tyrosine hydroxylase in the cerebral cortex of adult male rats. J Neurosci. 1998;18(24):10735–48.
Leranth C , Hajszan T , MacLusky NJ . Androgens increase spine synapse density in the CA1 hippocampal subfield of ovariectomized female rats. J Neurosci. 2004;24(2):495–9.
Kritzer MF , McLaughlin PJ , Smirlis T , Robinson JK . Gonadectomy impairs T-maze acquisition in adult male rats. Horm Behav. 2001;39(2):167–74.
Naghdi N , Oryan S , Etemadi R . The study of spatial memory in adult male rats with injection of testosterone enanthate and flutamide into the basolateral nucleus of the amygdala in Morris water maze. Brain Res. 2003;972(1/2):1–8.
Naghdi N , Nafisy N , Majlessi N . The effects of intrahippocampal testosterone and flutamide on spatial localization in the Morris water maze. Brain Res. 2001;897(1/2):44–51.
Bimonte-Nelson HA , Singleton RS , Nelson ME , et al. Testosterone, but not nonaromatizable dihydrotestosterone, improves working memory and alters nerve growth factor levels in aged male rats. Exp Neurol. 2003;181(2):301–12.
Woolley CS . Effects of oestradiol on hippocampal circuitry. Novartis Found Symp. 2000;230:173–80.
Hajszan T , MacLusky NJ , Johansen JA , Jordan CL , Leranth C . Effects of androgens and estradiol on spine synapse formation in the prefrontal cortex of normal and testicular feminization mutant male rats. Endocrinology. 2007;148(5):1963–7.
Yarbrough WG , Quarmby VE , Simental JA , et al. A single base mutation in the androgen receptor gene causes androgen insensitivity in the testicular feminized rat. J Biol Chem. 1990;265(15):8893–900.
MacLusky NJ , Hajszan T , Prange-Kiel J , Leranth C . Androgen modulation of hippocampal synaptic plasticity. Neuroscience. 2006;138(3):957–65.
Gordon HW , Lee PA . A relationship between gonadotropins and visuospatial function. Neuropsychologia. 1986;24:563–76.
Van Goozen SHM , Cohen-Kettenis PT , Gooren LJG , Frijda NH , Van De Poll NE . Activating effects of androgens on cognitive performance: causal evidence in a group of female-to-male transsexuals. Neuropsychologia. 1994;32(10):1153–7.
Slabbekoorn D , van Goozen SH , Megens J , Gooren LJ , Cohen-Kettenis PT . Activating effects of cross-sex hormones on cognitive functioning: a study of short-term and long-term hormone effects in transsexuals. Psychoneuroendocrinology. 1999;24(4): 423–47.
Miles C , Green R , Sanders G , Hines M . Estrogen and memory in a transsexual population. Horm Behav. 1998;34:199–208.
Postma A , Meyer G , Tuiten A , et al. Effects of testosterone administration on selective aspects of object-location memory in healthy young women. Psychoneuroendocrinology. 2000;25(6):563–75.
Sommer IE , Cohen-Kettenis PT , van Raalten T , et al. Effects of cross-sex hormones on cerebral activation during language and mental rotation: an fMRI study in transsexuals. Eur Neuropsychopharmacol. 2008;18(3):215–21.
Matsumoto AM . ‘Andropause’ – are reduced androgen levels in aging men physiologically important? [editorial; comment]. West J Med. 1993;159(5):618–20.
Oursler MJ , Osdoby P , Pyfferoen J , Riggs BL , Spelsberg TC . Avian osteoclasts as estrogen target cells. Proc Natl Acad Sci USA. 1991;88(15):6613–17.
Eriksen EF , Colvard DS , Berg NJ , et al. Evidence of estrogen receptors in normal human osteoblast-like cells. Science. 1988;241(4861):84–6.
Colvard DS , Eriksen EF , Keeting PE , et al. Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci USA. 1989;86(3):854–7.
Khosla S , Riggs BL . Androgens, estrogens, and bone turnover in men. J Clin Endocrinol Metab. 2003;88(5):2352.
Korach KS , Couse JF , Curtis SW , et al. Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Prog Horm Res. 1996;51:159–86; discussion 86–8.
Snyder PJ , Peachey H , Berlin JA , et al. Effect of transdermal testosterone treatment on serum lipid and apolipoprotein levels in men more than 65 years of age. Am J Med. 2001;111(4):255–60.
Barrett-Connor EL . Testosterone and risk factors for cardiovascular disease in men. Diabetes Metab. 1995;21(3):156–61.
Moorjani S , Dupont A , Labrie F , et al. Changes in plasma lipoproteins during various androgen suppression therapies in men with prostatic carcinoma: effects of orchiectomy, estrogen, and combination treatment with luteinizing-hormone-releasing hormone agonist and flutamide. J Clin Endocrinol Metab. 1988;66(2):314–22.
Leder BZ . Testosterone, estradiol and aromatase inhibitor therapy in elderly men. J Steroid Biochem Mol Biol. 2007;106(1/5):162–7.
Sih R , Morley JE , Kaiser FE , et al. Testosterone replacement in older hypogonadal men: a 12 month randomized controlled trial. J Clin Endocrinol Metab. 1997;82(6):1661–7.
Janowsky JS , Oviatt SK , Orwoll ES . Testosterone influences spatial cognition in older men. Behav Neurosci. 1994;108(2):325–32.
Janowsky JS , Chavez B , Orowoll E . Sex steroids modify working memory. J Cogn Neurosci. 2000;12(3):407–14.
Cherrier MM , Asthana S , Baker LD , et al. Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology. 2001;57:80–8.
Maki PM , Ernst M , London ED , et al. Intramuscular testosterone treatment in elderly men: evidence of memory decline and altered brain function. J Clin Endocrinol Metab. 2007;92(11):4107–14.
Salminen E , Portin R , Korpela J , et al. Androgen deprivation and cognition in prostate cancer. Br J Cancer. 2003;89(6):971–6.
Salminen EK , Portin RI , Koskinen A , Helenius H , Nurmi M . Associations between serum testosterone fall and cognitive function in prostate cancer patients. Clin Cancer Res. 2004;10(22):7575–82.
Salminen EK , Portin RI , Koskinen AI , Helenius HY , Nurmi MJ . Estradiol and cognition during androgen deprivation in men with prostate carcinoma. Cancer. 2005;103(7):1381–7.
Almeida OP , Waterreus A , Spry N , Flicker L , Martins RN . One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men. Psychoneuroendocrinology. 2004;29(8):1071–81.
Green HJ , Pakenham KI , Headley BC , et al. Altered cognitive function in men treated for prostate cancer with luteinizing-hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial. BJU Int. 2002;90(4):427–32.
Green HJ , Pakenham KI , Headley BC , et al. Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: a randomized controlled trial. BJU Int. 2004;93(7):975–9.
Cherrier MM , Rose AL , Higano C . The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer. J Urol. 2003;170(5):1808–11.
Taxel P , Stevens MC , Trahiotis M , Zimmerman J , Kaplan RF . The effect of short-term estradiol therapy on cognitive function in older men receiving hormonal suppression therapy for prostate cancer. J Am Geriatr Soc. 2004;52(2):269–73.
Beer TM , Bland LB , Bussiere JR , et al. Testosterone loss and estradiol administration modify memory in men. J Urol. 2006;175(1):130–5.
Kenny AM , Bellantonio S , Gruman CA , Acosta RD , Prestwood KM . Effects of transdermal testosterone on cognitive function and health perception in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci. 2002;57(5):M321–5.
Cherrier MM , Craft S , Matsumoto AH . Cognitive changes associated with supplementation of testosterone or dihydrotestosterone in mildly hypogonadal men: a preliminary report. J Androl. 2003;24(4):568–76.
Vaughan C , Goldstein FC , Tenover JL . Exogenous testosterone alone or with finasteride does not improve measurements of cognition in healthy older men with low serum testosterone. J Androl. 2007;28(6):875–82.
Azad N , Pitale S , Barnes WE , Friedman N . Testosterone treatment enhances regional brain perfusion in hypogonadal men. J Clin Endocrinol Metab. 2003;88(7):3064–8.
Zitzmann M , Weckesser M , Schober O , Nieschlag E . Changes in cerebral glucose metabolism and visuospatial capability in hypogonadal males under testosterone substitution therapy. Exp Clin Endocrinol Diabetes. 2001;109(5):302–4.
Tan RS , Pu SJ . A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer's disease. Aging Male. 2003;6(1):13–17.
Lu PH , Masterman DA , Mulnard R , et al. Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men. Arch Neurol. 2006;63(2):177–85.
Kenny AM , Fabregas G , Song C , Biskup B , Bellantonio S . Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss. J Gerontol A Biol Sci Med Sci. 2004;59(1):75–8.
Cherrier MM , Matsumoto AH , Asthana S , et al. Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment. Neurology. 2005;64:2063–8.
Cherrier MM , Matsumoto AM , Amory JK , et al. The role of aromatization in testosterone supplementation: effects on cognition in older men. Neurology. 2005;64:290–6.

Reference Title: References

Reference Type: reference-list

Becker JB , Breedlove SM , Crews D. Behavioral Endocrinology. Cambridge, MA: MIT Press.
Kerr JE , Allore RJ , Beck SG , Handa RJ. Distribution and hormonal regulation of androgen receptor (AR) and AR messenger ribonucleic acid in the rat hippocampus. Endocrinology. 1995;136(8):3213–21.
Roof RL , Havens MD. Testosterone improves maze performance and induces development of a male hippocampus in females. Brain Res. 1992;572(1/2): 310–13.
Williams CL , Meck WH. The organizational effects of gonadal steroids on sexually dimorphic spatial ability. Psychoneuroendocrinology. 1991;16(1/3):155–76.
Jacobson CD , Csernus VJ , Shryne JE , Gorski RA. The influence of gonadectomy, androgen exposure, or a gonadal graft in the neonatal rat on the volume of the sexually dimorphic nucleus of the preoptic area. J Neurosci. 1981;1(10): 1142–7.
Diamond MC. Hormonal effects on the development of cerebral lateralization. Psychoneuroendocrinology. 1991;16(1–3):121–9.
Flood JF , Farr SA , Kaiser FE , La Regina M , Morley JE. Age-related decrease of plasma testosterone in SAMP8 mice: replacement improves age-related impairment of learning and memory. Physiol Behav. 1995;57(4):669–73.
Pouliot WA , Handa RJ , Beck SG. Androgen modulates N-methyl-D-aspartate-mediated depolarization in CA1 hippocampal pyramidal cells. Synapse. 1996;23(1):10–19.
Morse JK , DeKosky ST , Scheff SW. Neurotrophic effects of steroids on lesion-induced growth in the hippocampus. II. Hormone replacement. Exp Neurol. 1992;118(1):47–52.
Tirassa P , Thiblin I , Agren G , et al. High-dose anabolic androgenic steroids modulate concentrations of nerve growth factor and expression of its low affinity receptor (p75-NGFr) in male rat brain. J Neurosci Res. 1997;47(2):198–207.
Gouras GK , Xu H , Gross RS , et al. Testosterone reduces neuronal secretion of Alzheimer's beta-amyloid peptides. Proc Natl Acad Sci USA. 2000;97(3):1202–5.
Pike CJ. Testosterone attenuates beta-amyloid toxicity in cultured hippocampal neurons. Brain Res. 2001;919(1):160–5.
Rosario ER , Carroll JC , Oddo S , LaFerla FM , Pike CJ. Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer's disease. J Neurosci. 2006;26(51): 13384–9.
Hammond J , Le Q , Goodyer C , et al. Testosterone-mediated neuroprotection through the androgen receptor in human primary neurons. J Neurochem. 2001;77(5):1319–26.
Harman SM , Metter EJ , Tobin JD , Pearson J , Blackman MR . Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001;86(2):724–31.
Lamberts SW , van den Beld AW , van der Lely AJ . The endocrinology of aging. Science. 1997;278(5337): 419–24.
Carruthers M. Androgen Deficiency in the Adult Male. London, UK: Taylor & Francis.
Gruenewald DA , Matsumoto AM . Testosterone supplementation therapy for older men: potential benefits and risks. J Am Geriatr Soc. 2003;51(1):101–15; discussion 115.
Tan RS. Memory loss as a reported symptom of andropause. Arch Androl. 2001;47(3): 185–9.
Christiansen K , Knussmann R. . Sex hormones and cognitive functioning in men. Neuropsychobiology. 1987;18(1):27–36.
Gouchie C , Kimura D . The relationship between testosterone levels and cognitive ability patterns. Psychoneuroendocrinology. 1991;16(4):323–34.
Moffat SD , Hampson E . A curvilinear relationship between testosterone and spatial cognition in humans: possible influence of hand preference. Psychoneuroendocrinology. 1996;21(3):323–37.
Aleman A , de Vries WR , Koppeschaar HP , et al. Relationship between circulating levels of sex hormones and insulin-like growth factor-1 and fluid intelligence in older men. Exp Aging Res. 2001;27(3): 283–91.
Barrett-Connor E , Goodman-Gruen D , Patay B. Endogenous sex hormones and cognitive function in older men. J Clin Endocrinol Metab. 1999;84(10): 3681–5.
Burkhardt MS , Foster JK , Clarnette RM , et al.Interaction between testosterone and apolipoprotein E epsilon4 status on cognition in healthy older men. J Clin Endocrinol Metab. 2006;91(3):1168–72.
Driscoll I , Hamilton DA , Yeo RA , Brooks WM , Sutherland RJ . Virtual navigation in humans: the impact of age, sex, and hormones on place learning. Horm Behav. 2005;47(3):326–35.
Fonda SJ , Bertrand R , O'Donnell A , Longcope C , McKinlay JB . Age, hormones, and cognitive functioning among middle-aged and elderly men: cross-sectional evidence from the Massachusetts Male Aging Study. J Gerontol A Biol Sci Med Sci. 2005;60(3):385–90.
Geerlings MI , Strozyk D , Masaki K , et al. Endogenous sex hormones, cognitive decline, and future dementia in old men. Ann Neurol. 2006;60(3):346–55.
Hogervorst E , De Jager C , Budge M , Smith AD. Serum levels of estradiol and testosterone and performance in different cognitive domains in healthy elderly men and women. Psychoneuroendocrinology. 2004;29(3):405–21.
Martin DM , Wittert G , Burns NR , Haren MT , Sugarman R. Testosterone and cognitive function in ageing men: data from the Florey Adelaide Male Ageing Study (FAMAS). Maturitas. 2007;57(2):182–94.
Moffat SD , Zonderman AB , Metter EJ , et al. Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab. 2002;87(11):5001–7.
Morley JE , Kaiser F , Raum WJ , et al. Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone. Proc Natl Acad Sci USA. 1997;94(14):7537–42.
Muller M , Aleman A , Grobbee DE , de Haan EH , van der Schouw YT. Endogenous sex hormone levels and cognitive function in aging men: is there an optimal level? Neurology. 2005;64(5):866–71.
Perry PJ , Lund BC , Arndt S , et al. Bioavailable testosterone as a correlate of cognition, psychological status, quality of life, and sexual function in aging males: implications for testosterone replacement therapy. Ann Clin Psychiatry. 2001;13(2):75–80.
Thilers PP , Macdonald SW , Herlitz A. The association between endogenous free testosterone and cognitive performance: a population-based study in 35 to 90 year-old men and women. Psychoneuroendocrinology. 2006;31(5):565–76.
Wolf OT , Kirschbaum C. Endogenous estradiol and testosterone levels are associated with cognitive performance in older women and men. Horm Behav. 2002;41(3):259–66.
Yaffe K , Lui LY , Zmuda J , Cauley J. Sex hormones and cognitive function in older men. J Am Geriatr Soc. 2002;50(4):707–12.
Yeap BB , Almeida OP , Hyde Z , et al. Higher serum free testosterone is associated with better cognitive function in older men, while total testosterone is not. The Health in Men Study. Clin Endocrinol (Oxf). 2008;68(3):404–12.
Brinton RD . Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Ann N Y Acad Sci. 2005;1052:57–74.
Sherwin BB . Estrogen and memory in women: how can we reconcile the findings? Horm Behav. 2005;47(3):371–5.
Guazzo EP , Kirkpatrick PJ , Goodyer IM , Shiers HM , Herbert J. Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age. J Clin Endocrinol Metab. 1996;81(11):3951–60.
Mulchahey JJ , Ekhator NN , Zhang H , et al. Cerebrospinal fluid and plasma testosterone levels in post-traumatic stress disorder and tobacco dependence. Psychoneuroendocrinology. 2001;26(3):273–85.
Moffat SD , Zonderman AB , Metter EJ , et al. Free testosterone and risk for Alzheimer disease in older men. Neurology. 2004;62(2):188–93.
Bowen RL , Isley JP , Atkinson RL . An association of elevated serum gonadotropin concentrations and Alzheimer disease. J Neuroendocrinol. 2000;12(4):351–354.
Hogervorst E , Williams J , Budge M , et al. Serum total testosterone is lower in men with Alzheimer's disease. Neuroendocrinol Lett. 2001;22(3):163–8.
Paoletti AM , Congia S , Lello S , et al. Low androgenization index in elderly women and elderly men with Alzheimer's disease. Neurology. 2004;62(2):301–3.
Watanabe T , Koba S , Kawamura M , et al. Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia. Metabolism. 2004;53(4):476–82.
Ravaglia G , Forti P , Maioli F , et al. Endogenous sex hormones as risk factors for dementia in elderly men and women. J Gerontol A Biol Sci Med Sci. 2007;62(9):1035–41.
Pennanen C , Laakso MP , Kivipelto M , Ramberg J , Soininen H. Serum testosterone levels in males with Alzheimer's disease. J Neuroendocrinol. 2004;16(2):95–8.
Rosario ER , Chang L , Stanczyk FZ , Pike CJ. Age-related testosterone depletion and the development of Alzheimer disease. JAMA. 2004;292(12):1431–2.
Hogervorst E , Bandelow S , Combrinck M , Smith AD . Low free testosterone is an independent risk factor for Alzheimer's disease. Exp Gerontol. 2004;39(11/12): 1633–9.
Rasmuson S , Nasman B , Carlstrom K , Olsson T. Increased levels of adrenocortical and gonadal hormones in mild to moderate Alzheimer's disease. Dement Geriatr Cogn Disord. 2002;13(2):74–9.
Chu LW , Tam S , Lee PW , et al. Bioavailable testosterone is associated with a reduced risk of amnestic mild cognitive impairment in older men. Clin Endocrinol (Oxf). 2008;68(4):589–98.
Hogervorst E , Bandelow S. The controversy over levels of sex steroids in cases with Alzheimer's disease. J Neuroendocrinol. 2004;16(2):93–4.
Meethal SV , Smith MA , Bowen RL , Atwood CS. The gonadotropin connection in Alzheimer's disease. Endocrine. 2005;26(3):317–26.
Bowen RL , Smith MA , Harris PL , et al. Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology. J Neurosci Res. 2002;70(3):514–18.

Reference Title: References

Reference Type: reference-list

Maki PM , Ernst M , London ED , et al. Intramuscular testosterone treatment in elderly men: evidence of memory decline and altered brain function. J Clin Endocrinol Metab. 2007;92(11):4107–14.
Resnick SM , Maki PM , Rapp SR , et al. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J Clin Endocrinol Metab. 2006;91(5):1802–10.
Shumaker S , Legault C , Rapp S , et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289:2651–62.
Morley JE , Kaiser FE , Perry HM , 3rd, et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism. 1997;46(4):410–13.
Harman SM , Metter EJ , Tobin JD , Pearson J , Blackman MR . Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001 Feb;86(2):724–31.
Feldman HA , Longcope C , Derby CA , et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab. 2002;87(2):589–98.
Rosario ER , Chang L , Stanczyk FZ , Pike CJ . Age-related testosterone depletion and the development of Alzheimer disease. JAMA. 2004;292(12):1431–2.
Hogervorst E , Williams J , Budge M , et al. Serum total testosterone is lower in men with Alzheimer's disease. Neuro Endocrinol Lett. 2001;22(3):163–8.
Moffat SD , Zonderman AB , Metter EJ , et al. Free testosterone and risk for Alzheimer disease in older men. Neurology. 2004;62(2):188–93.
Moffat SD , Zonderman AB , Metter EJ , et al. Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab. 2002;87(11):5001–7.
Ramsden M , Nyborg AC , Murphy MP , et al. Androgens modulate beta-amyloid levels in male rat brain. J Neurochem. 2003;87(4):1052–5.
Gouras GK , Xu H , Gross RS , et al. Testosterone reduces neuronal secretion of Alzheimer's beta-amyloid peptides. Proc Natl Acad Sci USA. 2000;97(3):1202–5.
Goodenough S , Engert S , Behl C . Testosterone stimulates rapid secretory amyloid precursor protein release from rat hypothalamic cells via the activation of the mitogen-activated protein kinase pathway. Neurosci Lett. 2000;296(1):49–52.
Gandy S , Almeida OP , Fonte J , et al. Chemical andropause and amyloid-beta peptide. JAMA. 2001;285(17):2195–6.
Almeida OP , Waterreus A , Spry N , Flicker L , Martins RN . One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men. Psychoneuroendocrinology. 2004;29(8):1071–81.
Janowsky JS , Chavez B , Orwoll E . Sex steroids modify working memory. J Cogn Neurosci. 2000;12(3):407–14.
Janowsky JS , Oviatt SK , Orwoll ES . Testosterone influences spatial cognition in older men. Behav Neurosci. 1994;108(2):325–32.
Sih R , Morley JE , Kaiser FE , et al. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab. 1997;82(6):1661–7.
Kenny AM , Bellantonio S , Gruman CA , Acosta RD , Prestwood KM . Effects of transdermal testosterone on cognitive function and health perception in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci. 2002;57(5):M321–5.
Kenny AM , Fabregas G , Song C , Biskup B , Bellantonio S . Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss. J Gerontol A Biol Sci Med Sci. 2004;59(1):75–8.
Cherrier MM , Asthana S , Plymate S , et al. Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology. 2001;57(1):80–8.
Haren MT , Wittert GA , Chapman IM , Coates P , Morley JE . Effect of oral testosterone undecanoate on visuospatial cognition, mood and quality of life in elderly men with low-normal gonadal status. Maturitas. 2005;50(2):124–33.
Cherrier MM , Matsumoto AM , Amory JK , et al. The role of aromatization in testosterone supplementation: effects on cognition in older men. Neurology. 2005;64(2):290–6.
Cherrier MM , Matsumoto AM , Amory JK , et al. Characterization of verbal and spatial memory changes from moderate to supraphysiological increases in serum testosterone in healthy older men. Psychoneuroendocrinology. 2007;32(1):72–9.
Yue X , Lu M , Lancaster T , et al. Brain estrogen deficiency accelerates A-beta plaque formation in an Alzheimer's disease animal model. Proc Natl Acad Sci USA. 2005;102(52):19198–203.
Snyder PJ , Peachey H , Hannoush P , et al. Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab. 1999;84(6):1966–72.
Liverman CT , Blazer DG . Testosterone and aging: clinical research directions . Institute of Medicine Committee on Assessing the Need for Clinical Trials of Testosterone Replacement Therapy. Washington DC: National Academies Press, 2003.
Swerdloff RS , Wang C . Androgens and the ageing male. Best Pract Res Clin Endocrinol Metab. 2004;18(3):349–62.
Krause W , Mueller U , Mazur A . Testosterone supplementation in the aging male: which questions have been answered? Aging Male. 2005;8(1):31–8.
Snyder PJ , Peachey H , Hannoush P , et al. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab. 1999;84(8):2647–53.
Bhasin S , Woodhouse L , Casaburi R , et al. Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle. J Clin Endocrinol Metab. 2005;90(2):678–88.
Wang C , Catlin DH , Starcevic B , et al. Testosterone metabolic clearance and production rates determined by stable isotope dilution/tandem mass spectrometry in normal men: influence of ethnicity and age. J Clin Endocrinol Metab. 2004 ;89(6):2936–41.
Snyder PJ . Effects of age on testicular function and consequences of testosterone treatment. J Clin Endocrinol Metab. 2001;86(6):2369–72.
Brinton RD . Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Ann N Y Acad Sci. 2005;1052:57–74.
Cherrier MM , Matsumoto AM , Amory JK , et al. Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment. Neurology. 2005;64(12):2063–8.
Mulnard RA , Cotman CW , Kawas C , et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. JAMA. 2000;283:1007–15.
Lu PH , Masterman DA , Mulnard R , et al. Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men. Arch Neurol. 2006;63(2):177–85.
Moffat SD , Resnick SM . Long-term measures of free testosterone predict regional cerebral blood flow patterns in elderly men. Neurobiol Aging. 2007;28(6):914–20.
Simerly RB , Chang C , Muramatsu M , Swanson LW . Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J Comp Neurol. 1990;294(1):76–95.
Beyenburg S , Watzka M , Clusmann H , et al. Androgen receptor mRNA expression in the human hippocampus. Neurosci Lett. 2000;294(1):25–8.
Leranth C , Prange-Kiel J , Frick KM , Horvath TL . Low CA1 spine synapse density is further reduced by castration in male non-human primates. Cereb Cortex. 2004;14(5):503–10.
Leranth C , Petnehazy O , MacLusky NJ . Gonadal hormones affect spine synaptic density in the CA1 hippocampal subfield of male rats. J Neurosci. 2003;23(5):1588–92.
Finley SK , Kritzer MF . Immunoreactivity for intracellular androgen receptors in identified subpopulations of neurons, astrocytes and oligodendrocytes in primate prefrontal cortex. J Neurobiol. 1999;40(4):446–57.
Cabeza R , Nyberg L . Imaging cognition II: an empirical review of 275 PET and fMRI studies. J Cogn Neurosci. 2000;12(1):1–47.
Kritzer M . The distribution of immunoreactivity for intracellular androgen receptors in the cerebral cortex of hormonally intact adult male and female rats: localization in pyramidal neurons making corticocortical connections. Cereb Cortex. 2004;14(3):268–80.
Redoute J , Stoleru S , Gregoire MC , et al. Brain processing of visual sexual stimuli in human males. Hum Brain Mapp. 2000;11(3):162–77.
Tierney MC , Yao C , Kiss A , McDowell I . Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years. Neurology. 2005;64(11):1853–9.

Reference Title: References

Reference Type: reference-list

Twist SJ , Taylor GA , Weddell A , et al. Brain oestradiol and testosterone levels in Alzheimer's disease. Neurosci Lett. 2000;286(1):1–4.
NAMS continuing medical education activity . Menopause. 2005;12(5):496.
Burger HG , Dudley EC , Cui J , et al. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab. 2000;85:2832–8.
Overlie I , Moen MH , Morkrid L , et al. The endocrine transition around menopause – a five year prospective study with profiles of gonadotropins, estrogens and SHBG among healthy women. Acta Obstetr Gynecol Scand. 1999;78:642–7.
Zumoff B , Strain GW , Miller KL , et al. Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab. 1995;80(4):1429–30.
Davison SL , Bell R , Donath S , et al. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab. 2005;90:3847–53.
Gleason CE , Schmitz TW , Koscik RL , et al. Hormone effects on fMRI and cognitive measures of encoding: importance of hormone preparation. Neurology. 2006;67:2039–41.
Wharton W , Fitzgerald A , Carlsson C , et al. Effects of hormone therapy duration on functional MRI activation. Graylyn Conference in Women's Cognitive Health, 2007, Abstract.
Shaywitz SE , Shaywitz BA , Pugh KR , et al. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA. 1999;281:1197–202.
Hogervorst E , Bandelow S , Combrinck M , et al. Low free testosterone is an independent risk factor for Alzheimer's disease. Exp Gerontol. 2004;39(11/12):1633–9.
Cherrier MM , Asthana S , Plymate S . Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology. 2001;57:80–8.
Cherrier MM , Matsumoto AM , Amory JK , et al. Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment. Neurology. 2005;64:2063–8.
Smith MD , Jones LS , Wilson MA . Sex differences in hippocampal slice excitability: role of testosterone. Neuroscience. 2002;109:517–30.
Pouliot WA , Handa RJ , Beck SG . Synapse. 1996;23:10–19.
Morse JK , DeKosky ST , Schett SW . Exp Neurol. 1992;118:47–52.
Tirassa P , Thiblin I , Agren G , et al. Neurosci Res. 1997;47:198–207.
Archer JS , Love-Geffen TE , Herbst-Damm KL , et al. NAMS Fellowship findings: effect of estradiol versus estradiol and testosterone on brain-activation patterns in postmenopausal women. Menopause. 2006;13(3):528–37.
Leranth C , Hajszan T , MacLusky NJ . Androgens increase spine synapse density in the CA1 hippocampal subfield of ovariectomized female rats. J Neurosci. 2004;24(2):495–9.
Gandy S , Almeida OP , Fonte J , et al. Chemical andropause and amyloid-beta peptide. JAMA. 2001;285:2195–6.
Papasozomenos SC . The heat-shock induced hyperphosphorylation of tau is estrogen-independent and prevented by androgens: implications for Alzheimer's disease. Proc Natl Acad Sci USA. 1997;94:6612–17.
Gouras GK , Xu H , Gross RS , et al. Testosterone reduces neuronal secretion of Alzheimer's beta-amyloid peptides. Proc Natl Acad Sci USA. 2000;97(3):1202–5.
Papasozomenos SC , Shanavas A . Testosterone prevents the heat shock-induced overactivation of glycogen synthase kinase-3β but not of cyclin-dependent kinase 5 and c-Jun NH2-terminal kinase and concomitantly abolishes hyperphosphorylation of τ: Implications for Alzheimer's disease. Proc Natl Acad Sci. 2002;99(3):1140–5.
Davison SL , Davis SR . Androgens in women. J Steroid Biochem Mol Biol. 2003;85:363–6.
Simon JA . Safety of estrogen/androgen regimens. J Reprod Med. 2001;46(3 Suppl.):281–90.
Wierman ME , Basson R , Davis SR , et al. Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab. 2006;91(10):3697–710.
Wharton W , Hirshman E , Merritt P , et al. Oral contraceptives and androgenicity: influences on visuospatial task performance in younger individuals. Exp Clin Psychopharm. 2008;16(2):156–64.
Moffat SD , Hampson E . A curvilinear relationship between testosterone and spatial cognition in humans: possible influence of hand preference. Psychoneuroendocrinology. 1996;21:323–37.
Miller KK , Grieco KA , Klibanski A . Testosterone administration in women with anorexia nervosa. J Clin Endocrinol Metab. 2005;90:1428–33.
Aleman A , Bronk E , Kessels R , et al. A single administration of testosterone improves visuospatial ability in young women. Psychoneuroendocrinology. 2004;29:612–17.
Drake EB , Henderson VW , Stanczyk FZ , et al. Associations between circulating sex steroid hormones and cognition in normal elderly women. Neurology. 2000;54:599–603.
Wolf OT , Kirschbaum C . Endogenous estradiol and testosterone levels are associated with cognitive performance in older women and men. Horm Behav. 2002;41:259–66.
Wisniewski AB , Nguyen TT , Dobs AS . Evaluation of high-dose estrogen and high-dose estrogen plus methyltestosterone treatment on cognitive task performance in postmenopausal women. Horm Res. 2002;58:150–5.
Regestein QR , Friebely J , Shifren J , et al. Neuropsychological effects of methyltestosterone in women using menopausal hormone replacement. J Womens Health Gend Based Med. 2001;10(7):671–6.
Sherwin BB . Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology. 1988;13:345–57.
Rosenberg L , Park S . Verbal and spatial functions across the menstrual cycle in healthy young women. Psychoneuroendocrinology. 2002;27(7):835–41.
Sherwin BB . Mild cognitive impairment: potential pharmacological treatment options. J Am Geriatr Soc. 2000;48(4):431–41.

Reference Title: References

Reference Type: reference-list

Cummings JL , Cole G . Alzheimer disease. JAMA. 2002;287:2335–8.
Yaffe K , Lui LY , Grady D , et al. Cognitive decline in women in relation to non-protein-bound oestradiol concentrations. Lancet. 2000;356:708–12.
Tang MX , Jacobs D , Stern Y , et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 1996;348:429–32.
Veiga S , Melcangi RC , Doncarlos LL , Garcia-Segura LM , Azcoitia I. Sex hormones and brain aging. Exp Gerontol. 2004;39:1623–31.
Den Heijer T , Geerlings MI , Hofman A , et al. Higher estrogen levels are not associated with larger hippocampi and better memory performance. Arch Neurol. 2003;60:213–20.
Geerlings MI , Launer LJ , de Jong FH , et al. Endogenous estradiol and risk of dementia in women and men: the Rotterdam Study. Ann Neurol. 2003;53:607–15.
Geerlings MI , Ruitenberg A , Witteman JC , et al. Reproductive period and risk of dementia in postmenopausal women. JAMA. 2001;285:1475–81.
Shumaker SA , Legault C , Kuller L , et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study. JAMA. 2004;291:2947–58.
Muller M , van der Schouw YT , Thijssen JH , Grobbee DE . Endogenous sex hormones and cardiovascular disease in men. J Clin Endocrinol Metab. 2003;88:5076–86.
Muller M , Grobbee DE , Thijssen JH , van den Beld AW , van der Schouw YT . Sex hormones and male health: effects on components of the frailty syndrome. Trends Endocrinol Metab. 2003;14:289–96.
de Ronde W , Pols HA , van Leeuwen JP , de Jong FH . The importance of oestrogens in males. Clin Endocrinol (Oxf). 2003;58:529–42.
Lessov-Schlaggar CN , Reed T , Swan GE , et al. Association of sex steroid hormones with brain morphology and cognition in healthy elderly men. Neurology. 2005;65:1591–6.
Aleman A , de Vries WR , Koppeschaar HP , et al. Relationship between circulating levels of sex hormones and insulin-like growth factor-1 and fluid intelligence in older men. Exp Aging Res. 2001;27:283–91.
Martin DM , Wittert G , Burns NR , Haren MT , Sugarman R . Testosterone and cognitive function in ageing men: data from the Florey Adelaide Male Ageing Study (FAMAS). Maturitas. 2007;57:182–94.
Muller M , Aleman A , Grobbee DE , de Haan EH , van der Schouw YT . Endogenous sex hormone levels and cognitive function in aging men. Is there an optimal level? Neurology. 2005;64(5):866–71.
Wolf OT , Kirschenbaum C . Endogenous estradiol and testosterone levels are associated with cognitive performance in older women and men. Horm Behav. 2002;41:259–66.
Yaffe K , Lui LY , Zmuda J , Cauley J . Sex hormones and cognitive function in older men. J Am Geriatr Soc. 2002;50:707–12.
Hogervorst E , De Jager C , Budge M , Smith AD . Serum levels of estradiol and testosterone and performance in different cognitive domains in healthy elderly men and women. Psychoneuroendocrinology. 2004;29:405–21.
Senanarong V , Vannasaeng S , Poungvarin N , et al. Endogenous estradiol in elderly individuals: cognitive and noncognitive associations. Arch Neurol. 2002;59:385–9.
Paoletti AM , Congia S , Lello S , et al. Low androgenization index in elderly women and elderly men with Alzheimer's disease. Neurology. 2004;62:301–3.
Irie F , Strozyk D , Peila R , et al. Brain lesions on MRI and endogenous sex hormones in elderly men. Neurobiol Aging. 2006;27:1137–44.
Strozyk D , White LR , Petrovitch H , et al. Sex hormones and neuropathology in elderly men: the HAAS. Neurobiol Aging. 2007;28(1): 62–8.
Barrett-Connor E , Goodman-Gruen D , Patay B . Endogenous sex hormones and cognitive function in older men. J Clin Endocrinol Metab. 1999;84:3681–5.
Muller M , van den Beld AW , Grobbee DE , de Jong FH , Lamberts SW . Sex hormones and cognitive decline in elderly men. Psychoneuroendocrinology. 2009; 34(1):27–31.
Ravaglia G , Forti P , Maioli F , et al. Endogenous sex hormones as risk factors for dementia in elderly men and women. J Gerontol A Biol Sci Med Sci. 2007;62:1035–41.
Yaffe K , Barnes D , Lindquist K , et al. Endogenous sex hormone levels and risk of cognitive decline in an older biracial cohort. Neurobiol Aging. 2007;28:171–8.
Geerlings MI , Strozyk D , Masaki K , et al. Endogenous sex hormones, cognitive decline, and future dementia in old men. Ann Neurol. 2006;60:346–55.
Elias MF , Beiser A , Wolf PA , et al. The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham Cohort. Arch Neurol. 2000;57:808–13.
Hogervorst E , Lehmann DJ , Warden DR , McBroom J , Smith AD . Apolipoprotein E epsilon4 and testosterone interact in the risk of Alzheimer's disease in men. Int J Geriatr Psychiatry. 2002;17:938–40.
Yaffe K , Haan M , Byers A , Tangen C , Kuller L . Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction. Neurology. 2000;54:1949–54.
Breteler MM . Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging. 2000;21:153–60.
Luchsinger JA , Mayeux R . Cardiovascular risk factors and Alzheimer's disease. Curr Atheroscler Rep. 2004;6:261–6.
Sudhir K , Komesaroff PA . Clinical review 110: Cardiovascular actions of estrogens in men. J Clin Endocrinol Metab. 1999;84:3411–15.
Arnlov J , Pencina MJ , Amin S , et al. Endogenous sex hormones and cardiovascular disease incidence in men. Ann Intern Med. 2006;145:176–84.
Muller M , den Tonkelaar I , Thijssen JHH , Grobbee DE , van der Schouw YT . Endogenous sex hormones in men aged 40–80 years. Eur J Endocrinol. 2003;149:583–9.
Muller M , Grobbee De, den Tonkelaar I , Lamberts SW , van der Schouw YT . Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab. 2005;90:2618–23.
Phillips GB , Jing T , Heymsfield SB . Relationships in men of sex hormones, insulin, adiposity, and risk factors for myocardial infarction. Metabolism. 2003;52:784–90.
Nakhai Pour HR , Grobbee DE , Muller M , van der Schouw YT . Association of endogenous sex hormone with C-reactive protein levels in middle-aged and elderly men. Clin Endocrinol (Oxf). 2007;66:394–8.
Tivesten A , Mellstrom D , Jutberger H , et al. Low serum testosterone and high serum estradiol associate with lower extremity peripheral arterial disease in elderly men. The MrOS Study in Sweden. J Am Coll Cardiol. 2007;50:1070–6.
Phillips GB , Pinkernell BH , Jing TY . The association of hyperestrogenemia with coronary thrombosis in men. Arterioscler Thromb Vasc Biol. 1996;16:1383–7.
Muller M , van den Beld AW , Bots ML , et al. Endogenous sex hormones and progression of carotid atherosclerosis in elderly men. Circulation. 2004;109:2074–9.
Tivesten A , Hulthe J , Wallenfeldt K , et al. Circulating estradiol is an independent predictor of progression of carotid artery intima-media thickness in middle-aged men. J Clin Endocrinol Metab. 2006;91:4433–7.
Abbott RD , Launer LJ , Rodriguez BL , et al. Serum estradiol and risk of stroke in elderly men. Neurology. 2007;68:563–8.
de Ronde W , van der Schouw YT , Muller M , et al. Associations of sex-hormone-binding globulin (SHBG) with non-SHBG-bound levels of testosterone and estradiol in independently living men. J Clin Endocrinol Metab. 2005;90:157–62.
Hammond GL . Potential functions of plasma steroid-binding proteins. Trends Endocrinol Metab. 1995;6:298–304.
Caldwell JD , Suleman F , Chou SH , et al. Emerging roles of steroid-binding globulins. Horm Metab Res. 2006;38:206–18.
Herbert Z , Gothe S , Caldwell JD , et al. Identification of sex hormone-binding globulin in the human hypothalamus. Neuroendocrinology. 2005;81:287–93.
Hogervorst E , Bandelow S , Combrinck M , Smith AD . Low free testosterone is an independent risk factor for Alzheimer's disease. Exp Gerontol. 2004;39:1633–9.
Hoskin EK , Tang MX , Manly JJ , Mayeux R . Elevated sex-hormone-binding globulin in elderly women with Alzheimer's disease. Neurobiol Aging. 2004;25:141–7.
Muller M , Schupf N , Manly JJ , Mayeux R , Luchsinger JA . Sex hormone-binding globulin and incident Alzheimer's disease in elderly men and women. Neurobiol Aging. 2008. [Epub ahead of print].
Garcia-Segura LM , Veiga S , Sierra A , Melcangi RC , Azcoitia I . Aromatase: a neuroprotective enzyme. Prog Neurobiol. 2003;71:31–41.
Longcope C , Billiar RB , Takaoka Y , et al. Tissue sites of aromatization in the female rhesus monkey. Endocrinology. 1983;113:1679–82.
Lambert JC , Harris JM , Mann D , et al. Are the estrogen receptors involved in Alzheimer's disease? Neurosci Lett. 2001;306:193–7.

Reference Title: References

Reference Type: reference-list

Kaufman JM , Vermeulen A . The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev. 2005;26(6):833–76.
Morley JE . Androgens and aging. Maturitas. 2001;38(1):61–71; discussion 3.
Pike CJ , Rosario ER , Nguyen TV . Androgens, aging, and Alzheimer's disease. Endocrine. 2006;29(2):233–41.
Rosario ER , Pike CJ . Androgen regulation of beta-amyloid protein and the risk of Alzheimer's disease. Brain Res Rev. 2008;57(2):444–53.
Hogervorst E , Combrinck M , Smith AD . Testosterone and gonadotropin levels in men with dementia. Neuroendocrinol Lett. 2003;24(3/4):203–8.
Hogervorst E , Williams J , Budge M , et al. Serum total testosterone is lower in men with Alzheimer's disease. Neuroendocrinol Lett. 2001;22(3):163–8.
Pennanen C , Laakso MP , Kivipelto M , Ramberg J , Soininen H . Serum testosterone levels in males with Alzheimer's disease. J Neuroendocrinol. 2004;16(2):95–8.
Moffat SD , Zonderman AB , Metter EJ , et al. Free testosterone and risk for Alzheimer disease in older men. Neurology. 2004;62(2):188–93.
Rosario ER , Chang L , Stanczyk FZ , Pike CJ . Age-related testosterone depletion and the development of Alzheimer disease. JAMA. 2004;292(12):1431–2.
MacLusky NJ , Hajszan T , Prange-Kiel J , Leranth C . Androgen modulation of hippocampal synaptic plasticity. Neuroscience. 2006;138(3):957–65.
Galea LA . Gonadal hormone modulation of neurogenesis in the dentate gyrus of adult male and female rodents. Brain Res Rev. 2008;57(2):332–41.
Pike CJ , Nguyen TV , Ramsden M , et al. Androgen cell signaling pathways involved in neuroprotective actions. Horm Behav. 2008;53(5):693–705.
Ramsden M , Shin TM , Pike CJ . Androgens modulate neuronal vulnerability to kainate lesion. Neuroscience. 2003;122(3):573–8.
Papasozomenos SC , Papasozomenos T . Androgens prevent the heat shock-induced hyperphosphorylation but not dephosphorylation of tau in female rats. Implications for Alzheimer's disease. J Alzheimers Dis. 1999;1(3):147–53.
Hardy J . Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal. J Alzheimers Dis. 2006;9(3 Suppl):151–3.
Almeida OP , Flicker L . Testosterone and dementia: too much ado about too little data. J Br Menopause Soc. 2003;9(3):107–10.
Gandy S , Almeida OP , Fonte J , et al. Chemical andropause and amyloid-beta peptide. JAMA. 2001;285(17):2195–6.
Gillett MJ , Martins RN , Clarnette RM , et al. Relationship between testosterone, sex hormone binding globulin and plasma amyloid beta peptide 40 in older men with subjective memory loss or dementia. J Alzheimers Dis. 2003;5(4):267–9.
Ramsden M , Nyborg AC , Murphy MP , et al. Androgens modulate beta-amyloid levels in male rat brain. J Neurochem. 2003;87(4):1052–5.
Rosario ER , Carroll JC , Oddo S , LaFerla FM , Pike CJ . Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer's disease. J Neurosci. 2006;26(51):13384–9.
Gouras GK , Xu H , Gross RS , et al. Testosterone reduces neuronal secretion of Alzheimer's beta-amyloid peptides. Proc Natl Acad Sci USA. 2000;97(3):1202–5.
Yao M , Nguyen TV , Rosario ER , Ramsden M , Pike CJ . Androgens regulate neprilysin expression: role in reducing beta-amyloid levels. J Neurochem 2008.
Azcoitia I , Sierra A , Veiga S , Garcia-Segura LM . Aromatase expression by reactive astroglia is neuroprotective. Ann N Y Acad Sci. 2003;1007:298–305.
Xu H , Wang R , Zhang YW , Zhang X . Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer's disease. Ann N Y Acad Sci. 2006;1089:324–42.
Goodenough S , Engert S , Behl C . Testosterone stimulates rapid secretory amyloid precursor protein release from rat hypothalamic cells via the activation of the mitogen-activated protein kinase pathway. Neurosci Lett. 2000;296(1):49–52.
Bowen RL , Isley JP , Atkinson RL . An association of elevated serum gonadotropin concentrations and Alzheimer disease? J Neuroendocrinol. 2000;12(4):351–4.
Casadesus G , Webber KM , Atwood CS , et al. Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice. Biochim Biophys Acta. 2006;1762(4):447–52.
Bowen RL , Verdile G , Liu T , et al. Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition. J Biol Chem. 2004;279(19):20539–45.
Gharib SD , Wierman ME , Shupnik MA , Chin WW . Molecular biology of the pituitary gonadotropins. Endocr Rev. 1990;11(1):177–99.
Hersh LB , Rodgers DW . Neprilysin and amyloid beta peptide degradation. Curr Alzheimer Res. 2008;5(2):225–31.
Janowsky JS . The role of androgens in cognition and brain aging in men. Neuroscience. 2006;138(3):1015–20.
Cherrier MM , Craft S , Matsumoto AH . Cognitive changes associated with supplementation of testosterone or dihydrotestosterone in mildly hypogonadal men: a preliminary report. J Androl. 2003;24(4):568–76.
Janowsky JS , Oviatt SK , Orwoll ES . Testosterone influences spatial cognition in older men. Behav Neurosci. 1994;108(2):325–32.
Moffat SD , Zonderman AB , Metter EJ , et al. Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab. 2002;87(11):5001–7.
Emmelot-Vonk MH , Verhaar HJ , Nakhai Pour HR , et al. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. JAMA. 2008;299(1):39–52.
Haren MT , Wittert GA , Chapman IM , Coates P , Morley JE . Effect of oral testosterone undecanoate on visuospatial cognition, mood and quality of life in elderly men with low-normal gonadal status. Maturitas. 2005;50(2):124–33.
Maki PM , Ernst M , London ED , et al. Intramuscular testosterone treatment in elderly men: evidence of memory decline and altered brain function. J Clin Endocrinol Metab. 2007;92(11):4107–14.
Cherrier MM , Matsumoto AM , Amory JK , et al. Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment. Neurology. 2005;64(12):2063–8.
Tan RS , Culberson JW . An integrative review on current evidence of testosterone replacement therapy for the andropause. Maturitas. 2003;45(1):15–27.
Lu PH , Masterman DA , Mulnard R , et al. Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men. Arch Neurol. 2006;63(2):177–85.
Green HJ . Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing analogues and cyproterone acetate: a randomized controlled trial. BJU International. 2002;90(4):427–32.
Salminen EK , Portin RI , Koskinen A , Helenius H , Nurmi M . Associations between serum testosterone fall and cognitive function in prostate cancer patients. Clin Cancer Res. 2004;10(22):7575–82.
Lu-Yao GL , Albertsen PC , Moore DF , et al. Survival following primary androgen deprivation therapy among men with localized prostate cancer. JAMA. 2008;300(2):173–81.
Fleshner N , Zlotta AR . Prostate cancer prevention: past, present, and future. Cancer. 2007;110(9):1889–99.
Wilson EM , French FS . Binding properties of androgen receptors. Evidence for identical receptors in rat testis, epididymis, and prostate. J Biol Chem. 1976;251(18):5620–9.
Ostrowski J , Kuhns JE , Lupisella JA , et al. Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in rats. Endocrinology. 2007;148(1):4–12.
Shao TC , Li HL , Kasper S , et al. Comparison of the growth-promoting effects of testosterone and 7-alpha-methyl-19-nor-testosterone (MENT) on the prostate and levator ani muscle of LPB-tag transgenic mice. Prostate. 2006;66(4):369–76.
Venken K , Boonen S , Van Herck E , et al. Bone and muscle protective potential of the prostate-sparing synthetic androgen 7alpha-methyl-19-nortestosterone: evidence from the aged orchidectomized male rat model. Bone. 2005;36(4):663–70.
von Eckardstein S , Noe G , Brache V , et al. A clinical trial of 7 alpha-methyl-19-nortestosterone implants for possible use as a long-acting contraceptive for men. J Clin Endocrinol Metab. 2003;88(11):5232–9.
Gao W , Reiser PJ , Coss CC , et al. Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats. Endocrinology. 2005;146(11):4887–97.
Rosario ER , Chang L , Head EH , Stanczyk FZ , Pike CJ . Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease. Neurobiol Aging, 2009 May 8 [Epub ahead of print].

Reference Title: References

Reference Type: reference-list

Smith MA . Alzheimer disease. Int Rev Neurobiol. 1998;42:1–54.
Hebert LE , Scherr PA , Bienias JL , Bennett DA , Evans DA . Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003;60:1119–22.
Hardy J , Selkoe DJ . The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297:353–6.
Walsh DM , Selkoe DJ . Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration. Protein Pept Lett. 2004;11:213–28.
Smith MA , Casadesus G , Joseph JA , Perry G . Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain. Free Radic Biol Med. 2002;33:1194–9.
Lee HG , Zhu X , Nunomura A , Perry G , Smith MA . Amyloid-beta vaccination: testing the amyloid hypothesis? Heads we win, tails you lose! Am J Pathol. 2006;169:738–9.
Joseph J , Shukitt-Hale B , Denisova NA , et al. Copernicus revisited: amyloid beta in Alzheimer's disease. Neurobiol Aging. 2001;22:131–46.
Rottkamp CA , Atwood CS , Joseph JA , et al. The state versus amyloid-beta: the trial of the most wanted criminal in Alzheimer disease. Peptides. 2002;23:1333–41.
Smith MA , Rottkamp CA , Nunomura A , Raina AK , Perry G . Oxidative stress in Alzheimer's disease. Biochim Biophys Acta. 2000;1502:139–44.
Raina AK , Zhu X , Smith MA . Alzheimer's disease and the cell cycle. Acta Neurobiol Exp (Wars). 2004;64:107–12.
Zhu X , Raina AK , Perry G , Smith MA . Alzheimer's disease: the two-hit hypothesis. Lancet Neurol. 2004;3:219–26.
Casadesus G , Atwood CS , Zhu X , et al. Evidence for the role of gonadotropin hormones in the development of Alzheimer disease. Cell Mol Life Sci. 2005;62:293–8.
Marlatt MW , Webber KM , Moreira PI , et al. Therapeutic opportunities in Alzheimer disease: one for all or all for one? Curr Med Chem. 2005;12:1137–47.
Tang MX , Jacobs D , Stern Y , et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 1996;348:429–32.
Barnes LL , Wilson RS , Bienias JL , et al. Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry. 2005;62:685–91.
Wu JM , Zelinski MB , Ingram DK , Ottinger MA . Ovarian aging and menopause: current theories, hypotheses, and research models. Exp Biol Med (Maywood). 2005;230:818–28.
Meredith S , Dudenhoeffer G , Butcher RL , Lerner SP , Walls T . Unilateral ovariectomy increases loss of primordial follicles and is associated with increased metestrous concentration of follicle-stimulating hormone in old rats. Biol Reprod. 1992;47:162–8.
Nelson HD . Menopause. Lancet. 2008;371:760–70.
Fillit H , Weinreb H , Cholst I , et al. Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type. Psychoneuroendocrinology. 1986;11:337–45.
Sherwin BB . Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology. 1988;13:345–57.
Garcia-Segura LM , Azcoitia I , DonCarlos LL . Neuroprotection by estradiol. Prog Neurobiol. 2001;63:29–60.
Woolley CS , McEwen BS . Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol. 1993;336:293–306.
Hao J , Janssen WG , Tang Y , et al. Estrogen increases the number of spinophilin-immunoreactive spines in the hippocampus of young and aged female rhesus monkeys. J Comp Neurol. 2003;465:540–50.
Choi JM , Romeo RD , Brake WG , et al. Estradiol increases pre- and post-synaptic proteins in the CA1 region of the hippocampus in female rhesus macaques (Macaca mulatta). Endocrinology. 2003;144:4734–8.
Kretz O , Fester L , Wehrenberg U , et al. Hippocampal synapses depend on hippocampal estrogen synthesis. J Neurosci. 2004;24:5913–21.
Sudhof TC , Jahn R . Proteins of synaptic vesicles involved in exocytosis and membrane recycling. Neuron. 1991;6:665–77.
Feng J , Yan Z , Ferreira A , et al. Spinophilin regulates the formation and function of dendritic spines. Proc Natl Acad Sci USA. 2000;97:9287–92.
Qiu J , Bosch MA , Tobias SC , et al. Rapid signaling of estrogen in hypothalamic neurons involves a novel G-protein-coupled estrogen receptor that activates protein kinase C. J Neurosci. 2003;23:9529–40.
Bales KR , Verina T , Cummins DJ , et al. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. Proc Natl Acad Sci USA. 1999;96:15233–8.
Gibbs RB , Aggarwal P . Estrogen and basal forebrain cholinergic neurons: implications for brain aging and Alzheimer's disease-related cognitive decline. Horm Behav. 1998;34:98–111.
Luine VN , Khylchevskaya RI , McEwen BS . Effect of gonadal steroids on activities of monoamine oxidase and choline acetylase in rat brain. Brain Res. 1975;86:293–306.
Shumaker SA , Legault C , Rapp SR , et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289:2651–62.
Rapp SR , Espeland MA , Shumaker SA , et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289:2663–72.
Baum LW . Sex, hormones, and Alzheimer's disease. J Gerontol A Biol Sci Med Sci. 2005;60:736–43.
Henderson VW . Hormone therapy and Alzheimer's disease: benefit or harm? Expert Opin Pharmacother. 2004;5:389–406.
Hoskin EK , Tang MX , Manly JJ , Mayeux R . Elevated sex-hormone binding globulin in elderly women with Alzheimer's disease. Neurobiol Aging. 2004;25:141–7.
Hogervorst E , Bandelow S , Combrinck M , Smith AD . Low free testosterone is an independent risk factor for Alzheimer's disease. Exp Gerontol. 2004;39:1633–9.
Rocca WA , Hofman A , Brayne C , et al. Frequency and distribution of Alzheimer's disease in Europe: a collaborative study of 1980–1990 prevalence findings. The EURODEM-Prevalence Research Group. Ann Neurol. 1991;30:381–90.
Zandi PP , Carlson MC , Plassman BL , et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA. 2002;288:2123–9.
Hogervorst E , Williams J , Combrinck M , David Smith A . Measuring serum oestradiol in women with Alzheimer's disease: the importance of the sensitivity of the assay method. Eur J Endocrinol. 2003;148:67–72.
Tsolaki M , Grammaticos P , Karanasou C , et al. Serum estradiol, progesterone, testosterone, FSH and LH levels in postmenopausal women with Alzheimer's dementia. Hell J Nucl Med. 2005;8:39–42.
Short RA , Bowen RL , O'Brien PC , Graff-Radford NR . Elevated gonadotropin levels in patients with Alzheimer disease. Mayo Clin Proc. 2001;76:906–9.
Neaves WB , Johnson L , Porter JC , Parker CR, Jr. , Petty CS . Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men. J Clin Endocrinol Metab. 1984;59:756–63.
Schupf N , Kapell D , Nightingale B , et al. Earlier onset of Alzheimer's disease in men with Down syndrome. Neurology. 1998;50:991–5.
Yang EJ , Nasipak BT , Kelley DB . Direct action of gonadotropin in brain integrates behavioral and reproductive functions. Proc Natl Acad Sci USA. 2007;104:2477–82.
Mak GK , Enwere EK , Gregg C , et al. Male pheromone-stimulated neurogenesis in the adult female brain: possible role in mating behavior. Nat Neurosci. 2007;10:1003–11.
Lukacs H . Rat as model for studying behavior effects of hCG. Semin Reprod Med. 2001;19:111–19.
Lei ZM , Rao CV , Kornyei JL , Licht P , Hiatt ES . Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain. Endocrinology. 1993;132:2262–70.
Bowen RL , Smith MA , Harris PL , et al. Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology. J Neurosci Res. 2002;70:514–18.
Apaja PM , Harju KT , Aatsinki JT , Petaja-Repo UE , Rajaniemi HJ . Identification and structural characterization of the neuronal luteinizing hormone receptor associated with sensory systems. J Biol Chem. 2004;279:1899–906.
Ji I , Ji TH . Asp383 in the second transmembrane domain of the lutropin receptor is important for high affinity hormone binding and cAMP production. J Biol Chem. 1991;266:14953–7.
Cooke BA . Signal transduction involving cyclic AMP-dependent and cyclic AMP-independent mechanisms in the control of steroidogenesis. Mol Cell Endocrinol. 1999;151:25–35.
Seger R , Hanoch T , Rosenberg R , et al. The ERK signaling cascade inhibits gonadotropin-stimulated steroidogenesis. J Biol Chem. 2001;276:13957–64.
Webber KM , Stocco DM , Casadesus G , et al. Steroidogenic acute regulatory protein (StAR): evidence of gonadotropin-induced steroidogenesis in Alzheimer disease. Mol Neurodegener. 2006;1:14.
Liu Q , Merkler KA , Zhang X , McLean MP . Prostaglandin F2alpha suppresses rat steroidogenic acute regulatory protein expression via induction of Yin Yang 1 protein and recruitment of histone deacetylase 1 protein. Endocrinology. 2007;148:5209–19.
Bowen RL , Verdile G , Liu T . Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition. J Biol Chem. 2004;279:20539–45.
Lukacs H , Hiatt ES , Lei ZM , Rao CV . Peripheral and intracerebroventricular administration of human chorionic gonadotropin alters several hippocampus-associated behaviors in cycling female rats. Horm Behav. 1995;29:42–58.
Casadesus G , Milliken EL , Webber KM , et al. Increases in luteinizing hormone are associated with declines in cognitive performance. Mol Cell Endocrinol. 2007;269:107–11.
Casadesus G , Puig ER , Webber KM , et al. Targeting gonadotropins: an alternative option for Alzheimer disease treatment. J Biomed Biotechnol. 2006;2006(3):39508.
Bowen RL , Atwood CS , Perry G , Smith MA . Mechanisms involved in gender differences in Alzheimer's disease: the role of leuteinizing and follicle stimulating hormones. In Legato ML , ed. Principles of Gender Specific Medicine. San Diego CA: Academic Press, 2004, pp. 1234–7.
Bowen RL . Sex hormones, amyloid protein, and Alzheimer disease. JAMA. 2001;286:790–1.
Varney NR , Syrop C , Kubu CS , et al. Neuropsychologic dysfunction in women following leuprolide acetate induction of hypoestrogenism. J Assist Reprod Genet. 1993;10:53–7.
MacLennan AH , Henderson VW , Paine BJ , et al. Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study. Menopause. 2006;13:28–36.
Daniel JM , Hulst JL , Berbling JL . Estradiol replacement enhances working memory in middle-aged rats when initiated immediately after ovariectomy but not after a long-term period of ovarian hormone deprivation. Endocrinology. 2006;147:607–14.
King JC , Anthony EL , Damassa DA , Elkind-Hirsch KE . Morphological evidence that luteinizing hormone-releasing hormone neurons participate in the suppression by estradiol of pituitary luteinizing hormone secretion in ovariectomized rats. Neuroendocrinology. 1987;45:1–13.
Joshi D , Lekhtman I , Billiar RB , Miller MM . Gonadotropin hormone-releasing hormone induced luteinizing hormone responses in young and old female C57BL/6J mice. Proc Soc Exp Biol Med. 1993;204:191–4.
Weiss G , Skurnick JH , Goldsmith LT , Santoro NF , Park SJ . Menopause and hypothalamic-pituitary sensitivity to estrogen. JAMA. 2004;292:2991–6.

Reference Title: References

Reference Type: reference-list

Verdile G , Fuller S , Atwood CS , et al. The role of beta amyloid in Alzheimer's disease: still a cause of everything or the only one who got caught? Pharmacol Res. 2004;50(4):397–409.
Verdile G , Gandy SE , Martins RN . The role of presenilin and its interacting proteins in the biogenesis of Alzheimer's beta amyloid. Neurochem Res. 2007;32(4/5):609–23.
Zhou S , Zhou H , Walian PJ , Jap BK . Regulation of gamma-secretase activity in Alzheimer's disease. Biochemistry. 2007;46(10):2553–63.
Cappai R , Barnham KJ . Delineating the mechanism of Alzheimer's disease abeta peptide neurotoxicity. Neurochem Res. 2008;33(3):526–32.
Walsh DM , Selkoe DJ . A beta oligomers – a decade of discovery. J Neurochem. 2007;101(5):1172–84.
McLean CA , Cherny RA , Fraser FW , et al. Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol. 1999;46(6):860–6.
Fonte J , Miklossy J , Atwood C , Martins R . The severity of cortical Alzheimer's type changes is positively correlated with increased amyloid-beta levels: resolubilization of amyloid-beta with transition metal ion chelators. J Alzheimers Dis. 2001;3(2):209–19.
Pike CJ , Rosario ER , Nguyen TV . Androgens, aging, and Alzheimer's disease. Endocrine 2006;29(2):233–41.
Bowen RL , Isley JP , Atkinson RL . An association of elevated serum gonadotropin concentrations and Alzheimer disease? J Neuroendocrinol. 2000;12(4):351–4.
Hogervorst E , Williams J , Budge M , et al. Serum total testosterone is lower in men with Alzheimer's disease. Neuro Endocrinol Lett. 2001;22(3):163–8.
Hogervorst E , Combrinck M , Smith AD . Testosterone and gonadotropin levels in men with dementia. Neuro Endocrinol Lett. 2003;24(3/4):203–8.
Hogervorst E , Bandelow S , Combrinck M , Smith AD . Low free testosterone is an independent risk factor for Alzheimer's disease. Exp Gerontol. 2004;39(11/12):1633–9.
Rosario ER , Chang L , Stanczyk FZ , Pike CJ . Age-related testosterone depletion and the development of Alzheimer disease. JAMA. 2004;292(12):1431–2.
Moffat SD , Zonderman AB , Metter EJ , et al. Free testosterone and risk for Alzheimer disease in older men. Neurology. 2004;62(2):188–93.
Burkhardt MS , Foster JK , Clarnette RM , et al. Interaction between testosterone and apolipoprotein E epsilon4 status on cognition in healthy older men. J Clin Endocrinol Metab. 2006;91(3):1168–72.
Ahlbom E , Prins GS , Ceccatelli S . Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism. Brain Res. 2001;892(2):255–62.
Behl C , Skutella T , Lezoualch F , et al. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol. 1997;51(4):535–41.
Azcoitia I , Sierra A , Veiga S , et al. Brain aromatase is neuroprotective. J Neurobiol. 2001;47(4):318–29.
Atroshi F , Paulin L , Paalanen T , Westermarck T . Glutathione level in mice brain after testosterone administration. Adv Exp Med Biol. 1990;264:199–202.
Garcia-Estrada J , Luquin S , Fernandez AM , Garcia-Segura LM . Dehydroepiandrosterone, pregnenolone and sex steroids down-regulate reactive astroglia in the male rat brain after a penetrating brain injury. Int J Dev Neurosci. 1999;17(2):145–51.
Gouras GK , Xu H , Gross RS , et al. Testosterone reduces neuronal secretion of Alzheimer's beta-amyloid peptides. Proc Natl Acad Sci USA. 2000;97(3):1202–5.
Goodenough S , Engert S , Behl C . Testosterone stimulates rapid secretory amyloid precursor protein release from rat hypothalamic cells via the activation of the mitogen-activated protein kinase pathway. Neurosci Lett. 2000;296(1):49–52.
Desdouits-Magnen J , Desdouits F , Takeda S , et al. Regulation of secretion of Alzheimer amyloid precursor protein by the mitogen-activated protein kinase cascade. J Neurochem. 1998;70(2):524–30.
Nguyen TV , Yao M , Pike CJ . Androgens activate mitogen-activated protein kinase signaling: role in neuroprotection. J Neurochem. 2005;94(6):1639–51.
Bi R , Broutman G , Foy MR , Thompson RF , Baudry M . The tyrosine kinase and mitogen-activated protein kinase pathways mediate multiple effects of estrogen in hippocampus. Proc Natl Acad Sci USA. 2000;97(7):3602–7.
Manthey D , Heck S , Engert S , Behl C . Estrogen induces a rapid secretion of amyloid beta precursor protein via the mitogen-activated protein kinase pathway. Eur J Biochem. 2001;268(15):4285–91.
Ramsden M , Nyborg AC , Murphy MP , et al. Androgens modulate beta-amyloid levels in male rat brain. J Neurochem. 2003;87(4):1052–5.
Gandy S , Almeida OP , Fonte J , et al. Chemical andropause and amyloid-beta peptide. JAMA. 2001;285(17):2195–6.
Gillett MJ , Martins RN , Clarnette RM , et al. Relationship between testosterone, sex hormone binding globulin and plasma amyloid beta peptide 40 in older men with subjective memory loss or dementia. J Alzheimers Dis. 2003;5(4):267–9.
Almeida OP , Waterreus A , Spry N , Flicker L , Martins RN . One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men. Psychoneuroendocrinology. 2004;29(8):1071–81.
Rosario ER , Carroll JC , Oddo S , LaFerla FM , Pike CJ . Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer's disease. J Neurosci. 2006;26(51):13384–9.
Hobbs CJ , Jones RE , Plymate SR . The effects of sex hormone binding globulin (SHBG) on testosterone transport into the cerebrospinal fluid. J Steroid Biochem Mol Biol. 1992;42(6):629–35.
Dubey AK , Herbert J , Abbott DH , Martensz ND . Serum and CSF concentrations of testosterone and LH related to negative feedback in male rhesus monkeys. Neuroendocrinology. 1984;39(2):176–85.
Moffat SD . Does testosterone mediate cognitive decline in elderly men? J Gerontol A Biol Sci Med Sci. 2006;61(5):521.
Yaffe K , Haan M , Byers A , Tangen C , Kuller L . Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction. Neurology. 2000;54(10):1949–54.
Burkhardt MS , Foster JK , Laws SM , et al. Oestrogen replacement therapy may improve memory functioning in the absence of APOE epsilon4. J Alzheimers Dis. 2004;6(3):221–8.
Raber J , Bongers G , LeFevour A , Buttini M , Mucke L . Androgens protect against apolipoprotein E4-induced cognitive deficits. J Neurosci. 2002;22(12):5204–9.
Johnson MEBJ . Essential Reproduction. London: Blackwell Science, 2000.
Short RA , Bowen RL , O'Brien PC , Graff-Radford NR . Elevated gonadotropin levels in patients with Alzheimer disease. Mayo Clin Proc. 2001;76(9):906–9.
Bowen RL , Smith MA , Harris PL , et al. Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology. J Neurosci Res. 2002;70(3):514–18.
Bowen RL , Verdile G , Liu T , et al. Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition. J Biol Chem. 2004;279(19): 20539–45.
Wilson AC , Salamat MS , Haasl RJ , et al. Human neurons express type I GnRH receptor and respond to GnRH I by increasing luteinizing hormone expression. J Endocrinol. 2006;191(3):651–63.
Lei ZM , Rao CV . Neural actions of luteinizing hormone and human chorionic gonadotropin. Semin Reprod Med. 2001;19(1):103–9.
Wood JR , Strauss JF, 3rd . Multiple signal transduction pathways regulate ovarian steroidogenesis. Rev Endocr Metab Disord. 2002;3(1):33–46.
Webber KM , Stocco DM , Casadesus G , et al. Steroidogenic acute regulatory protein (StAR): evidence of gonadotropin-induced steroidogenesis in Alzheimer disease. Mol Neurodegener. 2006;1:14.
Marambaud P , Chevallier N , Ancolio K , Checler F . Post-transcriptional contribution of a cAMP-dependent pathway to the formation of alpha- and beta/gamma-secretases-derived products of beta APP maturation in human cells expressing wild-type and Swedish mutated beta APP. Mol Med. 1998;4(11):715–23.
Su Y , Ryder J , Ni B . Inhibition of Abeta production and APP maturation by a specific PKA inhibitor. FEBS Lett. 2003;546(2/3):407–10.
Bagshawe KD , Orr AH , Rushworth AG . Relationship between concentrations of human chorionic gonadotrophin in plasma and cerebrospinal fluid. Nature. 1968;217(5132):950–1.
Lukacs H , Hiatt ES , Lei ZM , Rao CV . Peripheral and intracerebroventricular administration of human chorionic gonadotropin alters several hippocampus-associated behaviors in cycling female rats. Horm Behav. 1995;29(1):42–58.
Casadesus G , Webber KM , Atwood CS , et al. Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice. Biochim Biophys Acta. 2006;1762(4): 447–52.

Reference Title: Reference

Reference Type: reference-list

Utian WH , Archer DF , Bachmann GA , et al. Estrogen and progestogen use in postmenopausal women: July 2008 position statement of the North American Menopause Society. Menopause. 2008;15:584–602.

Reference Title: Reference

Reference Type: reference-list

Craft S . Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment. Curr Alzheimer Res. 2007;4(2):147–52.